1	IMMUNOSUPPRESSION	NN	O	immunosuppression	_	0	SENT_1	[p1l739t122r1421b187],

1	Sulﬁnpyrazone	NNP	O	Sulﬁnpyrazone	_	0	SENT_2	[p1l283t288r906b388],
2	Reduces	VBZ	O	reduce	dep	1	SENT_2	[p1l944t288r1297b365],
3	Cyclosporine	NN	O	cyclosporine	nn	4	SENT_2	[p1l283t401r839b500],
4	Levels	NNS	O	level	dobj	2	SENT_2	[p1l877t401r1156b478],
5	:	:	O	:	_	0	SENT_2	[p1l877t401r1156b478],
6	A	DT	O	a	det	9	SENT_2	[p1l1195t404r1260b476],
7	New	NNP	O	New	nn	9	SENT_2	[p1l1294t405r1495b478],
8	Drug	NNP	O	Drug	nn	9	SENT_2	[p1l281t517r491b610],
9	Interaction	NN	O	interaction	dep	1	SENT_2	[p1l527t517r994b589],
10	in	IN	O	in	_	0	SENT_2	[p1l1029t517r1110b588],
11	Heart	NNP	O	Heart	nn	13	SENT_2	[p1l1145t517r1376b589],
12	Transplant	NNP	O	Transplant	nn	13	SENT_2	[p1l279t625r732b725],
13	Recipients	NNS	O	recipient	prep_in	9	SENT_2	[p1l767t629r1209b725],

1	A.	NN	PERSON	a.	_	0	SENT_3	[p1l279t770r319b800],
2	L.	NNP	PERSON	L.	nn	4	SENT_3	[p1l336t771r370b800],
3	P.	NNP	PERSON	P.	nn	4	SENT_3	[p1l387t771r420b800],
4	Caforio	NNP	PERSON	Caforio	dep	1	SENT_3	[p1l438t770r581b807],
5	,	,	O	,	_	0	SENT_3	[p1l438t770r581b807],
6	MD	NNP	O	MD	appos	4	SENT_3	[p1l598t771r679b807],
7	,	,	O	,	_	0	SENT_3	[p1l598t771r679b807],
8	PhD	NNP	O	PhD	appos	4	SENT_3	[p1l695t770r800b807],
9	,	,	O	,	_	0	SENT_3	[p1l695t770r800b807],
10	“	NNP	O	“	nn	12	SENT_3	[p1l695t770r800b807],
11	A.	NNP	PERSON	A.	nn	12	SENT_3	[p1l814t770r855b800],
12	Gambino	NNP	PERSON	Gambino	appos	4	SENT_3	[p1l873t770r1047b807],
13	,	,	O	,	_	0	SENT_3	[p1l873t770r1047b807],
14	MD	NNP	O	MD	appos	4	SENT_3	[p1l1064t768r1161b807],
15	,	,	O	,	_	0	SENT_3	[p1l1064t768r1161b807],
16	"	``	O	"	punct	18	SENT_3	[p1l1064t768r1161b807],
17	F.	NNP	PERSON	F.	nn	18	SENT_3	[p1l1177t771r1210b800],
18	Tona	NNP	PERSON	Tona	appos	4	SENT_3	[p1l1226t771r1328b807],
19	,	,	O	,	_	0	SENT_3	[p1l1226t771r1328b807],
20	MD	NNP	O	MD	appos	4	SENT_3	[p1l1345t771r1441b807],
21	,	,	O	,	_	0	SENT_3	[p1l1345t771r1441b807],
22	“	CD	NUMBER	“	num	24	SENT_3	[p1l1345t771r1441b807],
23	G.	NNP	PERSON	G.	nn	24	SENT_3	[p1l281t819r321b850],
24	Feltrin	NNP	PERSON	Feltrin	appos	4	SENT_3	[p1l338t819r467b856],
25	,	,	O	,	_	0	SENT_3	[p1l338t819r467b856],
26	MD	NNP	O	MD	appos	4	SENT_3	[p1l484t817r581b856],
27	,	,	O	,	_	0	SENT_3	[p1l484t817r581b856],
28	b	NN	O	b	nn	30	SENT_3	[p1l484t817r581b856],
29	F.	NNP	PERSON	F.	nn	30	SENT_3	[p1l597t820r630b849],
30	Marchini	NNP	PERSON	Marchini	appos	4	SENT_3	[p1l647t819r817b856],
31	,	,	O	,	_	0	SENT_3	[p1l647t819r817b856],
32	MD	NNP	O	MD	appos	4	SENT_3	[p1l834t820r929b856],
33	,	,	O	,	_	0	SENT_3	[p1l834t820r929b856],
34	“	NNP	O	“	nn	36	SENT_3	[p1l834t820r929b856],
35	E.	NNP	PERSON	E.	nn	36	SENT_3	[p1l944t820r981b849],
36	Pompei	NNP	PERSON	Pompei	appos	4	SENT_3	[p1l998t819r1142b859],
37	,	,	O	,	_	0	SENT_3	[p1l998t819r1142b859],
38	MD	NNP	O	MD	appos	36	SENT_3	[p1l1159t817r1256b856],
39	,	,	O	,	_	0	SENT_3	[p1l1159t817r1256b856],
40	"	``	O	"	punct	42	SENT_3	[p1l1159t817r1256b856],
41	L.	FW	PERSON	l.	nn	42	SENT_3	[p1l1272t820r1306b849],
42	Testolin	FW	PERSON	testolin	appos	4	SENT_3	[p1l1322t819r1476b856],
43	,	,	O	,	_	0	SENT_3	[p1l1322t819r1476b856],
44	MD	NN	O	md	appos	42	SENT_3	[p1l1493t817r1590b856],
45	,	,	O	,	_	0	SENT_3	[p1l1493t817r1590b856],
46	b	NN	O	b	nn	48	SENT_3	[p1l1493t817r1590b856],
47	A.	NN	PERSON	a.	nn	48	SENT_3	[p1l279t868r319b899],
48	Angelini	NNP	PERSON	Angelini	conj_and	44	SENT_3	[p1l335t868r497b908],
49	,	,	O	,	_	0	SENT_3	[p1l335t868r497b908],
50	MD	NNP	O	MD	conj_and	44	SENT_3	[p1l514t866r611b905],
51	,	,	O	,	_	0	SENT_3	[p1l514t866r611b905],
52	“	NNP	O	“	nn	55	SENT_3	[p1l514t866r611b905],
53	S.	NNP	LOCATION	S.	nn	55	SENT_3	[p1l628t868r657b899],
54	Dalla	NNP	LOCATION	Dalla	nn	55	SENT_3	[p1l674t868r770b899],
55	Volta	NNP	LOCATION	Volta	conj_and	44	SENT_3	[p1l785t868r893b905],
56	,	,	O	,	_	0	SENT_3	[p1l785t868r893b905],
57	MD	NNP	O	MD	conj_and	44	SENT_3	[p1l910t869r1006b905],
58	,	,	O	,	_	0	SENT_3	[p1l910t869r1006b905],
59	“	NN	O	“	conj_and	44	SENT_3	[p1l910t869r1006b905],
60	and	CC	O	and	_	0	SENT_3	[p1l1022t868r1086b899],
61	D.	NNP	PERSON	D.	nn	62	SENT_3	[p1l1101t869r1142b899],
62	Casarotto	NNP	PERSON	Casarotto	appos	42	SENT_3	[p1l1160t868r1342b905],
63	,	,	O	,	_	0	SENT_3	[p1l1160t868r1342b905],
64	MD	NNP	O	MD	appos	42	SENT_3	[p1l1359t866r1446b898],
65	"	''	O	"	punct	42	SENT_3	[p1l1359t866r1446b898],

1	Background	NN	O	background	_	0	SENT_4	[p1l280t985r507b1023],
2	:	:	O	:	_	0	SENT_4	[p1l280t985r507b1023],
3	Management	NN	O	management	dep	1	SENT_4	[p1l531t985r765b1024],
4	of	IN	O	of	_	0	SENT_4	[p1l780t984r817b1015],
5	cyclosporine	NN	O	cyclosporine	nn	8	SENT_4	[p1l830t984r1050b1024],
6	(	CD	NUMBER	(	num	8	SENT_4	[p1l1067t983r1377b1025],
7	CsA	NN	O	csa	nn	8	SENT_4	[p1l1067t983r1377b1025],
8	)	NN	O	)	prep_of	3	SENT_4	[p1l1067t983r1377b1025],
9	.	.	O	.	_	0	SENT_4	[p1l1067t983r1377b1025],

1	—	NN	O	—	_	0	SENT_5	[p1l1067t983r1377b1025],
2	.	.	O	.	_	0	SENT_5	[p1l1067t983r1377b1025],

1	associated	VBN	O	associate	dep	10	SENT_6	[p1l1067t983r1377b1025],
2	hyperuricemia	NN	O	hyperuricemia	dobj	1	SENT_6	[p1l1392t984r1647b1024],
3	in	IN	O	in	_	0	SENT_6	[p1l1662t984r1695b1014],
4	heart	NN	O	heart	nn	5	SENT_6	[p1l1710t984r1802b1015],
5	transplantation	NN	O	transplantation	prep_in	2	SENT_6	[p1l280t1034r550b1074],
6	(	CD	NUMBER	(	num	8	SENT_6	[p1l567t1033r655b1075],
7	HT	NN	O	ht	nn	8	SENT_6	[p1l567t1033r655b1075],
8	)	NN	O	)	nsubj	10	SENT_6	[p1l567t1033r655b1075],
9	is	VBZ	O	be	cop	10	SENT_6	[p1l672t1034r698b1065],
10	difﬁcult	NN	O	difﬁcult	_	0	SENT_6	[p1l714t1034r858b1065],
11	.	.	O	.	_	0	SENT_6	[p1l714t1034r858b1065],

1	Because	IN	O	because	_	0	SENT_7	[p1l875t1035r1021b1065],
2	of	IN	O	of	prepc_because_of	12	SENT_7	[p1l1037t1034r1074b1065],
3	the	DT	O	the	det	4	SENT_7	[p1l1087t1034r1142b1065],
4	myelotoxicity	NN	O	myelotoxicity	pobj	12	SENT_7	[p1l1157t1034r1393b1074],
5	of	IN	O	of	_	0	SENT_7	[p1l1407t1034r1444b1065],
6	combined	JJ	O	combined	amod	7	SENT_7	[p1l1457t1034r1631b1065],
7	allopurinol	NN	O	allopurinol	prep_of	4	SENT_7	[p1l1647t1034r1840b1074],
8	and	CC	O	and	_	0	SENT_7	[p1l281t1083r345b1114],
9	azathioprine	NN	O	azathioprine	prep_of	4	SENT_7	[p1l361t1083r591b1124],
10	,	,	O	,	_	0	SENT_7	[p1l361t1083r591b1124],
11	we	PRP	O	we	nsubj	12	SENT_7	[p1l606t1093r655b1114],
12	tested	VBD	O	test	_	0	SENT_7	[p1l671t1083r776b1114],
13	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	dobj	12	SENT_7	[p1l792t1083r1057b1124],
14	.	.	O	.	_	0	SENT_7	[p1l792t1083r1057b1124],

1	Methods	NNS	O	method	_	0	SENT_8	[p1l280t1139r446b1169],
2	:	:	O	:	_	0	SENT_8	[p1l280t1139r446b1169],
3	We	PRP	O	we	nsubj	4	SENT_8	[p1l469t1139r529b1169],
4	studied	VBD	O	study	dep	1	SENT_8	[p1l543t1138r666b1169],
5	120	CD	NUMBER	120	num	7	SENT_8	[p1l683t1138r739b1169],
6	HT	NN	O	ht	nn	7	SENT_8	[p1l753t1139r813b1168],
7	recipients	NNS	O	recipient	nsubj	8	SENT_8	[p1l826t1138r991b1178],
8	(	VBP	O	(	ccomp	4	SENT_8	[p1l1006t1137r1079b1179],
9	109	CD	NUMBER	109	num	10	SENT_8	[p1l1006t1137r1079b1179],
10	men	NNS	O	man	dobj	8	SENT_8	[p1l1093t1147r1176b1175],
11	;	:	O	;	_	0	SENT_8	[p1l1093t1147r1176b1175],
12	mean	VB	O	mean	dep	10	SENT_8	[p1l1192t1147r1286b1169],
13	age	NN	O	age	nn	20	SENT_8	[p1l1301t1147r1358b1178],
14	at	IN	O	at	_	0	SENT_8	[p1l1373t1142r1404b1169],
15	HT	NNP	O	HT	prep_at	13	SENT_8	[p1l1417t1139r1485b1175],
16	,	,	O	,	_	0	SENT_8	[p1l1417t1139r1485b1175],
17	52	CD	NUMBER	52	num	15	SENT_8	[p1l1500t1138r1539b1169],
18	:	:	O	:	_	0	SENT_8	[p1l1557t1142r1582b1167],
19	10	CD	DURATION	10	num	15	SENT_8	[p1l1602t1138r1639b1169],
20	years	NNS	NUMBER	year	tmod	12	SENT_8	[p1l1651t1137r1763b1179],
21	)	RB	O	)	advmod	12	SENT_8	[p1l1651t1137r1763b1179],
22	.	.	O	.	_	0	SENT_8	[p1l1651t1137r1763b1179],

1	All	DT	O	all	nsubj	3	SENT_9	[p1l1777t1138r1830b1168],
2	had	VBD	O	have	aux	3	SENT_9	[p1l280t1187r343b1218],
3	received	VBN	O	receive	_	0	SENT_9	[p1l357t1187r499b1218],
4	allopurinol	NN	O	allopurinol	dobj	3	SENT_9	[p1l513t1187r699b1227],
5	for	IN	O	for	_	0	SENT_9	[p1l712t1187r762b1218],
6	at	IN	DURATION	at	quantmod	8	SENT_9	[p1l776t1191r807b1218],
7	least	JJS	DURATION	least	mwe	6	SENT_9	[p1l821t1187r898b1218],
8	6	CD	DURATION	6	num	9	SENT_9	[p1l913t1188r931b1218],
9	months	NNS	NUMBER	month	prep_for	3	SENT_9	[p1l945t1187r1080b1224],
10	,	,	O	,	_	0	SENT_9	[p1l945t1187r1080b1224],
11	which	WDT	O	which	nsubjpass	13	SENT_9	[p1l1093t1187r1194b1218],
12	was	VBD	O	be	auxpass	13	SENT_9	[p1l1206t1197r1269b1218],
13	stopped	VBN	O	stop	rcmod	9	SENT_9	[p1l1283t1187r1418b1227],
14	for	IN	O	for	_	0	SENT_9	[p1l1431t1187r1481b1218],
15	1	CD	DURATION	1	prep_for	13	SENT_9	[p1l1497t1188r1511b1217],
16	month	NN	NUMBER	month	tmod	13	SENT_9	[p1l1527t1187r1639b1218],
17	before	IN	O	before	_	0	SENT_9	[p1l1651t1187r1762b1218],
18	initiation	NN	O	initiation	prep_before	13	SENT_9	[p1l280t1237r433b1268],
19	of	IN	O	of	_	0	SENT_9	[p1l447t1237r483b1268],
20	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_of	18	SENT_9	[p1l495t1236r750b1277],
21	.	.	O	.	_	0	SENT_9	[p1l495t1236r750b1277],

1	Mean	NN	O	mean	nn	2	SENT_10	[p1l766t1238r865b1268],
2	follow-up	NN	O	follow-up	_	0	SENT_10	[p1l878t1237r1039b1277],
3	from	IN	O	from	_	0	SENT_10	[p1l1053t1237r1136b1268],
4	HT	NNP	O	HT	prep_from	2	SENT_10	[p1l1150t1238r1210b1267],
5	to	TO	O	to	_	0	SENT_10	[p1l1223t1241r1256b1268],
6	onset	NN	O	onset	prep_to	2	SENT_10	[p1l1271t1241r1362b1268],
7	of	IN	O	of	_	0	SENT_10	[p1l1376t1237r1412b1268],
8	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	9	SENT_10	[p1l1424t1236r1670b1277],
9	(	NN	O	(	prep_of	6	SENT_10	[p1l1686t1236r1758b1278],
10	200	CD	NUMBER	200	num	11	SENT_10	[p1l1686t1236r1758b1278],
11	mg	NN	O	mg	dep	9	SENT_10	[p1l1772t1237r1836b1277],
12	/	:	O	/	punct	2	SENT_10	[p1l1772t1237r1836b1277],
13	day	NN	DURATION	day	nsubj	16	SENT_10	[p1l281t1286r352b1328],
14	)	CD	NUMBER	)	num	13	SENT_10	[p1l281t1286r352b1328],
15	was	VBD	O	be	cop	16	SENT_10	[p1l366t1296r429b1318],
16	59	CD	NUMBER	59	dep	2	SENT_10	[p1l443t1287r482b1318],
17	:	:	O	:	_	0	SENT_10	[p1l500t1291r525b1316],
18	41	CD	DURATION	41	num	19	SENT_10	[p1l543t1287r580b1317],
19	months	NNS	NUMBER	month	dep	16	SENT_10	[p1l596t1287r731b1318],
20	.	.	O	.	_	0	SENT_10	[p1l596t1287r731b1318],

1	We	PRP	O	we	nsubj	2	SENT_11	[p1l745t1288r805b1318],
2	stopped	VBD	O	stop	_	0	SENT_11	[p1l820t1287r954b1327],
3	the	DT	O	the	det	4	SENT_11	[p1l968t1287r1021b1318],
4	drug	NN	O	drug	dobj	2	SENT_11	[p1l1036t1287r1113b1327],
5	after	IN	O	after	_	0	SENT_11	[p1l1128t1287r1207b1318],
6	6	CD	NUMBER	6	prep_after	4	SENT_11	[p1l1221t1287r1239b1318],
7	:	:	O	:	_	0	SENT_11	[p1l1257t1291r1283b1316],
8	2	CD	DURATION	2	num	9	SENT_11	[p1l1301t1287r1320b1317],
9	months	NNS	NUMBER	month	dep	4	SENT_11	[p1l1333t1287r1468b1318],
10	.	.	O	.	_	0	SENT_11	[p1l1333t1287r1468b1318],

1	We	PRP	O	we	nsubj	2	SENT_12	[p1l1483t1288r1542b1318],
2	compared	VBD	O	compare	_	0	SENT_12	[p1l1557t1287r1727b1327],
3	CsA	NN	O	csa	nn	4	SENT_12	[p1l1742t1287r1817b1318],
4	level	NN	O	level	dobj	2	SENT_12	[p1l280t1336r358b1367],
5	and	CC	O	and	_	0	SENT_12	[p1l373t1336r435b1367],
6	daily	JJ	SET	daily	amod	7	SENT_12	[p1l449t1336r529b1376],
7	dose	NN	O	dose	dobj	2	SENT_12	[p1l543t1336r629b1373],
8	,	,	O	,	_	0	SENT_12	[p1l543t1336r629b1373],
9	serum	NN	O	serum	nn	10	SENT_12	[p1l644t1346r749b1367],
10	creatinine	NN	O	creatinine	conj_and	4	SENT_12	[p1l762t1336r940b1373],
11	,	,	O	,	_	0	SENT_12	[p1l762t1336r940b1373],
12	blood	NN	O	blood	nn	13	SENT_12	[p1l954t1336r1052b1367],
13	urea	NN	O	urea	conj_and	4	SENT_12	[p1l1065t1346r1150b1373],
14	,	,	O	,	_	0	SENT_12	[p1l1065t1346r1150b1373],
15	and	CC	O	and	_	0	SENT_12	[p1l1166t1336r1228b1367],
16	uric	JJ	O	uric	amod	17	SENT_12	[p1l1241t1336r1307b1367],
17	acid	NN	O	acid	conj_and	4	SENT_12	[p1l1321t1336r1389b1367],
18	at	IN	O	at	_	0	SENT_12	[p1l1404t1341r1435b1367],
19	onset	NN	O	onset	prep_at	17	SENT_12	[p1l1449t1340r1539b1367],
20	and	CC	O	and	_	0	SENT_12	[p1l1554t1336r1616b1367],
21	before	IN	O	before	_	0	SENT_12	[p1l1629t1336r1739b1367],
22	interruption	NN	O	interruption	prep_before	17	SENT_12	[p1l280t1385r486b1425],
23	of	IN	O	of	_	0	SENT_12	[p1l500t1385r537b1416],
24	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_of	22	SENT_12	[p1l548t1385r795b1425],
25	and	CC	O	and	_	0	SENT_12	[p1l810t1385r880b1422],
26	,	,	O	,	_	0	SENT_12	[p1l810t1385r880b1422],
27	as	IN	O	as	conj_and	4	SENT_12	[p1l896t1395r929b1416],
28	control	NN	O	control	pobj	27	SENT_12	[p1l943t1385r1072b1422],
29	,	,	O	,	_	0	SENT_12	[p1l943t1385r1072b1422],
30	in	IN	O	in	_	0	SENT_12	[p1l1087t1385r1119b1415],
31	the	DT	DURATION	the	det	34	SENT_12	[p1l1133t1385r1187b1416],
32	last	JJ	DURATION	last	amod	34	SENT_12	[p1l1201t1385r1258b1416],
33	6	CD	DURATION	6	num	34	SENT_12	[p1l1273t1386r1291b1416],
34	months	NNS	NUMBER	month	prep_in	27	SENT_12	[p1l1305t1385r1431b1416],
35	of	IN	O	of	_	0	SENT_12	[p1l1446t1385r1482b1416],
36	allopurinol	NN	O	allopurinol	prep_of	27	SENT_12	[p1l1494t1385r1687b1425],
37	.	.	O	.	_	0	SENT_12	[p1l1494t1385r1687b1425],

1	Results	NNS	O	result	_	0	SENT_13	[p1l280t1442r422b1471],
2	:	:	O	:	_	0	SENT_13	[p1l280t1442r422b1471],
3	Mean	NN	O	mean	nn	4	SENT_13	[p1l446t1441r545b1471],
4	uricemia	NN	O	uricemia	dep	1	SENT_13	[p1l559t1440r707b1471],
5	decreased	VBD	O	decrease	rcmod	4	SENT_13	[p1l722t1440r891b1471],
6	with	IN	O	with	_	0	SENT_13	[p1l903t1440r977b1471],
7	allopurinol	NN	O	allopurinol	prep_with	5	SENT_13	[p1l992t1440r1177b1481],
8	(	CD	NUMBER	(	number	9	SENT_13	[p1l1192t1439r1274b1481],
9	0.58	CD	NUMBER	0.58	dep	7	SENT_13	[p1l1192t1439r1274b1481],
10	:	:	O	:	_	0	SENT_13	[p1l1292t1444r1318b1469],
11	0.12	CD	NUMBER	0.12	dep	7	SENT_13	[p1l1336t1440r1405b1471],
12	vs	CC	O	vs	_	0	SENT_13	[p1l1416t1450r1450b1471],
13	0.41	CD	NUMBER	0.41	conj_vs	11	SENT_13	[p1l1464t1440r1531b1471],
14	:	:	O	:	_	0	SENT_13	[p1l1551t1444r1576b1469],
15	0.07	CD	NUMBER	0.07	num	16	SENT_13	[p1l1594t1440r1663b1471],
16	mmol/liter	NN	O	mmol/liter	dep	7	SENT_13	[p1l1677t1440r1863b1478],
17	,	,	O	,	_	0	SENT_13	[p1l1677t1440r1863b1478],
18	p	NN	O	p	appos	7	SENT_13	[p1l273t1500r299b1529],
19	=	JJ	O	=	amod	21	SENT_13	[p1l317t1501r343b1511],
20	0.0001	CD	NUMBER	0.0001	tmod	19	SENT_13	[p1l361t1489r483b1530],
21	)	NN	O	)	dep	18	SENT_13	[p1l361t1489r483b1530],
22	as	RB	O	as	_	0	SENT_13	[p1l499t1499r532b1520],
23	well	RB	O	well	_	0	SENT_13	[p1l544t1489r614b1520],
24	as	IN	O	as	_	0	SENT_13	[p1l628t1499r661b1520],
25	with	IN	O	with	_	0	SENT_13	[p1l673t1489r747b1520],
26	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	5	SENT_13	[p1l762t1489r1008b1530],
27	(	CD	NUMBER	(	num	28	SENT_13	[p1l1024t1489r1104b1530],
28	0.51	CD	NUMBER	0.51	dobj	5	SENT_13	[p1l1024t1489r1104b1530],
29	:	:	O	:	_	0	SENT_13	[p1l1124t1493r1149b1519],
30	0.13	CD	NUMBER	0.13	dep	1	SENT_13	[p1l1167t1490r1234b1520],
31	vs	CC	O	vs	_	0	SENT_13	[p1l1248t1499r1282b1520],
32	0.40	CD	NUMBER	0.40	dep	1	SENT_13	[p1l1296t1490r1365b1520],
33	i	FW	O	i	nn	35	SENT_13	[p1l1383t1494r1408b1519],
34	0.12	CD	NUMBER	0.12	dep	33	SENT_13	[p1l1426t1490r1495b1520],
35	mmol/liter	NN	O	mmol/liter	dep	32	SENT_13	[p1l1508t1489r1694b1527],
36	,	,	O	,	_	0	SENT_13	[p1l1508t1489r1694b1527],
37	p	NN	O	p	appos	1	SENT_13	[p1l1703t1500r1728b1529],
38	=	JJ	O	=	amod	40	SENT_13	[p1l1747t1501r1772b1511],
39	0.0001	CD	NUMBER	0.0001	tmod	38	SENT_13	[p1l280t1538r412b1580],
40	)	NN	O	)	dep	37	SENT_13	[p1l280t1538r412b1580],
41	.	.	O	.	_	0	SENT_13	[p1l280t1538r412b1580],

1	Mean	NN	O	mean	nn	2	SENT_14	[p1l428t1540r527b1570],
2	creatinine	NN	O	creatinine	_	0	SENT_14	[p1l541t1539r710b1570],
3	increased	VBD	O	increase	rcmod	2	SENT_14	[p1l724t1539r885b1570],
4	(	CD	NUMBER	(	number	5	SENT_14	[p1l900t1538r971b1580],
5	171	CD	NUMBER	171	nn	17	SENT_14	[p1l900t1538r971b1580],
6	:	:	O	:	_	0	SENT_14	[p1l991t1543r1016b1568],
7	42	CD	NUMBER	42	dep	5	SENT_14	[p1l1034t1539r1073b1570],
8	and	CC	O	and	_	0	SENT_14	[p1l1088t1539r1150b1570],
9	164	CD	NUMBER	164	conj_and	7	SENT_14	[p1l1166t1539r1223b1570],
10	:	:	O	:	_	0	SENT_14	[p1l1241t1543r1266b1568],
11	35	CD	NUMBER	35	num	12	SENT_14	[p1l1284t1539r1322b1570],
12	umol/liter	NN	O	umol/liter	dep	7	SENT_14	[p1l1339t1539r1516b1578],
13	,	,	O	,	_	0	SENT_14	[p1l1339t1539r1516b1578],
14	p	NN	O	p	appos	12	SENT_14	[p1l1525t1549r1550b1579],
15	=	JJ	O	=	amod	17	SENT_14	[p1l1569t1551r1594b1561],
16	0.01	CD	NUMBER	0.01	tmod	15	SENT_14	[p1l1612t1538r1694b1580],
17	)	NN	O	)	dobj	3	SENT_14	[p1l1612t1538r1694b1580],
18	with	IN	O	with	_	0	SENT_14	[p1l1708t1539r1782b1570],
19	allopurinol	NN	O	allopurinol	prep_with	3	SENT_14	[p1l281t1588r475b1629],
20	,	,	O	,	_	0	SENT_14	[p1l281t1588r475b1629],
21	whereas	IN	O	whereas	mark	23	SENT_14	[p1l488t1588r628b1619],
22	it	PRP	O	it	nsubj	23	SENT_14	[p1l642t1588r664b1619],
23	tended	VBD	O	tend	advcl	3	SENT_14	[p1l678t1588r796b1619],
24	to	TO	O	to	aux	25	SENT_14	[p1l810t1593r843b1619],
25	decrease	VB	O	decrease	xcomp	23	SENT_14	[p1l858t1588r1005b1619],
26	with	IN	O	with	_	0	SENT_14	[p1l1017t1588r1091b1619],
27	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	25	SENT_14	[p1l1105t1588r1351b1629],
28	(	NN	O	(	dep	2	SENT_14	[p1l1367t1588r1440b1629],
29	160	CD	NUMBER	160	num	28	SENT_14	[p1l1367t1588r1440b1629],
30	:	:	O	:	_	0	SENT_14	[p1l1458t1593r1483b1618],
31	35	CD	NUMBER	35	dep	28	SENT_14	[p1l1501t1589r1539b1619],
32	and	CC	O	and	_	0	SENT_14	[p1l1555t1589r1617b1619],
33	154	CD	NUMBER	154	dep	28	SENT_14	[p1l1633t1589r1690b1619],
34	:	:	O	:	_	0	SENT_14	[p1l1708t1593r1733b1618],
35	48	CD	NUMBER	48	num	36	SENT_14	[p1l1751t1589r1790b1619],
36	ptmol/1iter	NN	O	ptmol/1iter	dep	31	SENT_14	[p1l283t1638r493b1678],
37	,	,	O	,	_	0	SENT_14	[p1l283t1638r493b1678],
38	p	NN	O	p	appos	31	SENT_14	[p1l283t1638r493b1678],
39	=	JJ	O	=	amod	41	SENT_14	[p1l512t1650r537b1660],
40	NS	NN	O	n	nn	41	SENT_14	[p1l555t1637r631b1679],
41	)	NN	O	)	dep	38	SENT_14	[p1l555t1637r631b1679],
42	.	.	O	.	_	0	SENT_14	[p1l555t1637r631b1679],

1	Mean	NN	O	mean	nn	2	SENT_15	[p1l646t1639r746b1669],
2	urea	NN	O	urea	nsubj	26	SENT_15	[p1l759t1648r836b1669],
3	did	VBD	O	do	aux	5	SENT_15	[p1l850t1638r903b1669],
4	not	RB	O	not	neg	5	SENT_15	[p1l917t1642r973b1669],
5	change	VB	O	change	_	0	SENT_15	[p1l987t1638r1106b1678],
6	with	IN	O	with	_	0	SENT_15	[p1l1118t1638r1192b1669],
7	allopurinol	NN	O	allopurinol	prep_with	5	SENT_15	[p1l1207t1638r1392b1679],
8	(	CD	NUMBER	(	number	9	SENT_15	[p1l1408t1637r1460b1679],
9	14	CD	NUMBER	14	dobj	5	SENT_15	[p1l1408t1637r1460b1679],
10	:	:	O	:	_	0	SENT_15	[p1l1478t1642r1503b1667],
11	5	CD	NUMBER	5	dep	9	SENT_15	[p1l1521t1638r1539b1669],
12	vs	CC	O	vs	_	0	SENT_15	[p1l1553t1648r1586b1669],
13	15	CD	NUMBER	15	dep	9	SENT_15	[p1l1603t1638r1638b1669],
14	:	:	O	:	_	0	SENT_15	[p1l1658t1642r1683b1667],
15	7	CD	NUMBER	7	num	16	SENT_15	[p1l1701t1639r1720b1669],
16	mmol	NN	O	mmol	dep	9	SENT_15	[p1l1733t1638r1844b1673],
17	/	:	O	/	punct	18	SENT_15	[p1l1733t1638r1844b1673],
18	liter	NN	O	liter	dep	16	SENT_15	[p1l280t1688r357b1726],
19	,	,	O	,	_	0	SENT_15	[p1l280t1688r357b1726],
20	p	NN	O	p	appos	18	SENT_15	[p1l365t1699r390b1728],
21	=	JJ	O	=	amod	23	SENT_15	[p1l409t1700r434b1710],
22	NS	NN	O	n	nn	23	SENT_15	[p1l452t1687r528b1729],
23	)	NN	O	)	dep	16	SENT_15	[p1l452t1687r528b1729],
24	,	,	O	,	_	0	SENT_15	[p1l452t1687r528b1729],
25	but	CC	O	but	_	0	SENT_15	[p1l542t1688r598b1719],
26	fell	VBD	O	fall	conj_but	5	SENT_15	[p1l612t1688r665b1719],
27	with	IN	O	with	_	0	SENT_15	[p1l677t1688r751b1719],
28	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	30	SENT_15	[p1l765t1688r1011b1729],
29	(	CD	NUMBER	(	number	30	SENT_15	[p1l1027t1687r1127b1729],
30	14.01	CD	NUMBER	14.01	nn	42	SENT_15	[p1l1027t1687r1127b1729],
31	:	:	O	:	_	0	SENT_15	[p1l1148t1692r1173b1717],
32	5	CD	NUMBER	5	dep	30	SENT_15	[p1l1190t1688r1208b1719],
33	vs	CC	O	vs	_	0	SENT_15	[p1l1222t1698r1256b1719],
34	12.60	CD	NUMBER	12.60	conj_vs	32	SENT_15	[p1l1272t1688r1359b1719],
35	:	:	O	:	_	0	SENT_15	[p1l1377t1692r1402b1717],
36	5	CD	NUMBER	5	num	37	SENT_15	[p1l1419t1688r1437b1719],
37	mmol/liter	NN	O	mmol/liter	dep	30	SENT_15	[p1l1452t1688r1639b1726],
38	,	,	O	,	_	0	SENT_15	[p1l1452t1688r1639b1726],
39	p	NN	O	p	appos	37	SENT_15	[p1l1647t1699r1672b1728],
40	=	JJ	O	=	amod	42	SENT_15	[p1l1691t1700r1716b1710],
41	0.0004	CD	NUMBER	0.0004	tmod	40	SENT_15	[p1l1734t1687r1866b1729],
42	)	NN	O	)	dobj	26	SENT_15	[p1l1734t1687r1866b1729],
43	.	.	O	.	_	0	SENT_15	[p1l1734t1687r1866b1729],

1	Mean	NN	O	mean	nn	3	SENT_16	[p1l280t1739r379b1769],
2	CsA	NN	O	csa	nn	3	SENT_16	[p1l394t1738r469b1769],
3	levels	NNS	O	level	nsubj	5	SENT_16	[p1l481t1738r574b1769],
4	were	VBD	O	be	cop	5	SENT_16	[p1l586t1748r669b1769],
5	constant	JJ	O	constant	_	0	SENT_16	[p1l683t1742r827b1769],
6	with	IN	O	with	_	0	SENT_16	[p1l838t1738r912b1769],
7	allopurinol	NN	O	allopurinol	nn	8	SENT_16	[p1l927t1738r1112b1779],
8	(	NN	O	(	prep_with	5	SENT_16	[p1l1128t1737r1199b1779],
9	193	CD	NUMBER	193	dep	8	SENT_16	[p1l1128t1737r1199b1779],
10	:	:	O	:	_	0	SENT_16	[p1l1218t1742r1243b1767],
11	73	CD	NUMBER	73	dep	8	SENT_16	[p1l1262t1738r1299b1769],
12	vs	CC	O	vs	_	0	SENT_16	[p1l1313t1748r1346b1769],
13	188	CD	NUMBER	188	dep	8	SENT_16	[p1l1363t1738r1419b1769],
14	:	:	O	:	_	0	SENT_16	[p1l1438t1742r1463b1767],
15	65	CD	NUMBER	65	num	16	SENT_16	[p1l1481t1738r1518b1769],
16	ng/ml	NN	O	ng/ml	dep	8	SENT_16	[p1l1534t1738r1637b1778],
17	,	,	O	,	_	0	SENT_16	[p1l1534t1738r1637b1778],
18	p	NN	O	p	appos	16	SENT_16	[p1l1645t1748r1671b1778],
19	=	JJ	O	=	amod	21	SENT_16	[p1l1690t1750r1715b1760],
20	NS	NN	O	n	nn	21	SENT_16	[p1l1732t1737r1809b1779],
21	)	NN	O	)	dep	18	SENT_16	[p1l1732t1737r1809b1779],
22	,	,	O	,	_	0	SENT_16	[p1l1732t1737r1809b1779],
23	although	IN	O	although	mark	28	SENT_16	[p1l281t1788r430b1828],
24	CsA	NN	O	csa	nn	25	SENT_16	[p1l445t1788r519b1819],
25	dose	NN	O	dose	nsubjpass	28	SENT_16	[p1l532t1788r609b1819],
26	was	VBD	O	be	auxpass	28	SENT_16	[p1l622t1798r685b1819],
27	slightly	RB	O	slightly	advmod	28	SENT_16	[p1l699t1788r818b1828],
28	reduced	VBN	O	reduce	dep	8	SENT_16	[p1l831t1788r968b1819],
29	(	NN	O	(	nn	42	SENT_16	[p1l984t1787r1046b1829],
30	2.7	CD	NUMBER	2.7	dep	29	SENT_16	[p1l984t1787r1046b1829],
31	:	:	O	:	_	0	SENT_16	[p1l1064t1792r1089b1817],
32	0.8	CD	NUMBER	0.8	dep	29	SENT_16	[p1l1107t1788r1155b1819],
33	vs	CC	O	vs	_	0	SENT_16	[p1l1168t1798r1202b1819],
34	2.6	CD	NUMBER	2.6	dep	29	SENT_16	[p1l1216t1788r1264b1819],
35	:	:	O	:	_	0	SENT_16	[p1l1282t1792r1308b1817],
36	0.8	CD	NUMBER	0.8	num	37	SENT_16	[p1l1326t1788r1374b1819],
37	mg/kg/day	NN	O	mg/kg/day	dep	29	SENT_16	[p1l1388t1788r1569b1828],
38	,	,	O	,	_	0	SENT_16	[p1l1388t1788r1569b1828],
39	p	NN	O	p	appos	37	SENT_16	[p1l1578t1798r1603b1828],
40	=	JJ	O	=	amod	42	SENT_16	[p1l1622t1800r1647b1810],
41	0.007	CD	NUMBER	0.007	tmod	40	SENT_16	[p1l1665t1787r1777b1829],
42	)	NN	O	)	dobj	28	SENT_16	[p1l1665t1787r1777b1829],
43	.	.	O	.	_	0	SENT_16	[p1l1665t1787r1777b1829],

1	Conversely	RB	O	conversely	advmod	5	SENT_17	[p1l281t1838r476b1878],
2	,	,	O	,	_	0	SENT_17	[p1l281t1838r476b1878],
3	CsA	NN	O	csa	nn	4	SENT_17	[p1l492t1838r567b1869],
4	levels	NNS	O	level	nsubj	5	SENT_17	[p1l580t1838r672b1869],
5	dropped	VBD	O	drop	_	0	SENT_17	[p1l687t1838r830b1879],
6	with	IN	O	with	_	0	SENT_17	[p1l842t1838r916b1869],
7	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	8	SENT_17	[p1l931t1838r1177b1879],
8	(	NN	O	(	prep_with	5	SENT_17	[p1l1193t1837r1264b1879],
9	183	CD	NUMBER	183	dep	8	SENT_17	[p1l1193t1837r1264b1879],
10	:	:	O	:	_	0	SENT_17	[p1l1283t1842r1308b1867],
11	89	CD	NUMBER	89	dep	8	SENT_17	[p1l1327t1838r1365b1869],
12	vs	CC	O	vs	_	0	SENT_17	[p1l1378t1848r1411b1869],
13	121	CD	NUMBER	121	conj_vs	11	SENT_17	[p1l1428t1838r1483b1869],
14	:	:	O	:	_	0	SENT_17	[p1l1503t1842r1528b1867],
15	63	CD	NUMBER	63	num	16	SENT_17	[p1l1546t1838r1584b1869],
16	ng/ml	NN	O	ng/ml	dep	8	SENT_17	[p1l1599t1838r1702b1878],
17	,	,	O	,	_	0	SENT_17	[p1l1599t1838r1702b1878],
18	p	NN	O	p	appos	16	SENT_17	[p1l1710t1849r1736b1878],
19	=	JJ	O	=	advmod	29	SENT_17	[p1l1755t1850r1780b1860],
20	0.0001	CD	NUMBER	0.0001	num	21	SENT_17	[p1l280t1887r403b1929],
21	)	CD	NUMBER	)	dep	19	SENT_17	[p1l280t1887r403b1929],
22	despite	IN	O	despite	_	0	SENT_17	[p1l419t1888r539b1929],
23	an	DT	O	a	det	24	SENT_17	[p1l554t1898r594b1919],
24	increase	NN	O	increase	prep_despite	19	SENT_17	[p1l608t1888r746b1919],
25	in	IN	O	in	_	0	SENT_17	[p1l761t1888r792b1919],
26	CsA	NN	O	csa	nn	28	SENT_17	[p1l807t1888r882b1919],
27	daily	JJ	SET	daily	amod	28	SENT_17	[p1l895t1888r975b1928],
28	dose	NN	O	dose	prep_in	24	SENT_17	[p1l989t1888r1065b1919],
29	(	NN	O	(	rcmod	18	SENT_17	[p1l1081t1887r1143b1929],
30	2.6	CD	NUMBER	2.6	num	29	SENT_17	[p1l1081t1887r1143b1929],
31	:	:	O	:	_	0	SENT_17	[p1l1162t1892r1187b1917],
32	0.9	CD	NUMBER	0.9	dep	8	SENT_17	[p1l1205t1888r1253b1919],
33	vs	CC	O	vs	_	0	SENT_17	[p1l1266t1898r1299b1919],
34	2.8	CD	NUMBER	2.8	conj_vs	32	SENT_17	[p1l1314t1888r1362b1919],
35	:	:	O	:	_	0	SENT_17	[p1l1380t1892r1405b1917],
36	0.9	CD	NUMBER	0.9	num	37	SENT_17	[p1l1423t1888r1471b1919],
37	mg/kg/day	NN	O	mg/kg/day	dep	8	SENT_17	[p1l1486t1888r1667b1928],
38	,	,	O	,	_	0	SENT_17	[p1l1486t1888r1667b1928],
39	p	NN	O	p	appos	37	SENT_17	[p1l1675t1898r1701b1928],
40	=	JJ	O	=	amod	8	SENT_17	[p1l1720t1900r1745b1910],
41	0.0001	CD	NUMBER	0.0001	num	42	SENT_17	[p1l280t1937r412b1979],
42	)	NN	O	)	dep	40	SENT_17	[p1l280t1937r412b1979],
43	.	.	O	.	_	0	SENT_17	[p1l280t1937r412b1979],

1	Two	CD	NUMBER	two	num	2	SENT_18	[p1l427t1939r502b1969],
2	subjects	NNS	O	subject	nsubjpass	4	SENT_18	[p1l517t1938r649b1979],
3	were	VBD	O	be	auxpass	4	SENT_18	[p1l662t1948r744b1969],
4	treated	VBN	O	treat	_	0	SENT_18	[p1l759t1938r880b1969],
5	for	IN	O	for	_	0	SENT_18	[p1l893t1938r943b1969],
6	acute	JJ	O	acute	amod	7	SENT_18	[p1l957t1942r1047b1969],
7	rejection	NN	O	rejection	prep_for	4	SENT_18	[p1l1061t1938r1218b1979],
8	.	.	O	.	_	0	SENT_18	[p1l1061t1938r1218b1979],

1	We	PRP	O	we	nsubj	2	SENT_19	[p1l1233t1939r1293b1969],
2	observed	VBD	O	observe	_	0	SENT_19	[p1l1307t1938r1459b1969],
3	no	DT	O	no	det	6	SENT_19	[p1l1473t1948r1516b1969],
4	other	JJ	O	other	amod	6	SENT_19	[p1l1530t1938r1621b1969],
5	side	JJ	O	side	amod	6	SENT_19	[p1l1635t1938r1701b1969],
6	effects	NNS	O	effect	dobj	2	SENT_19	[p1l1716t1938r1833b1969],
7	.	.	O	.	_	0	SENT_19	[p1l1716t1938r1833b1969],

1	Conclusions	NNS	O	conclusion	dep	15	SENT_20	[p1l281t1993r499b2024],
2	:	:	O	:	_	0	SENT_20	[p1l281t1993r499b2024],
3	In	IN	O	in	dep	1	SENT_20	[p1l522t1993r558b2023],
4	HT	JJ	O	ht	amod	5	SENT_20	[p1l572t1993r632b2023],
5	recipients	NNS	O	recipient	pobj	3	SENT_20	[p1l645t1992r809b2033],
6	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nsubj	15	SENT_20	[p1l824t1992r1079b2033],
7	,	,	O	,	_	0	SENT_20	[p1l824t1992r1079b2033],
8	as	IN	O	as	_	0	SENT_20	[p1l1095t2002r1127b2023],
9	an	DT	O	a	det	10	SENT_20	[p1l1142t2002r1183b2023],
10	alternative	NN	O	alternative	prep_as	6	SENT_20	[p1l1197t1992r1376b2023],
11	to	TO	O	to	_	0	SENT_20	[p1l1390t1997r1424b2023],
12	allopurinol	NN	O	allopurinol	prep_to	10	SENT_20	[p1l1439t1992r1633b2033],
13	,	,	O	,	_	0	SENT_20	[p1l1439t1992r1633b2033],
14	is	VBZ	O	be	cop	15	SENT_20	[p1l1648t1992r1672b2023],
15	effective	JJ	O	effective	_	0	SENT_20	[p1l1687t1992r1829b2023],
16	in	IN	O	in	_	0	SENT_20	[p1l1843t1992r1875b2023],
17	achieving	VBG	O	achieve	prepc_in	15	SENT_20	[p1l281t2042r439b2083],
18	metabolic	JJ	O	metabolic	amod	19	SENT_20	[p1l453t2042r620b2073],
19	control	NN	O	control	dobj	17	SENT_20	[p1l634t2042r755b2073],
20	of	IN	O	of	_	0	SENT_20	[p1l769t2042r805b2073],
21	hyperuricemia	NN	O	hyperuricemia	prep_of	19	SENT_20	[p1l816t2042r1069b2083],
22	.	.	O	.	_	0	SENT_20	[p1l816t2042r1069b2083],

1	However	RB	O	however	advmod	5	SENT_21	[p1l1084t2043r1247b2080],
2	,	,	O	,	_	0	SENT_21	[p1l1084t2043r1247b2080],
3	this	DT	O	this	det	4	SENT_21	[p1l1262t2042r1322b2073],
4	drug	NN	O	drug	nsubj	5	SENT_21	[p1l1336t2042r1414b2083],
5	reduced	VBD	O	reduce	_	0	SENT_21	[p1l1427t2042r1565b2073],
6	CsA	NN	O	csa	nn	7	SENT_21	[p1l1580t2043r1654b2074],
7	levels	NNS	O	level	dobj	5	SENT_21	[p1l1667t2042r1768b2080],
8	,	,	O	,	_	0	SENT_21	[p1l1667t2042r1768b2080],
9	thus	RB	O	thus	advmod	5	SENT_21	[p1l1783t2042r1854b2073],
10	the	DT	O	the	det	11	SENT_21	[p1l280t2092r333b2123],
11	risk	NN	O	risk	nsubj	15	SENT_21	[p1l348t2092r410b2123],
12	of	IN	O	of	_	0	SENT_21	[p1l423t2092r459b2123],
13	rejection	NN	O	rejection	prep_of	11	SENT_21	[p1l470t2092r619b2133],
14	is	VBZ	O	be	cop	15	SENT_21	[p1l633t2092r658b2123],
15	present	JJ	DATE	present	ccomp	5	SENT_21	[p1l671t2097r806b2133],
16	.	.	O	.	_	0	SENT_21	[p1l671t2097r806b2133],

1	J	NNP	O	J	nn	4	SENT_22	[p1l820t2093r838b2124],
2	Heart	NNP	O	Heart	nn	4	SENT_22	[p1l852t2093r952b2123],
3	Lung	NN	O	lung	nn	4	SENT_22	[p1l965t2093r1054b2133],
4	Transplant	NN	O	transplant	_	0	SENT_22	[p1l1068t2092r1253b2133],
5	2000	CD	DATE	2000	dep	4	SENT_22	[p1l1267t2092r1595b2130],
6	;	:	O	;	_	0	SENT_22	[p1l1267t2092r1595b2130],
7	19:1205	CD	NUMBER	19:1205	number	8	SENT_22	[p1l1267t2092r1595b2130],
8	—	CD	NUMBER	—	dep	4	SENT_22	[p1l1267t2092r1595b2130],
9	1208	CD	DATE	1208	dep	8	SENT_22	[p1l1267t2092r1595b2130],
10	.	.	O	.	_	0	SENT_22	[p1l1267t2092r1595b2130],

1	From	IN	O	from	dep	8	SENT_23	[p1l105t2243r183b2267],
2	the	DT	O	the	det	3	SENT_23	[p1l193t2242r237b2267],
3	Department	NNP	ORGANIZATION	Department	pobj	1	SENT_23	[p1l247t2243r421b2275],
4	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l432t2242r461b2267],
5	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	3	SENT_23	[p1l470t2242r645b2275],
6	,	,	O	,	_	0	SENT_23	[p1l470t2242r645b2275],
7	“	NNP	O	“	nn	8	SENT_23	[p1l470t2242r645b2275],
8	Department	NNP	ORGANIZATION	Department	_	0	SENT_23	[p1l655t2243r828b2275],
9	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l839t2242r869b2267],
10	Cardiovas	NNP	ORGANIZATION	Cardiovas	prep_of	8	SENT_23	[p1l877t2242r1028b2267],
11	-	:	O	-	_	0	SENT_23	[p1l877t2242r1028b2267],
12	Gallucci	NNP	PERSON	Gallucci	dep	38	SENT_23	[p1l1164t2242r1304b2272],
13	,	,	O	,	_	0	SENT_23	[p1l1164t2242r1304b2272],
14	”	NNP	O	”	nn	15	SENT_23	[p1l1164t2242r1304b2272],
15	University	NNP	ORGANIZATION	University	appos	12	SENT_23	[p1l1315t2242r1462b2275],
16	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l1472t2242r1502b2267],
17	Padova-Policlinico	NNP	ORGANIZATION	Padova-Policlinico	prep_of	15	SENT_23	[p1l1510t2242r1782b2272],
18	,	,	O	,	_	0	SENT_23	[p1l1510t2242r1782b2272],
19	Via	NNP	PERSON	Via	nn	20	SENT_23	[p1l1793t2242r1844b2267],
20	Giustiniani	NNP	PERSON	Giustiniani	appos	12	SENT_23	[p1l1855t2242r2019b2272],
21	,	,	O	,	_	0	SENT_23	[p1l1855t2242r2019b2272],
22	2	CD	NUMBER	2	appos	12	SENT_23	[p1l2031t2243r2054b2273],
23	,	,	O	,	_	0	SENT_23	[p1l2031t2243r2054b2273],
24	cular	JJ	O	cular	amod	25	SENT_23	[p1l138t2280r208b2305],
25	Surgery	NN	O	surgery	appos	12	SENT_23	[p1l222t2278r350b2313],
26	,	,	O	,	_	0	SENT_23	[p1l222t2278r350b2313],
27	‘’	NNP	O	‘’	nn	28	SENT_23	[p1l222t2278r350b2313],
28	Department	NNP	O	Department	appos	12	SENT_23	[p1l364t2281r538b2313],
29	of	IN	O	of	_	0	SENT_23	[p1l551t2280r581b2305],
30	Nephrology	NNP	O	Nephrology	prep_of	28	SENT_23	[p1l592t2280r778b2313],
31	,	,	O	,	_	0	SENT_23	[p1l592t2280r778b2313],
32	°	NN	O	°	nn	36	SENT_23	[p1l592t2280r778b2313],
33	and	CC	O	and	_	0	SENT_23	[p1l791t2280r842b2305],
34	Department	NNP	ORGANIZATION	Department	conj_and	32	SENT_23	[p1l856t2281r1029b2313],
35	35128	CD	NUMBER	35128	num	36	SENT_23	[p1l1164t2280r1245b2304],
36	Padova	NNP	ORGANIZATION	Padova	appos	12	SENT_23	[p1l1257t2279r1368b2310],
37	,	,	O	,	_	0	SENT_23	[p1l1257t2279r1368b2310],
38	Italy	NNP	LOCATION	Italy	parataxis	8	SENT_23	[p1l1381t2279r1451b2312],
39	.	.	O	.	_	0	SENT_23	[p1l1381t2279r1451b2312],

1	Telephone	NNP	O	Telephone	_	0	SENT_24	[p1l1464t2279r1624b2312],
2	:	:	O	:	_	0	SENT_24	[p1l1464t2279r1624b2312],
3	+3949-8212348	CD	NUMBER	+3949-8212348	dep	1	SENT_24	[p1l1640t2280r1865b2304],
4	.	.	O	.	_	0	SENT_24	[p1l1640t2280r1865b2304],

1	Fax	NN	O	fax	_	0	SENT_25	[p1l1878t2280r1936b2304],
2	:	:	O	:	_	0	SENT_25	[p1l1878t2280r1936b2304],
3	+3949	CD	NUMBER	+3949	dep	1	SENT_25	[p1l1953t2280r2054b2304, p1l139t2318r168b2343],
4	of	IN	O	of	_	0	SENT_25	[p1l1953t2280r2054b2304, p1l139t2318r168b2343],
5	Cardiac	JJ	O	cardiac	amod	6	SENT_25	[p1l179t2318r289b2344],
6	Pathology	NN	O	pathology	prep_of	3	SENT_25	[p1l301t2316r463b2351],
7	,	,	O	,	_	0	SENT_25	[p1l301t2316r463b2351],
8	“	NNP	O	“	nn	9	SENT_25	[p1l301t2316r463b2351],
9	University	NNP	ORGANIZATION	University	appos	1	SENT_25	[p1l475t2318r621b2351],
10	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l633t2318r663b2343],
11	Padova	NNP	ORGANIZATION	Padova	prep_of	9	SENT_25	[p1l673t2318r784b2349],
12	,	,	O	,	_	0	SENT_25	[p1l673t2318r784b2349],
13	Padova	NNP	ORGANIZATION	Padova	appos	1	SENT_25	[p1l797t2318r908b2349],
14	,	,	O	,	_	0	SENT_25	[p1l797t2318r908b2349],
15	Italy	NNP	LOCATION	Italy	appos	1	SENT_25	[p1l921t2318r991b2351],
16	.	.	O	.	_	0	SENT_25	[p1l921t2318r991b2351],

1	8754179	CD	NUMBER	8754179	_	0	SENT_26	[p1l1164t2316r1286b2341],
2	.	.	O	.	_	0	SENT_26	[p1l1164t2316r1286b2341],

1	E-mail	NN	O	e-mail	_	0	SENT_27	[p1l1299t2316r1402b2341],
2	:	:	O	:	_	0	SENT_27	[p1l1299t2316r1402b2341],
3	acaforio@ux1.unipd.it	NN	O	acaforio@ux1.unipd.it	dep	1	SENT_27	[p1l1417t2316r1740b2349],
4	.	.	O	.	_	0	SENT_27	[p1l1417t2316r1740b2349],

1	Submitted	VBN	O	submit	_	0	SENT_28	[p1l105t2356r251b2382],
2	March	NNP	DATE	March	dobj	1	SENT_28	[p1l263t2356r356b2381],
3	28	CD	DATE	28	num	2	SENT_28	[p1l368t2357r407b2387],
4	,	,	DATE	,	_	0	SENT_28	[p1l368t2357r407b2387],
5	2000	CD	DATE	2000	num	2	SENT_28	[p1l421t2357r494b2387],
6	;	:	O	;	_	0	SENT_28	[p1l421t2357r494b2387],
7	accepted	VBN	O	accept	partmod	2	SENT_28	[p1l508t2356r632b2389],
8	September	NNP	DATE	September	tmod	7	SENT_28	[p1l645t2356r798b2389],
9	5	CD	DATE	5	num	8	SENT_28	[p1l810t2357r833b2387],
10	,	,	DATE	,	_	0	SENT_28	[p1l810t2357r833b2387],
11	2000	CD	DATE	2000	num	8	SENT_28	[p1l847t2357r919b2381],
12	.	.	O	.	_	0	SENT_28	[p1l847t2357r919b2381],

1	Copyright	NN	O	copyright	_	0	SENT_29	[p1l1131t2353r1271b2386],
2	©	CD	NUMBER	©	num	12	SENT_29	[p1l1289t2354r1313b2378],
3	2000	CD	DATE	2000	dep	12	SENT_29	[p1l1332t2354r1397b2378],
4	by	IN	O	by	_	0	SENT_29	[p1l1413t2353r1446b2386],
5	the	DT	O	the	det	7	SENT_29	[p1l1462t2353r1506b2378],
6	International	NNP	ORGANIZATION	International	nn	7	SENT_29	[p1l1524t2353r1710b2378],
7	Society	NNP	ORGANIZATION	Society	prep_by	3	SENT_29	[p1l1728t2353r1829b2386],
8	for	IN	ORGANIZATION	for	_	0	SENT_29	[p1l1845t2353r1886b2378],
9	Heart	NNP	ORGANIZATION	Heart	prep_for	3	SENT_29	[p1l1903t2354r1986b2378],
10	and	CC	O	and	_	0	SENT_29	[p1l2003t2353r2054b2378],
11	Reprint	NNP	O	Reprint	prep_for	3	SENT_29	[p1l105t2395r215b2427],
12	requests	NNS	O	request	dep	1	SENT_29	[p1l227t2398r352b2427],
13	:	:	O	:	_	0	SENT_29	[p1l227t2398r352b2427],
14	Alida	NNP	PERSON	Alida	nn	17	SENT_29	[p1l365t2395r443b2419],
15	L.	NNP	PERSON	L.	nn	17	SENT_29	[p1l455t2396r483b2419],
16	P.	NNP	PERSON	P.	nn	17	SENT_29	[p1l496t2396r522b2419],
17	Caforio	NNP	PERSON	Caforio	dep	1	SENT_29	[p1l536t2395r651b2425],
18	,	,	O	,	_	0	SENT_29	[p1l536t2395r651b2425],
19	MD	NNP	O	MD	appos	17	SENT_29	[p1l665t2396r729b2425],
20	,	,	O	,	_	0	SENT_29	[p1l665t2396r729b2425],
21	Division	NNP	O	Division	appos	17	SENT_29	[p1l742t2395r860b2419],
22	of	IN	O	of	_	0	SENT_29	[p1l872t2395r902b2419],
23	Cardiol	NNP	O	Cardiol	prep_of	21	SENT_29	[p1l913t2395r1029b2420],
24	—	CD	NUMBER	—	num	23	SENT_29	[p1l913t2395r1029b2420],
25	Lung	NN	O	lung	nn	26	SENT_29	[p1l1163t2396r1237b2427],
26	Transplantation	NN	O	transplantation	dep	21	SENT_29	[p1l1249t2395r1483b2427],
27	.	.	O	.	_	0	SENT_29	[p1l1249t2395r1483b2427],

1	ogy	NN	O	ogy	_	0	SENT_30	[p1l138t2438r194b2462],
2	,	,	O	,	_	0	SENT_30	[p1l138t2438r194b2462],
3	Dept.	NNP	O	Dept.	appos	1	SENT_30	[p1l205t2431r284b2463],
4	of	IN	O	of	_	0	SENT_30	[p1l296t2430r326b2455],
5	Experimental	JJ	O	experimental	amod	8	SENT_30	[p1l335t2430r526b2463],
6	and	CC	O	and	_	0	SENT_30	[p1l538t2430r589b2455],
7	Clinical	JJ	O	clinical	conj_and	5	SENT_30	[p1l601t2430r708b2455],
8	Medicine	NN	O	medicine	prep_of	3	SENT_30	[p1l719t2430r859b2460],
9	,	,	O	,	_	0	SENT_30	[p1l719t2430r859b2460],
10	Centro	NNP	O	Centro	nn	12	SENT_30	[p1l872t2430r970b2455],
11	“	NNP	O	“	nn	12	SENT_30	[p1l982t2430r1028b2455],
12	V.	NNP	O	V.	appos	1	SENT_30	[p1l982t2430r1028b2455],
13	1053-2498/00	CD	DURATION	1053-2498/00	num	12	SENT_30	[p1l1132t2431r1403b2461],
14	/	:	O	/	punct	15	SENT_30	[p1l1132t2431r1403b2461],
15	$	$	MONEY	$	dep	12	SENT_30	[p1l1132t2431r1403b2461],
16	.	.	MONEY	.	_	0	SENT_30	[p1l1132t2431r1403b2461],

1	—	NN	O	—	_	0	SENT_31	[p1l1132t2431r1403b2461],
2	.	.	O	.	_	0	SENT_31	[p1l1132t2431r1403b2461],

1	see	VB	O	see	_	0	SENT_32	[p1l1132t2431r1403b2461],
2	front	JJ	O	front	amod	5	SENT_32	[p1l1416t2433r1486b2458],
3	matter	NN	O	matter	nn	5	SENT_32	[p1l1498t2437r1592b2458],
4	PII	NN	O	pius	nn	5	SENT_32	[p1l1626t2434r1670b2458],
5	S1053-2498	NN	O	s1053-2498	dobj	1	SENT_32	[p1l1684t2433r2013b2466],
6	(	CD	NUMBER	(	number	7	SENT_32	[p1l1684t2433r2013b2466],
7	00	CD	NUMBER	00	dep	5	SENT_32	[p1l1684t2433r2013b2466],
8	)	NN	O	)	dep	7	SENT_32	[p1l1684t2433r2013b2466],
9	00216-3	CD	NUMBER	00216-3	num	8	SENT_32	[p1l1684t2433r2013b2466],

1	1206	CD	DATE	1206	num	2	SENT_33	[p1l12t2709r179b2771],
2	Caforio	NNP	O	Caforio	_	0	SENT_33	[p1l280t2707r559b2771],
3	et	FW	O	et	nn	4	SENT_33	[p1l593t2716r661b2771],
4	al.	FW	O	al.	dep	2	SENT_33	[p1l694t2707r773b2771],
5	.	.	O	.	_	0	SENT_33	[p1l694t2707r773b2771],

1	yclosporine	NN	O	yclosporine	nn	4	SENT_34	[p1l191t3094r661b3187],
2	(	CD	NUMBER	(	num	4	SENT_34	[p1l708t3093r950b3188],
3	CsA	NN	O	csa	nn	4	SENT_34	[p1l708t3093r950b3188],
4	)	NN	O	)	nsubj	13	SENT_34	[p1l708t3093r950b3188],
5	and	CC	O	and	_	0	SENT_34	[p1l999t3094r1146b3165],
6	azathioprine	NN	O	azathioprine	nn	9	SENT_34	[p1l1190t3094r1700b3187],
7	(	CD	NUMBER	(	num	9	SENT_34	[p1l1747t3093r1974b3189],
8	Aza	NN	O	aza	nn	9	SENT_34	[p1l1747t3093r1974b3189],
9	)	NN	O	)	conj_and	4	SENT_34	[p1l1747t3093r1974b3189],
10	are	VBP	O	be	cop	13	SENT_34	[p1l2022t3117r2147b3165],
11	common	JJ	O	common	amod	13	SENT_34	[p1l9t3235r364b3284],
12	immunosuppressive	JJ	O	immunosuppressive	amod	13	SENT_34	[p1l408t3212r1218b3305],
13	agents	NNS	O	agent	_	0	SENT_34	[p1l1264t3222r1522b3305],
14	used	VBN	O	use	partmod	13	SENT_34	[p1l1565t3212r1752b3284],
15	in	IN	O	in	_	0	SENT_34	[p1l1796t3212r1872b3283],
16	organ	NN	O	organ	nn	17	SENT_34	[p1l1916t3235r2148b3305],
17	transplantation	NN	O	transplantation	prep_in	14	SENT_34	[p1l8t3326r687b3422],
18	}	CD	NUMBER	}	num	21	SENT_34	[p1l8t3326r687b3422],
19	Systemic	JJ	MISC	systemic	amod	21	SENT_34	[p1l723t3330r1079b3422],
20	arterial	JJ	O	arterial	amod	21	SENT_34	[p1l1111t3330r1406b3401],
21	hypertension	NN	O	hypertension	nsubj	25	SENT_34	[p1l1437t3329r1968b3422],
22	and	CC	O	and	_	0	SENT_34	[p1l2001t3330r2149b3400],
23	nephrotoxicity	NN	O	nephrotoxicity	conj_and	21	SENT_34	[p1l8t3447r599b3539],
24	are	VBP	O	be	aux	25	SENT_34	[p1l656t3469r781b3518],
25	known	JJ	O	known	rcmod	17	SENT_34	[p1l837t3447r1109b3518],
26	side	JJ	O	side	amod	27	SENT_34	[p1l1166t3446r1323b3518],
27	effects	NNS	O	effect	dobj	25	SENT_34	[p1l1382t3447r1646b3518],
28	of	IN	O	of	_	0	SENT_34	[p1l1703t3447r1789b3518],
29	CsA	NN	O	csa	nn	30	SENT_34	[p1l1841t3443r2148b3518],
30	.2	NN	NUMBER	.2	prep_of	27	SENT_34	[p1l1841t3443r2148b3518],
31	‘	CD	NUMBER	‘	number	32	SENT_34	[p1l1841t3443r2148b3518],
32	4	CD	NUMBER	4	num	34	SENT_34	[p1l1841t3443r2148b3518],
33	Transplant	NN	O	transplant	nn	34	SENT_34	[p1l8t3564r454b3657],
34	patients	NNS	O	patient	nsubj	37	SENT_34	[p1l508t3564r832b3657],
35	receiving	VBG	O	receive	partmod	34	SENT_34	[p1l889t3564r1257b3656],
36	CsA	NN	O	csa	dobj	35	SENT_34	[p1l1315t3565r1491b3635],
37	have	VBP	O	have	rcmod	27	SENT_34	[p1l1544t3564r1731b3635],
38	a	DT	O	a	det	40	SENT_34	[p1l1790t3586r1833b3634],
39	higher	JJR	O	higher	amod	40	SENT_34	[p1l1888t3563r2149b3656],
40	incidence	NN	O	incidence	dobj	37	SENT_34	[p1l9t3681r395b3752],
41	of	IN	O	of	_	0	SENT_34	[p1l441t3681r526b3752],
42	hyperuricemia	NN	O	hyperuricemia	prep_of	40	SENT_34	[p1l564t3681r1154b3774],
43	than	IN	O	than	_	0	SENT_34	[p1l1197t3681r1378b3752],
44	those	DT	O	those	prep_than	37	SENT_34	[p1l1422t3681r1638b3752],
45	on	IN	O	on	_	0	SENT_34	[p1l1684t3703r1785b3752],
46	conventional	JJ	O	conventional	prep_on	44	SENT_34	[p1l1828t3703r2146b3752, p2l8t20r242b91],

1	immunosuppression	NN	O	immunosuppression	nsubj	18	SENT_35	[p2l290t20r1136b113],
2	,	,	O	,	_	0	SENT_35	[p2l290t20r1136b113],
3	even	RB	O	even	advmod	8	SENT_35	[p2l1188t42r1376b91],
4	when	WRB	O	when	advmod	8	SENT_35	[p2l1418t20r1638b91],
5	renal	JJ	O	renal	amod	6	SENT_35	[p2l1685t20r1893b91],
6	function	NN	O	function	nsubj	8	SENT_35	[p2l1940t20r2146b91, p2l8t137r168b208],
7	is	VBZ	O	be	cop	8	SENT_35	[p2l212t137r271b208],
8	comparable	JJ	O	comparable	dep	18	SENT_35	[p2l316t133r930b230],
9	.5	CD	NUMBER	.5	tmod	8	SENT_35	[p2l316t133r930b230],
10	‘	CD	NUMBER	‘	number	11	SENT_35	[p2l316t133r930b230],
11	8	CD	NUMBER	8	num	14	SENT_35	[p2l316t133r930b230],
12	A	DT	O	a	det	14	SENT_35	[p2l971t139r1048b207],
13	great	JJ	O	great	amod	14	SENT_35	[p2l1088t148r1296b230],
14	number	NN	O	number	nsubj	18	SENT_35	[p2l1339t137r1657b208],
15	of	IN	O	of	_	0	SENT_35	[p2l1701t138r1787b208],
16	patients	NNS	O	patient	prep_of	14	SENT_35	[p2l1824t137r2147b230],
17	therefore	RB	O	therefore	advmod	18	SENT_35	[p2l8t255r389b326],
18	need	VBP	O	need	_	0	SENT_35	[p2l418t255r616b326],
19	treatment	NN	O	treatment	dobj	18	SENT_35	[p2l644t265r1047b326],
20	of	IN	O	of	_	0	SENT_35	[p2l1075t255r1161b326],
21	hyperuricemia	NN	O	hyperuricemia	prep_of	19	SENT_35	[p2l1183t255r1774b348],
22	either	CC	O	either	advmod	19	SENT_35	[p2l1802t255r2041b326],
23	to	TO	O	to	aux	24	SENT_35	[p2l2068t265r2147b326],
24	prevent	VB	O	prevent	xcomp	18	SENT_35	[p2l7t383r318b465],
25	uratic	JJ	O	uratic	amod	26	SENT_35	[p2l382t372r618b443],
26	arthritis	NN	O	arthritis	nsubjpass	51	SENT_35	[p2l684t372r1005b443],
27	or	CC	O	or	_	0	SENT_35	[p2l1071t395r1157b443],
28	uratic	JJ	O	uratic	amod	30	SENT_35	[p2l1220t372r1456b443],
29	nephropathy	NN	O	nephropathy	nn	30	SENT_35	[p2l1520t368r2148b465],
30	.5	NN	NUMBER	.5	nsubjpass	51	SENT_35	[p2l1520t368r2148b465],
31	=	JJ	O	=	dep	51	SENT_35	[p2l1520t368r2148b465],
32	6	CD	NUMBER	6	tmod	31	SENT_35	[p2l1520t368r2148b465],
33	Because	IN	O	because	mark	51	SENT_35	[p2l8t492r345b561],
34	of	IN	O	of	_	0	SENT_35	[p2l397t490r482b561],
35	the	DT	O	the	det	37	SENT_35	[p2l526t489r654b561],
36	known	JJ	O	known	amod	37	SENT_35	[p2l704t490r975b561],
37	myelotoxicity	NN	O	myelotoxicity	prep_of	51	SENT_35	[p2l1024t490r1569b582],
38	of	IN	O	of	_	0	SENT_35	[p2l1617t490r1703b561],
39	combined	JJ	O	combined	amod	40	SENT_35	[p2l1747t490r2149b561],
40	allopurinol	NN	O	allopurinol	prep_of	37	SENT_35	[p2l11t606r459b700],
41	and	CC	O	and	_	0	SENT_35	[p2l519t607r667b678],
42	Aza	NN	O	aza	nn	43	SENT_35	[p2l722t608r886b678],
43	therapy	NN	O	therapy	prep_of	37	SENT_35	[p2l943t606r1274b700],
44	,	,	O	,	_	0	SENT_35	[p2l943t606r1274b700],
45	treatment	NN	O	treatment	nsubjpass	51	SENT_35	[p2l1335t616r1738b678],
46	of	IN	O	of	_	0	SENT_35	[p2l1797t607r1883b678],
47	these	DT	O	these	det	49	SENT_35	[p2l1935t607r2147b678],
48	hyperuricemic	JJ	O	hyperuricemic	amod	49	SENT_35	[p2l8t724r594b817],
49	patients	NNS	O	patient	prep_of	45	SENT_35	[p2l622t724r946b817],
50	is	VBZ	O	be	auxpass	51	SENT_35	[p2l977t724r1036b795],
51	complicated	VBN	O	complicate	xcomp	24	SENT_35	[p2l1067t720r1622b817],
52	?	.	O	?	_	0	SENT_35	[p2l1067t720r1622b817],

1	Because	IN	O	because	_	0	SENT_36	[p2l1652t727r1989b795],
2	the	DT	O	the	det	3	SENT_36	[p2l2020t724r2147b795],
3	hyperuricemia	NN	O	hyperuricemia	prep_because	39	SENT_36	[p2l8t840r599b934],
4	commonly	RB	O	commonly	advmod	5	SENT_36	[p2l647t840r1073b933],
5	seen	VBN	O	see	partmod	3	SENT_36	[p2l1121t863r1301b912],
6	in	IN	O	in	_	0	SENT_36	[p2l1350t841r1425b911],
7	heart	NN	O	heart	nn	8	SENT_36	[p2l1474t840r1687b912],
8	transplant	NN	O	transplant	prep_in	5	SENT_36	[p2l1735t840r2148b934],
9	(	CD	NUMBER	(	num	12	SENT_36	[p2l13t956r218b1052],
10	HT	NNP	O	HT	nn	12	SENT_36	[p2l13t956r218b1052],
11	)	CD	NUMBER	)	num	12	SENT_36	[p2l13t956r218b1052],
12	recipients	NNS	O	recipient	nsubj	39	SENT_36	[p2l255t958r653b1051],
13	is	VBZ	O	be	cop	14	SENT_36	[p2l688t958r746b1029],
14	likely	JJ	O	likely	rcmod	12	SENT_36	[p2l781t958r1000b1050],
15	caused	VBN	O	cause	dep	14	SENT_36	[p2l1032t958r1308b1029],
16	by	IN	O	by	_	0	SENT_36	[p2l1340t958r1435b1050],
17	reduced	VBN	O	reduce	amod	20	SENT_36	[p2l1467t958r1796b1029],
18	glomerular	JJ	O	glomerular	amod	20	SENT_36	[p2l1830t957r2146b1050, p2l8t1075r169b1146],
19	ﬁltration	NN	O	ﬁltration	nn	20	SENT_36	[p2l217t1074r574b1146],
20	rate	NN	O	rate	prep_by	15	SENT_36	[p2l623t1084r781b1146],
21	and	CC	O	and	_	0	SENT_36	[p2l834t1074r982b1146],
22	not	RB	O	not	amod	28	SENT_36	[p2l1030t1085r1164b1146],
23	to	TO	O	to	_	0	SENT_36	[p2l1213t1084r1292b1146],
24	increased	VBN	O	increase	amod	27	SENT_36	[p2l1342t1074r1730b1146],
25	uric	JJ	O	uric	amod	27	SENT_36	[p2l1778t1075r1935b1146],
26	acid	NN	O	acid	nn	27	SENT_36	[p2l1985t1074r2148b1146],
27	production	NN	O	production	prep_to	22	SENT_36	[p2l7t1188r567b1285],
28	,5	NN	O	,5	conj_and	20	SENT_36	[p2l7t1188r567b1285],
29	=	JJ	O	=	amod	28	SENT_36	[p2l7t1188r567b1285],
30	8	CD	NUMBER	8	tmod	29	SENT_36	[p2l7t1188r567b1285],
31	increasing	VBG	O	increase	partmod	12	SENT_36	[p2l599t1192r1013b1284],
32	uric	JJ	O	uric	amod	34	SENT_36	[p2l1043t1192r1201b1263],
33	acid	NN	O	acid	nn	34	SENT_36	[p2l1233t1192r1396b1263],
34	elimination	NN	O	elimination	dobj	31	SENT_36	[p2l1429t1192r1894b1263],
35	could	MD	O	could	aux	39	SENT_36	[p2l1926t1192r2149b1263],
36	be	VB	O	be	cop	39	SENT_36	[p2l6t1309r102b1380],
37	a	DT	O	a	det	39	SENT_36	[p2l137t1331r179b1379],
38	good	JJ	O	good	amod	39	SENT_36	[p2l209t1309r411b1401],
39	approach	NN	O	approach	_	0	SENT_36	[p2l444t1308r844b1402],
40	.	.	O	.	_	0	SENT_36	[p2l444t1308r844b1402],

1	We	PRP	O	we	nsubj	2	SENT_37	[p2l877t1311r1016b1380],
2	report	VBP	O	report	_	0	SENT_37	[p2l1049t1318r1304b1402],
3	our	PRP$	O	we	poss	4	SENT_37	[p2l1336t1331r1474b1380],
4	experience	NN	O	experience	dobj	2	SENT_37	[p2l1505t1309r1944b1402],
5	with	IN	O	with	_	0	SENT_37	[p2l1972t1309r2148b1380],
6	the	DT	O	the	det	9	SENT_37	[p2l8t1425r136b1497],
7	uricosuric	JJ	O	uricosuric	amod	9	SENT_37	[p2l181t1426r587b1497],
8	drug	NN	O	drug	nn	9	SENT_37	[p2l633t1426r817b1518],
9	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	2	SENT_37	[p2l864t1425r1457b1519],
10	in	IN	O	in	_	0	SENT_37	[p2l1504t1426r1579b1496],
11	the	DT	O	the	det	12	SENT_37	[p2l1624t1425r1752b1497],
12	management	NN	O	management	prep_in	9	SENT_37	[p2l1798t1448r2146b1518, p2l8t1553r216b1614],
13	of	IN	O	of	_	0	SENT_37	[p2l253t1543r339b1614],
14	hyperuricemia	NN	O	hyperuricemia	prep_of	12	SENT_37	[p2l368t1542r959b1636],
15	in	IN	O	in	_	0	SENT_37	[p2l994t1543r1070b1613],
16	HT	NNP	O	HT	prep_in	14	SENT_37	[p2l1105t1545r1264b1614],
17	.	.	O	.	_	0	SENT_37	[p2l1105t1545r1264b1614],

1	METHODS	NNS	O	method	_	0	SENT_38	[p2l7t1727r429b1800],

1	We	PRP	O	we	nsubj	2	SENT_39	[p2l7t1896r146b1965],
2	studied	VBD	O	study	_	0	SENT_39	[p2l181t1894r477b1965],
3	120	CD	NUMBER	120	num	5	SENT_39	[p2l513t1895r648b1965],
4	HT	NN	O	ht	nn	5	SENT_39	[p2l681t1896r821b1964],
5	recipients	NNS	O	recipient	nsubj	6	SENT_39	[p2l851t1894r1248b1987],
6	(	VBP	O	(	ccomp	2	SENT_39	[p2l1285t1892r1457b1988],
7	109	CD	NUMBER	109	num	8	SENT_39	[p2l1285t1892r1457b1988],
8	men	NNS	O	man	nsubj	16	SENT_39	[p2l1490t1916r1689b1980],
9	;	:	O	;	_	0	SENT_39	[p2l1490t1916r1689b1980],
10	aged	JJ	O	aged	amod	11	SENT_39	[p2l1726t1894r1916b1986],
11	58	CD	NUMBER	58	dep	8	SENT_39	[p2l1947t1894r2038b1965],
12	:	:	O	:	_	0	SENT_39	[p2l2081t1903r2139b1961],
13	9	CD	DURATION	9	num	14	SENT_39	[p2l10t2012r52b2082],
14	years	NNS	NUMBER	year	dep	11	SENT_39	[p2l99t2033r334b2103],
15	;	:	O	;	_	0	SENT_39	[p2l99t2033r334b2103],
16	mean	VB	O	mean	ccomp	6	SENT_39	[p2l388t2033r612b2082],
17	age	NN	O	age	nn	24	SENT_39	[p2l664t2033r800b2103],
18	at	IN	O	at	_	0	SENT_39	[p2l853t2021r926b2082],
19	HT	NNP	O	HT	prep_at	17	SENT_39	[p2l977t2013r1137b2097],
20	,	,	O	,	_	0	SENT_39	[p2l977t2013r1137b2097],
21	52	CD	NUMBER	52	num	19	SENT_39	[p2l1190t2011r1283b2082],
22	:	:	O	:	_	0	SENT_39	[p2l1342t2020r1400b2078],
23	10	CD	DURATION	10	num	19	SENT_39	[p2l1465t2012r1552b2082],
24	years	NNS	NUMBER	year	tmod	16	SENT_39	[p2l1598t2009r1870b2105],
25	)	RB	O	)	advmod	16	SENT_39	[p2l1598t2009r1870b2105],
26	;	:	O	;	_	0	SENT_39	[p2l1598t2009r1870b2105],
27	mean	VB	O	mean	csubj	37	SENT_39	[p2l1924t2033r2148b2082],
28	follow-up	NN	O	follow-up	dobj	27	SENT_39	[p2l8t2127r396b2221],
29	from	IN	O	from	_	0	SENT_39	[p2l428t2128r626b2199],
30	HT	NNP	O	HT	prep_from	27	SENT_39	[p2l657t2130r796b2198],
31	to	TO	O	to	_	0	SENT_39	[p2l826t2137r905b2199],
32	onset	NN	O	onset	prep_to	27	SENT_39	[p2l939t2138r1156b2199],
33	of	IN	O	of	_	0	SENT_39	[p2l1188t2128r1274b2199],
34	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	35	SENT_39	[p2l1300t2127r1893b2221],
35	treatment	NN	O	treatment	prep_of	32	SENT_39	[p2l1925t2137r2146b2199, p2l8t2255r216b2316],
36	was	VBD	O	be	cop	37	SENT_39	[p2l239t2267r389b2316],
37	59	CD	NUMBER	59	parataxis	2	SENT_39	[p2l417t2245r509b2316],
38	:	:	O	:	_	0	SENT_39	[p2l547t2254r605b2312],
39	41	CD	DURATION	41	num	40	SENT_39	[p2l643t2246r730b2315],
40	months	NNS	NUMBER	month	dep	37	SENT_39	[p2l762t2245r1086b2316],
41	.	.	O	.	_	0	SENT_39	[p2l762t2245r1086b2316],

1	All	DT	O	all	nsubj	3	SENT_40	[p2l1115t2244r1240b2315],
2	had	VBD	O	have	aux	3	SENT_40	[p2l1268t2244r1417b2316],
3	been	VBN	O	be	_	0	SENT_40	[p2l1443t2245r1641b2316],
4	on	IN	O	on	_	0	SENT_40	[p2l1670t2267r1771b2316],
5	allopurinol	NN	O	allopurinol	prep_on	3	SENT_40	[p2l1800t2244r2146b2338, p2l8t2362r137b2434],
6	for	IN	O	for	_	0	SENT_40	[p2l173t2363r291b2434],
7	at	IN	DURATION	at	quantmod	9	SENT_40	[p2l329t2373r403b2434],
8	least	JJS	DURATION	least	mwe	7	SENT_40	[p2l439t2362r626b2434],
9	6	CD	DURATION	6	num	10	SENT_40	[p2l664t2364r705b2434],
10	months	NNS	NUMBER	month	prep_for	5	SENT_40	[p2l743t2363r1044b2434],
11	for	IN	O	for	_	0	SENT_40	[p2l1081t2363r1200b2434],
12	history	NN	O	history	prep_for	3	SENT_40	[p2l1235t2362r1515b2455],
13	of	IN	O	of	_	0	SENT_40	[p2l1550t2363r1635b2434],
14	gout	NN	O	gout	nn	16	SENT_40	[p2l1666t2372r1847b2455],
15	and/or	NN	O	and/or	nn	16	SENT_40	[p2l1885t2363r2149b2442],
16	hyperuricemia	NN	O	hyperuricemia	prep_of	12	SENT_40	[p2l8t2480r599b2573],
17	with	IN	O	with	_	0	SENT_40	[p2l660t2479r837b2551],
18	mild	JJ	O	mild	amod	20	SENT_40	[p2l903t2479r1085b2550],
19	renal	JJ	O	renal	amod	20	SENT_40	[p2l1151t2480r1358b2551],
20	dysfunction	NN	O	dysfunction	prep_with	16	SENT_40	[p2l1426t2479r1918b2572],
21	.	.	O	.	_	0	SENT_40	[p2l1426t2479r1918b2572],

1	The	DT	O	the	det	2	SENT_41	[p2l1987t2479r2147b2551],
2	drug	NN	O	drug	nsubjpass	4	SENT_41	[p2l10t2596r195b2689],
3	was	VBD	O	be	auxpass	4	SENT_41	[p2l233t2619r383b2668],
4	stopped	VBN	O	stop	_	0	SENT_41	[p2l427t2596r750b2690],
5	for	IN	O	for	_	0	SENT_41	[p2l791t2597r910b2668],
6	1	CD	DURATION	1	prep_for	4	SENT_41	[p2l957t2598r992b2667],
7	month	NN	NUMBER	month	tmod	4	SENT_41	[p2l1039t2596r1305b2668],
8	before	IN	O	before	_	0	SENT_41	[p2l1345t2596r1610b2668],
9	initiation	NN	O	initiation	prep_before	4	SENT_41	[p2l1654t2597r2025b2668],
10	of	IN	O	of	_	0	SENT_41	[p2l2069t2597r2154b2668],
11	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_of	9	SENT_41	[p2l10t2713r624b2807],
12	.	.	O	.	_	0	SENT_41	[p2l10t2713r624b2807],

1	We	PRP	O	we	nsubj	12	SENT_42	[p2l653t2716r792b2785],
2	administered	VBD	O	administer	_	0	SENT_42	[p2l822t2713r1355b2785],
3	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	dobj	2	SENT_42	[p2l1382t2713r1976b2807],
4	at	IN	O	at	_	0	SENT_42	[p2l2005t2723r2078b2785],
5	a	DT	O	a	det	7	SENT_42	[p2l2107t2736r2149b2785],
6	daily	JJ	SET	daily	amod	7	SENT_42	[p2l10t2831r203b2924],
7	dose	NN	O	dose	prep_at	2	SENT_42	[p2l232t2831r415b2903],
8	of	IN	O	of	_	0	SENT_42	[p2l446t2832r531b2903],
9	200	CD	NUMBER	200	num	10	SENT_42	[p2l555t2832r694b2903],
10	mg	NN	O	mg	prep_of	7	SENT_42	[p2l723t2854r847b2924],
11	and	CC	O	and	_	0	SENT_42	[p2l877t2831r1025b2902],
12	stopped	VBD	O	stop	conj_and	2	SENT_42	[p2l1055t2831r1377b2924],
13	the	DT	O	the	det	14	SENT_42	[p2l1405t2831r1533b2903],
14	drug	NN	O	drug	dobj	12	SENT_42	[p2l1564t2831r1750b2924],
15	after	IN	O	after	_	0	SENT_42	[p2l1780t2832r1971b2903],
16	6	CD	NUMBER	6	prep_after	12	SENT_42	[p2l2000t2833r2042b2903],
17	:	:	O	:	_	0	SENT_42	[p2l2081t2841r2139b2899],
18	2	CD	DURATION	2	num	19	SENT_42	[p2l9t2951r54b3020],
19	months	NNS	NUMBER	month	dep	16	SENT_42	[p2l100t2949r422b3021],
20	.	.	O	.	_	0	SENT_42	[p2l100t2949r422b3021],

1	We	PRP	O	we	nsubj	2	SENT_43	[p2l472t2952r611b3021],
2	conducted	VBD	O	conduct	_	0	SENT_43	[p2l659t2949r1083b3021],
3	follow-up	NN	O	follow-up	dobj	2	SENT_43	[p2l1129t2949r1517b3042],
4	of	IN	O	of	_	0	SENT_43	[p2l1565t2950r1651b3021],
5	all	DT	O	all	det	7	SENT_43	[p2l1694t2949r1788b3020],
6	HT	JJ	O	ht	amod	7	SENT_43	[p2l1834t2952r1975b3020],
7	patients	NNS	O	patient	prep_of	3	SENT_43	[p2l2018t2972r2146b3042, p2l8t3067r253b3154],
8	,	,	O	,	_	0	SENT_43	[p2l2018t2972r2146b3042, p2l8t3067r253b3154],
9	including	VBG	O	include	_	0	SENT_43	[p2l330t3067r707b3160],
10	complete	JJ	O	complete	amod	12	SENT_43	[p2l781t3067r1155b3160],
11	blood	NN	O	blood	nn	12	SENT_43	[p2l1228t3067r1462b3139],
12	tests	NNS	O	test	prep_including	2	SENT_43	[p2l1536t3077r1738b3154],
13	,	,	O	,	_	0	SENT_43	[p2l1536t3077r1738b3154],
14	every	DT	SET	every	det	16	SENT_43	[p2l1816t3090r2032b3160],
15	2	CD	SET	2	num	16	SENT_43	[p2l2105t3069r2149b3138],
16	months	NNS	NUMBER	month	appos	12	SENT_43	[p2l8t3185r310b3257],
17	at	IN	O	at	_	0	SENT_43	[p2l347t3195r421b3256],
18	our	PRP$	O	we	poss	20	SENT_43	[p2l455t3208r594b3257],
19	outpatient	NN	O	outpatient	nn	20	SENT_43	[p2l628t3185r1051b3278],
20	clinic	NN	O	clinic	prep_at	16	SENT_43	[p2l1086t3185r1319b3257],
21	.	.	O	.	_	0	SENT_43	[p2l1086t3185r1319b3257],

1	We	PRP	O	we	nsubj	2	SENT_44	[p2l1356t3188r1495b3257],
2	compared	VBD	O	compare	_	0	SENT_44	[p2l1531t3185r1939b3278],
3	CsA	NN	O	csa	nn	4	SENT_44	[p2l1975t3186r2152b3257],
4	level	NN	O	level	dobj	2	SENT_44	[p2l8t3302r196b3374],
5	(	CD	NUMBER	(	num	7	SENT_44	[p2l244t3301r539b3397],
6	ng/ml	NN	O	ng/ml	nn	7	SENT_44	[p2l244t3301r539b3397],
7	)	NN	O	)	dep	4	SENT_44	[p2l244t3301r539b3397],
8	and	CC	O	and	_	0	SENT_44	[p2l588t3302r736b3373],
9	daily	JJ	SET	daily	amod	10	SENT_44	[p2l781t3302r974b3395],
10	dosage	NN	O	dosage	conj_and	4	SENT_44	[p2l1017t3302r1296b3395],
11	(	CD	NUMBER	(	num	13	SENT_44	[p2l1344t3301r1852b3397],
12	mg/kg/day	NN	O	mg/kg/day	nn	13	SENT_44	[p2l1344t3301r1852b3397],
13	)	NN	O	)	dep	10	SENT_44	[p2l1344t3301r1852b3397],
14	,	,	O	,	_	0	SENT_44	[p2l1344t3301r1852b3397],
15	serum	NN	O	serum	nn	16	SENT_44	[p2l1900t3325r2148b3374],
16	creatinine	NN	O	creatinine	conj_and	4	SENT_44	[p2l9t3419r438b3506],
17	,	,	O	,	_	0	SENT_44	[p2l9t3419r438b3506],
18	blood	NN	O	blood	nn	19	SENT_44	[p2l484t3419r718b3491],
19	urea	NN	O	urea	appos	16	SENT_44	[p2l761t3442r965b3505],
20	,	,	O	,	_	0	SENT_44	[p2l761t3442r965b3505],
21	and	CC	O	and	_	0	SENT_44	[p2l1015t3419r1162b3490],
22	uric	JJ	O	uric	amod	23	SENT_44	[p2l1206t3419r1363b3491],
23	acid	NN	O	acid	conj_and	4	SENT_44	[p2l1409t3419r1572b3491],
24	at	IN	O	at	_	0	SENT_44	[p2l1619t3429r1692b3490],
25	onset	NN	O	onset	prep_at	23	SENT_44	[p2l1737t3429r1955b3491],
26	and	CC	O	and	_	0	SENT_44	[p2l2001t3419r2149b3490],
27	before	IN	O	before	_	0	SENT_44	[p2l6t3537r271b3609],
28	interruption	NN	O	interruption	prep_before	23	SENT_44	[p2l300t3537r798b3630],
29	of	IN	O	of	_	0	SENT_44	[p2l825t3538r911b3609],
30	therapy	NN	O	therapy	prep_of	28	SENT_44	[p2l931t3537r1243b3630],
31	and	CC	O	and	_	0	SENT_44	[p2l1270t3537r1438b3624],
32	,	,	O	,	_	0	SENT_44	[p2l1270t3537r1438b3624],
33	as	IN	O	as	conj_and	4	SENT_44	[p2l1470t3560r1548b3609],
34	control	NN	O	control	pobj	33	SENT_44	[p2l1576t3537r1888b3624],
35	,	,	O	,	_	0	SENT_44	[p2l1576t3537r1888b3624],
36	in	IN	O	in	_	0	SENT_44	[p2l1918t3537r1994b3608],
37	the	DT	DURATION	the	det	40	SENT_44	[p2l2020t3537r2147b3609],
38	last	JJ	DATE	last	amod	40	SENT_44	[p2l8t3655r148b3726],
39	6	CD	DATE	6	num	40	SENT_44	[p2l181t3657r223b3727],
40	months	NNS	DATE	month	prep_in	33	SENT_44	[p2l255t3655r557b3727],
41	of	IN	O	of	_	0	SENT_44	[p2l591t3656r676b3727],
42	allopurinol	NN	O	allopurinol	nn	43	SENT_44	[p2l705t3655r1153b3748],
43	treatment	NN	O	treatment	prep_of	33	SENT_44	[p2l1184t3665r1607b3727],
44	.	.	O	.	_	0	SENT_44	[p2l1184t3665r1607b3727],

1	Heart	NNP	O	Heart	_	0	SENT_45	[p2l1644t3658r1883b3727],
2	transplant	NN	O	transplant	dep	1	SENT_45	[p2l1914t3665r2146b3726, p3l7t19r216b112],

1	recipients	NNS	O	recipient	nsubj	2	SENT_46	[p3l281t19r678b112],
2	received	VBD	O	receive	_	0	SENT_46	[p3l744t19r1086b91],
3	CsA	NN	O	csa	dobj	2	SENT_46	[p3l1153t20r1330b91],
4	and	CC	O	and	_	0	SENT_46	[p3l1394t19r1541b90],
5	Aza	NN	O	aza	conj_and	3	SENT_46	[p3l1604t21r1767b90],
6	(	CD	NUMBER	(	num	8	SENT_46	[p3l1835t18r2147b114],
7	double	JJ	O	double	amod	8	SENT_46	[p3l1835t18r2147b114],
8	therapy	NN	O	therapy	dep	3	SENT_46	[p3l8t136r339b229],
9	,	,	O	,	_	0	SENT_46	[p3l8t136r339b229],
10	n	NN	O	n	dobj	2	SENT_46	[p3l371t161r419b208],
11	=	JJ	O	=	amod	13	SENT_46	[p3l465t164r522b186],
12	56	CD	NUMBER	56	tmod	11	SENT_46	[p3l564t135r715b231],
13	)	NN	O	)	dep	10	SENT_46	[p3l564t135r715b231],
14	,	,	O	,	_	0	SENT_46	[p3l564t135r715b231],
15	or	CC	O	or	_	0	SENT_46	[p3l752t159r837b208],
16	CsA	NN	O	csa	conj_or	3	SENT_46	[p3l871t137r1066b223],
17	,	,	O	,	_	0	SENT_46	[p3l871t137r1066b223],
18	Aza	NN	O	aza	conj_or	3	SENT_46	[p3l1099t138r1283b223],
19	,	,	O	,	_	0	SENT_46	[p3l1099t138r1283b223],
20	and	CC	O	and	_	0	SENT_46	[p3l1320t136r1468b207],
21	oral	JJ	O	oral	amod	25	SENT_46	[p3l1501t136r1660b208],
22	prednisone	NN	O	prednisone	nn	25	SENT_46	[p3l1691t136r2147b229],
23	(	NN	O	(	nn	25	SENT_46	[p3l13t252r262b348],
24	triple	JJ	O	triple	amod	25	SENT_46	[p3l13t252r262b348],
25	therapy	NN	O	therapy	dobj	2	SENT_46	[p3l317t253r648b346],
26	,	,	O	,	_	0	SENT_46	[p3l317t253r648b346],
27	n	NN	O	n	appos	25	SENT_46	[p3l701t278r750b325],
28	=	JJ	O	=	advmod	2	SENT_46	[p3l817t281r875b303],
29	64	CD	NUMBER	64	num	30	SENT_46	[p3l941t252r1065b348],
30	)	CD	NUMBER	)	dep	28	SENT_46	[p3l941t252r1065b348],
31	as	IN	O	as	prep	28	SENT_46	[p3l1125t276r1203b324],
32	previously	RB	DATE	previously	advmod	33	SENT_46	[p3l1256t253r1676b346],
33	detailed	VBN	O	detail	dep	31	SENT_46	[p3l1729t250r2148b325],
34	.	.	O	.	_	0	SENT_46	[p3l1729t250r2148b325],

1	”	NN	O	”	nn	3	SENT_47	[p3l1729t250r2148b325],
2	Oral	JJ	O	oral	amod	3	SENT_47	[p3l11t371r194b443],
3	prednisone	NN	O	prednisone	nsubjpass	5	SENT_47	[p3l221t371r677b464],
4	was	VBD	O	be	auxpass	5	SENT_47	[p3l702t394r852b443],
5	added	VBN	O	add	conj_or	5	SENT_47	[p3l884t371r1131b443],
6	to	TO	O	to	_	0	SENT_47	[p3l1160t381r1239b443],
7	CsA	NN	O	csa	nn	10	SENT_47	[p3l1271t372r1448b443],
8	and	CC	O	and	_	0	SENT_47	[p3l1475t371r1623b442],
9	Aza	NN	O	aza	nn	10	SENT_47	[p3l1648t373r1812b442],
10	therapy	NN	O	therapy	prep_to	5	SENT_47	[p3l1840t371r2151b464],
11	in	IN	O	in	_	0	SENT_47	[p3l9t489r84b560],
12	the	DT	O	the	det	13	SENT_47	[p3l109t489r237b561],
13	presence	NN	O	presence	prep_in	10	SENT_47	[p3l262t512r624b582],
14	of	IN	O	of	_	0	SENT_47	[p3l651t490r737b561],
15	repeated	VBN	O	repeat	prep_of	13	SENT_47	[p3l756t489r1117b582],
16	or	CC	O	or	_	0	SENT_47	[p3l1144t512r1230b561],
17	persistent	JJ	O	persistent	amod	18	SENT_47	[p3l1252t489r1652b582],
18	rejection	NN	O	rejection	prep_of	13	SENT_47	[p3l1677t489r2037b582],
19	or	CC	O	or	_	0	SENT_47	[p3l2064t512r2149b561],
20	of	IN	O	of	_	0	SENT_47	[p3l9t608r95b679],
21	CsA	NN	O	csa	nn	22	SENT_47	[p3l116t608r293b679],
22	nephrotoxicity	NN	O	nephrotoxicity	prep_of	5	SENT_47	[p3l315t607r924b700],
23	.	.	O	.	_	0	SENT_47	[p3l315t607r924b700],

1	We	PRP	O	we	nsubj	2	SENT_48	[p3l952t610r1091b679],
2	monitored	VBD	O	monitor	_	0	SENT_48	[p3l1117t607r1547b679],
3	graft	NN	O	graft	nn	4	SENT_48	[p3l1572t608r1764b700],
4	rejection	NN	O	rejection	dobj	2	SENT_48	[p3l1788t607r2148b700],
5	using	VBG	O	use	xcomp	2	SENT_48	[p3l7t725r222b818],
6	endomyocardial	JJ	O	endomyocardial	amod	7	SENT_48	[p3l262t725r917b818],
7	biopsy	NN	O	biopsy	dobj	5	SENT_48	[p3l954t725r1236b818],
8	,	,	O	,	_	0	SENT_48	[p3l954t725r1236b818],
9	following	VBG	O	follow	_	0	SENT_48	[p3l1278t725r1656b818],
10	established	JJ	O	established	amod	11	SENT_48	[p3l1696t725r2149b797],
11	protocols	NNS	O	protocol	prep_following	7	SENT_48	[p3l7t840r481b936],
12	.	.	O	.	_	0	SENT_48	[p3l7t840r481b936],

1	”	NN	O	”	nsubj	3	SENT_49	[p3l7t840r481b936],
2	We	PRP	O	we	nsubj	3	SENT_49	[p3l527t846r666b915],
3	graded	VBD	O	grade	_	0	SENT_49	[p3l714t843r995b936],
4	rejection	NN	O	rejection	dobj	3	SENT_49	[p3l1042t843r1402b936],
5	according	VBG	O	accord	_	0	SENT_49	[p3l1451t843r1847b936],
6	to	TO	O	to	prepc_according_to	3	SENT_49	[p3l1893t854r1972b914],
7	the	DT	O	the	det	9	SENT_49	[p3l2020t843r2147b914],
8	International	NNP	ORGANIZATION	International	nn	9	SENT_49	[p3l9t961r548b1032],
9	Society	NNP	ORGANIZATION	Society	pobj	3	SENT_49	[p3l604t961r897b1054],
10	for	IN	ORGANIZATION	for	_	0	SENT_49	[p3l949t962r1067b1032],
11	Heart	NNP	ORGANIZATION	Heart	prep_for	9	SENT_49	[p3l1121t963r1360b1032],
12	and	CC	O	and	_	0	SENT_49	[p3l1416t961r1563b1032],
13	Lung	NN	O	lung	nn	14	SENT_49	[p3l1617t963r1829b1054],
14	Transplantation	NN	O	transplantation	conj_and	9	SENT_49	[p3l1882t963r2146b1032, p3l7t1079r427b1172],
15	(	CD	NUMBER	(	num	16	SENT_49	[p3l475t1078r832b1174],
16	ISHLT	NNP	O	ISHLT	dep	14	SENT_49	[p3l475t1078r832b1174],
17	)	CD	NUMBER	)	num	16	SENT_49	[p3l475t1078r832b1174],
18	standardized	JJ	O	standardized	amod	20	SENT_49	[p3l882t1079r1405b1150],
19	scoring	VBG	O	score	amod	20	SENT_49	[p3l1451t1079r1741b1172],
20	system	NN	O	system	dep	3	SENT_49	[p3l1787t1076r2145b1172],
21	.	.	O	.	_	0	SENT_49	[p3l1787t1076r2145b1172],

1	“	NN	O	“	nsubjpass	5	SENT_50	[p3l1787t1076r2145b1172],
2	All	DT	O	all	det	3	SENT_50	[p3l6t1196r131b1266],
3	values	NNS	O	value	dep	1	SENT_50	[p3l174t1196r429b1267],
4	are	VBP	O	be	auxpass	5	SENT_50	[p3l479t1219r604b1267],
5	expressed	VBN	O	express	_	0	SENT_50	[p3l653t1196r1050b1289],
6	as	IN	O	as	_	0	SENT_50	[p3l1099t1219r1177b1267],
7	the	DT	O	the	det	8	SENT_50	[p3l1224t1196r1351b1267],
8	mean	NN	O	mean	prep_as	5	SENT_50	[p3l1399t1219r1623b1267],
9	:	:	O	:	_	0	SENT_50	[p3l1679t1206r1737b1264],
10	standard	JJ	O	standard	amod	11	SENT_50	[p3l1794t1196r2148b1267],
11	deviation	NN	O	deviation	dep	8	SENT_50	[p3l10t1314r407b1385],
12	.	.	O	.	_	0	SENT_50	[p3l10t1314r407b1385],

1	We	PRP	O	we	nsubj	2	SENT_51	[p3l437t1316r576b1386],
2	used	VBD	O	use	_	0	SENT_51	[p3l603t1314r791b1385],
3	paired	JJ	O	paired	amod	5	SENT_51	[p3l817t1314r1079b1407],
4	Student	NN	O	student	nn	5	SENT_51	[p3l1107t1314r1424b1386],
5	t-test	NN	O	t-test	dobj	2	SENT_51	[p3l1451t1324r1658b1385],
6	to	TO	O	to	aux	7	SENT_51	[p3l1685t1324r1764b1385],
7	compare	VB	O	compare	xcomp	2	SENT_51	[p3l1794t1337r2147b1407],
8	pre	JJ	O	pre	amod	12	SENT_51	[p3l7t1455r172b1525],
9	-	:	O	-	_	0	SENT_51	[p3l7t1455r172b1525],
10	and	CC	O	and	_	0	SENT_51	[p3l209t1432r356b1503],
11	post-therapy	JJ	O	post-therapy	amod	12	SENT_51	[p3l387t1432r905b1525],
12	values	NNS	O	value	dobj	7	SENT_51	[p3l931t1432r1207b1503],
13	.	.	O	.	_	0	SENT_51	[p3l931t1432r1207b1503],

1	We	PRP	O	we	nsubj	2	SENT_52	[p3l1242t1434r1382b1504],
2	considered	VBD	O	consider	_	0	SENT_52	[p3l1416t1432r1861b1503],
3	differences	NNS	O	difference	nn	4	SENT_52	[p3l1895t1432r2146b1503, p3l10t1573r232b1621],
4	signiﬁcant	NN	O	signiﬁcant	dobj	2	SENT_52	[p3l270t1550r683b1643],
5	at	IN	O	at	_	0	SENT_52	[p3l721t1560r794b1621],
6	p	NN	O	p	prep_at	4	SENT_52	[p3l814t1574r873b1642],
7	<	JJR	O	<	tmod	2	SENT_52	[p3l917t1561r982b1616],
8	.05	CD	NUMBER	.05	dep	7	SENT_52	[p3l1028t1550r1160b1622],
9	.	.	O	.	_	0	SENT_52	[p3l1028t1550r1160b1622],

1	The	DT	O	the	det	2	SENT_53	[p3l332t1662r476b1725],
2	Journal	NNP	O	Journal	_	0	SENT_53	[p3l508t1662r786b1726],
3	of	IN	O	of	_	0	SENT_53	[p3l819t1662r896b1725],
4	Heart	NNP	O	Heart	nn	8	SENT_53	[p3l922t1664r1137b1725],
5	and	CC	O	and	_	0	SENT_53	[p3l1172t1662r1304b1725],
6	Lung	NN	O	lung	nn	8	SENT_53	[p3l1336t1664r1526b1745],
7	Transplantation	NN	O	transplantation	nn	8	SENT_53	[p3l1558t1662r2148b1745],
8	December	NNP	DATE	December	prep_of	2	SENT_53	[p3l1547t1766r1931b1830],
9	2000	CD	DATE	2000	num	8	SENT_53	[p3l1978t1767r2147b1830],

1	RESULTS	NNS	O	result	_	0	SENT_54	[p3l9t2004r372b2077],

1	Mean	NN	O	mean	nn	2	SENT_55	[p3l12t2173r247b2241],
2	uricemia	NN	O	uricemia	nsubj	3	SENT_55	[p3l305t2170r662b2241],
3	decreased	VBD	O	decrease	_	0	SENT_55	[p3l723t2170r1129b2241],
4	with	IN	O	with	_	0	SENT_55	[p3l1184t2170r1361b2241],
5	allopurinol	NN	O	allopurinol	nn	7	SENT_55	[p3l1423t2170r1870b2263],
6	(	CD	NUMBER	(	num	7	SENT_55	[p3l1933t2169r2009b2265],
7	p	NN	O	p	prep_with	3	SENT_55	[p3l1933t2169r2009b2265],
8	=	JJ	O	=	advmod	3	SENT_55	[p3l2080t2198r2138b2220],
9	0.0001	CD	NUMBER	0.0001	num	10	SENT_55	[p3l12t2283r306b2379],
10	)	NN	O	)	dep	8	SENT_55	[p3l12t2283r306b2379],
11	as	RB	O	as	_	0	SENT_55	[p3l345t2307r423b2355],
12	well	RB	O	well	_	0	SENT_55	[p3l452t2284r618b2356],
13	as	IN	O	as	_	0	SENT_55	[p3l654t2307r731b2355],
14	with	IN	O	with	_	0	SENT_55	[p3l761t2284r938b2356],
15	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	17	SENT_55	[p3l973t2284r1564b2377],
16	(	NN	O	(	nn	17	SENT_55	[p3l1603t2283r1679b2379],
17	p	NN	O	p	conj_and	7	SENT_55	[p3l1603t2283r1679b2379],
18	=	JJ	O	=	amod	17	SENT_55	[p3l1724t2312r1782b2334],
19	0.0001	CD	NUMBER	0.0001	num	20	SENT_55	[p3l1825t2283r2143b2379],
20	)	NN	O	)	dep	18	SENT_55	[p3l1825t2283r2143b2379],
21	.	.	O	.	_	0	SENT_55	[p3l1825t2283r2143b2379],

1	The	DT	O	the	det	2	SENT_56	[p3l10t2401r169b2472],
2	reduction	NN	O	reduction	nsubj	10	SENT_56	[p3l213t2401r605b2472],
3	of	IN	O	of	_	0	SENT_56	[p3l648t2401r734b2472],
4	plasma	NN	O	plasma	nn	6	SENT_56	[p3l768t2400r1057b2494],
5	uric	JJ	O	uric	amod	6	SENT_56	[p3l1097t2401r1254b2472],
6	acid	NN	O	acid	prep_of	2	SENT_56	[p3l1297t2400r1460b2472],
7	with	IN	O	with	_	0	SENT_56	[p3l1498t2401r1674b2472],
8	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	6	SENT_56	[p3l1718t2400r2145b2494, p3l10t2539r201b2588],
9	was	VBD	O	be	cop	10	SENT_56	[p3l233t2539r382b2588],
10	rapid	JJ	O	rapid	_	0	SENT_56	[p3l418t2517r630b2610],
11	and	CC	O	and	_	0	SENT_56	[p3l667t2517r814b2588],
12	sustained	JJ	O	sustained	conj_and	10	SENT_56	[p3l850t2517r1230b2588],
13	in	IN	O	in	_	0	SENT_56	[p3l1265t2517r1340b2587],
14	all	DT	O	all	det	15	SENT_56	[p3l1378t2517r1471b2588],
15	patients	NNS	O	patient	prep_in	10	SENT_56	[p3l1505t2517r1850b2610],
16	,	,	O	,	_	0	SENT_56	[p3l1505t2517r1850b2610],
17	and	CC	O	and	_	0	SENT_56	[p3l1890t2517r2037b2588],
18	in	IN	O	in	_	0	SENT_56	[p3l2072t2517r2147b2587],
19	a	DT	O	a	det	22	SENT_56	[p3l13t2656r56b2704],
20	sizable	JJ	O	sizable	amod	22	SENT_56	[p3l110t2633r382b2704],
21	proportion	NN	O	proportion	nn	22	SENT_56	[p3l436t2633r882b2726],
22	(	NN	O	(	prep_in	29	SENT_56	[p3l940t2631r1258b2727],
23	57/120	CD	NUMBER	57/120	nsubjpass	29	SENT_56	[p3l940t2631r1258b2727],
24	,	,	O	,	_	0	SENT_56	[p3l940t2631r1258b2727],
25	48	CD	PERCENT	48	num	26	SENT_56	[p3l1315t2632r1532b2727],
26	%	NN	PERCENT	%	appos	23	SENT_56	[p3l1315t2632r1532b2727],
27	)	CD	NUMBER	)	dep	26	SENT_56	[p3l1315t2632r1532b2727],
28	was	VBD	O	be	auxpass	29	SENT_56	[p3l1585t2656r1735b2704],
29	achieved	VBN	O	achieve	conj_and	10	SENT_56	[p3l1793t2633r2147b2704],
30	earlier	JJR	O	earlier	advmod	29	SENT_56	[p3l12t2748r277b2820],
31	than	IN	O	than	_	0	SENT_56	[p3l324t2748r506b2819],
32	the	DT	O	the	det	35	SENT_56	[p3l554t2748r681b2820],
33	6-month	JJ	DURATION	6-month	amod	35	SENT_56	[p3l732t2748r1076b2820],
34	treatment	NN	O	treatment	nn	35	SENT_56	[p3l1123t2758r1526b2820],
35	period	NN	O	period	prep_than	29	SENT_56	[p3l1573t2748r1859b2841],
36	.	.	O	.	_	0	SENT_56	[p3l1573t2748r1859b2841],

1	Mean	NN	O	mean	nn	2	SENT_57	[p3l1913t2751r2147b2820],
2	creatinine	NN	O	creatinine	nsubj	3	SENT_57	[p3l12t2865r418b2936],
3	increased	VBD	O	increase	_	0	SENT_57	[p3l475t2864r862b2936],
4	(	CD	NUMBER	(	num	5	SENT_57	[p3l922t2863r997b2959],
5	p	NN	O	p	dobj	3	SENT_57	[p3l922t2863r997b2959],
6	=	JJ	O	=	amod	5	SENT_57	[p3l1065t2892r1123b2914],
7	0.01	CD	NUMBER	0.01	num	8	SENT_57	[p3l1189t2863r1386b2959],
8	)	NN	O	)	dep	6	SENT_57	[p3l1189t2863r1386b2959],
9	with	IN	O	with	_	0	SENT_57	[p3l1441t2864r1618b2936],
10	allopurinol	NN	O	allopurinol	prep_with	3	SENT_57	[p3l1676t2864r2144b2958],
11	,	,	O	,	_	0	SENT_57	[p3l1676t2864r2144b2958],
12	whereas	IN	O	whereas	mark	14	SENT_57	[p3l6t2981r341b3052],
13	it	PRP	O	it	nsubj	14	SENT_57	[p3l369t2981r423b3052],
14	tended	VBD	O	tend	advcl	3	SENT_57	[p3l449t2981r730b3052],
15	to	TO	O	to	aux	16	SENT_57	[p3l757t2991r836b3052],
16	decrease	VB	O	decrease	xcomp	14	SENT_57	[p3l865t2981r1218b3052],
17	with	IN	O	with	_	0	SENT_57	[p3l1241t2981r1418b3052],
18	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	20	SENT_57	[p3l1446t2980r2038b3074],
19	(	NN	O	(	nn	20	SENT_57	[p3l2069t2979r2145b3075],
20	p	NN	O	p	nn	23	SENT_57	[p3l2069t2979r2145b3075],
21	=	JJ	O	=	amod	23	SENT_57	[p3l20t3125r78b3147],
22	NS	NN	O	n	nn	23	SENT_57	[p3l123t3096r304b3191],
23	)	NN	O	)	prep_with	16	SENT_57	[p3l123t3096r304b3191],
24	.	.	O	.	_	0	SENT_57	[p3l123t3096r304b3191],

1	Mean	NN	O	mean	nn	2	SENT_58	[p3l345t3100r580b3168],
2	urea	NN	O	urea	nsubj	9	SENT_58	[p3l615t3120r798b3168],
3	did	VBD	O	do	aux	5	SENT_58	[p3l835t3097r962b3168],
4	not	RB	O	not	neg	5	SENT_58	[p3l997t3107r1131b3168],
5	change	VB	O	change	_	0	SENT_58	[p3l1168t3097r1452b3190],
6	with	IN	O	with	_	0	SENT_58	[p3l1485t3097r1662b3168],
7	allopurinol	NN	O	allopurinol	prep_with	5	SENT_58	[p3l1700t3097r2147b3190],
8	but	CC	O	but	_	0	SENT_58	[p3l8t3214r143b3285],
9	fell	VBD	O	fall	conj_but	5	SENT_58	[p3l170t3214r298b3285],
10	with	IN	O	with	_	0	SENT_58	[p3l321t3214r498b3285],
11	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	13	SENT_58	[p3l526t3214r1118b3307],
12	(	NN	O	(	nn	13	SENT_58	[p3l1150t3213r1225b3308],
13	p	NN	O	p	prep_with	9	SENT_58	[p3l1150t3213r1225b3308],
14	=	JJ	O	=	amod	13	SENT_58	[p3l1265t3242r1323b3264],
15	0.0004	CD	NUMBER	0.0004	num	16	SENT_58	[p3l1360t3213r1678b3308],
16	)	NN	O	)	dep	14	SENT_58	[p3l1360t3213r1678b3308],
17	.	.	O	.	_	0	SENT_58	[p3l1360t3213r1678b3308],

1	Mean	NN	O	mean	nn	3	SENT_59	[p3l1710t3217r1945b3285],
2	CSA	NN	O	csa	nn	3	SENT_59	[p3l1975t3215r2151b3286],
3	levels	NNS	O	level	nsubj	5	SENT_59	[p3l10t3328r234b3400],
4	were	VBD	O	be	cop	5	SENT_59	[p3l263t3351r460b3400],
5	constant	JJ	O	constant	_	0	SENT_59	[p3l494t3338r838b3400],
6	with	IN	O	with	_	0	SENT_59	[p3l865t3328r1042b3400],
7	allopurinol	NN	O	allopurinol	prep_with	5	SENT_59	[p3l1077t3328r1545b3421],
8	,	,	O	,	_	0	SENT_59	[p3l1077t3328r1545b3421],
9	although	IN	O	although	mark	14	SENT_59	[p3l1582t3328r1940b3421],
10	CsA	NN	O	csa	nn	11	SENT_59	[p3l1975t3329r2151b3400],
11	dose	NN	O	dose	nsubjpass	14	SENT_59	[p3l13t3445r196b3516],
12	was	VBD	O	be	auxpass	14	SENT_59	[p3l218t3467r367b3516],
13	slightly	RB	O	slightly	advmod	14	SENT_59	[p3l395t3445r683b3538],
14	reduced	VBN	O	reduce	advcl	5	SENT_59	[p3l706t3445r1035b3516],
15	(	NN	O	(	nn	16	SENT_59	[p3l1064t3443r1140b3539],
16	p	NN	O	p	dobj	14	SENT_59	[p3l1064t3443r1140b3539],
17	=	JJ	O	=	advmod	14	SENT_59	[p3l1178t3472r1236b3494],
18	0.007	CD	NUMBER	0.007	num	19	SENT_59	[p3l1271t3443r1541b3539],
19	)	NN	O	)	dep	17	SENT_59	[p3l1271t3443r1541b3539],
20	.	.	O	.	_	0	SENT_59	[p3l1271t3443r1541b3539],

1	Conversely	RB	O	conversely	_	0	SENT_60	[p3l1573t3445r2043b3537],
2	,	,	O	,	_	0	SENT_60	[p3l1573t3445r2043b3537],
3	at	IN	O	at	conj_and	1	SENT_60	[p3l2074t3455r2148b3516],
4	the	DT	O	the	det	5	SENT_60	[p3l11t3561r138b3632],
5	end	NN	O	end	pobj	3	SENT_60	[p3l187t3561r335b3632],
6	of	IN	O	of	_	0	SENT_60	[p3l383t3561r468b3632],
7	the	DT	O	the	det	9	SENT_60	[p3l508t3561r635b3632],
8	treatment	NN	O	treatment	nn	9	SENT_60	[p3l683t3571r1086b3632],
9	period	NN	O	period	prep_of	5	SENT_60	[p3l1130t3561r1397b3654],
10	and	CC	O	and	_	0	SENT_60	[p3l1446t3561r1593b3632],
11	not	RB	O	not	dep	12	SENT_60	[p3l1639t3571r1773b3632],
12	simultaneously	RB	O	simultaneously	conj_and	1	SENT_60	[p3l1820t3561r2145b3632, p3l10t3677r321b3770],
13	with	IN	O	with	_	0	SENT_60	[p3l354t3677r531b3748],
14	the	DT	O	the	det	15	SENT_60	[p3l570t3677r697b3748],
15	reduction	NN	O	reduction	prep_with	12	SENT_60	[p3l738t3677r1130b3748],
16	in	IN	O	in	_	0	SENT_60	[p3l1170t3677r1245b3747],
17	uric	JJ	O	uric	amod	19	SENT_60	[p3l1284t3677r1441b3748],
18	acid	NN	O	acid	nn	19	SENT_60	[p3l1481t3677r1644b3748],
19	levels	NNS	O	level	prep_in	15	SENT_60	[p3l1683t3677r1930b3763],
20	,	,	O	,	_	0	SENT_60	[p3l1683t3677r1930b3763],
21	CSA	NNP	O	CSA	appos	19	SENT_60	[p3l1975t3678r2151b3749],

1	levels	NNS	O	level	nsubj	2	SENT_61	[p4l11t18r234b90],
2	dropped	VBD	O	drop	_	0	SENT_61	[p4l294t18r637b111],
3	with	IN	O	with	_	0	SENT_61	[p4l690t18r867b90],
4	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	6	SENT_61	[p4l925t18r1517b111],
5	(	NN	O	(	nn	6	SENT_61	[p4l1579t17r1655b113],
6	p	NN	O	p	prep_with	2	SENT_61	[p4l1579t17r1655b113],
7	=	JJ	O	=	amod	6	SENT_61	[p4l1725t46r1782b68],
8	0.0001	CD	NUMBER	0.0001	tmod	7	SENT_61	[p4l1850t17r2144b113],
9	)	CD	NUMBER	)	nsubj	17	SENT_61	[p4l1850t17r2144b113],
10	despite	IN	O	despite	_	0	SENT_61	[p4l13t135r301b228],
11	increased	VBN	O	increase	amod	12	SENT_61	[p4l367t135r754b206],
12	CsA	NN	O	csa	prep_despite	9	SENT_61	[p4l820t136r996b206],
13	daily	RB	SET	daily	advmod	16	SENT_61	[p4l1058t134r1251b227],
14	dose	NN	O	dose	nn	16	SENT_61	[p4l1314t134r1497b206],
15	(	NN	O	(	nn	16	SENT_61	[p4l1566t133r1642b229],
16	p	NN	O	p	dep	12	SENT_61	[p4l1566t133r1642b229],
17	=	JJ	O	=	rcmod	6	SENT_61	[p4l1718t162r1776b184],
18	0.0001	CD	NUMBER	0.0001	num	19	SENT_61	[p4l1850t133r2144b229],
19	)	CD	NUMBER	)	iobj	17	SENT_61	[p4l1850t133r2144b229],
20	(	CD	NUMBER	(	num	22	SENT_61	[p4l15t249r337b345],
21	Table	NNP	O	Table	nn	22	SENT_61	[p4l15t249r337b345],
22	)	NN	O	)	dobj	17	SENT_61	[p4l15t249r337b345],
23	.	.	O	.	_	0	SENT_61	[p4l15t249r337b345],

1	Heart	NNP	O	Heart	nn	3	SENT_62	[p4l369t253r609b322],
2	transplant	NN	O	transplant	nn	3	SENT_62	[p4l637t251r1050b344],
3	patients	NNS	O	patient	nsubj	11	SENT_62	[p4l1077t251r1400b344],
4	on	IN	O	on	_	0	SENT_62	[p4l1431t273r1531b322],
5	double	JJ	O	double	prep_on	3	SENT_62	[p4l1562t251r1838b322],
6	and	CC	O	and	_	0	SENT_62	[p4l1870t251r2017b322],
7	on	IN	O	on	_	0	SENT_62	[p4l2046t273r2147b322],
8	triple	JJ	O	triple	amod	10	SENT_62	[p4l11t368r227b461],
9	immunosuppressive	JJ	O	immunosuppressive	amod	10	SENT_62	[p4l281t368r1090b461],
10	therapy	NN	O	therapy	prep_on	3	SENT_62	[p4l1144t368r1454b461],
11	had	VBD	O	have	_	0	SENT_62	[p4l1505t368r1655b439],
12	similar	JJ	O	similar	amod	13	SENT_62	[p4l1708t368r1983b439],
13	results	NNS	O	result	dobj	11	SENT_62	[p4l2035t391r2145b439, p4l12t484r212b570],
14	,	,	O	,	_	0	SENT_62	[p4l2035t391r2145b439, p4l12t484r212b570],
15	except	IN	O	except	_	0	SENT_62	[p4l251t494r511b577],
16	for	IN	O	for	_	0	SENT_62	[p4l545t484r663b555],
17	mean	NN	O	mean	nn	18	SENT_62	[p4l696t507r920b555],
18	CsA	NN	O	csa	prep_for	20	SENT_62	[p4l957t485r1133b556],
19	daily	RB	SET	daily	advmod	20	SENT_62	[p4l1166t484r1358b577],
20	dose	NN	O	dose	prep_except	11	SENT_62	[p4l1392t484r1576b555],
21	at	IN	O	at	_	0	SENT_62	[p4l1614t494r1687b555],
22	the	DT	O	the	det	23	SENT_62	[p4l1721t484r1848b555],
23	end	NN	O	end	prep_at	20	SENT_62	[p4l1885t484r2033b555],
24	of	IN	O	of	_	0	SENT_62	[p4l2068t484r2153b555],
25	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	26	SENT_62	[p4l12t600r604b693],
26	treatment	NN	O	treatment	prep_of	23	SENT_62	[p4l645t610r1068b686],
27	,	,	O	,	_	0	SENT_62	[p4l645t610r1068b686],
28	which	WDT	O	which	nsubj	30	SENT_62	[p4l1107t600r1347b671],
29	was	VBD	O	be	cop	30	SENT_62	[p4l1382t623r1532b671],
30	higher	JJR	O	higher	rcmod	26	SENT_62	[p4l1572t600r1833b693],
31	among	IN	O	among	prep	30	SENT_62	[p4l1874t623r2148b693],
32	patients	NNS	O	patient	dep	38	SENT_62	[p4l9t715r333b808],
33	on	IN	O	on	_	0	SENT_62	[p4l380t738r481b787],
34	triple	JJ	O	triple	amod	35	SENT_62	[p4l525t715r742b808],
35	therapy	NN	O	therapy	prep_on	32	SENT_62	[p4l789t715r1099b808],
36	(	NN	O	(	dep	38	SENT_62	[p4l1146t714r1295b810],
37	2.9	CD	NUMBER	2.9	num	36	SENT_62	[p4l1146t714r1295b810],
38	i	FW	O	i	dep	44	SENT_62	[p4l1350t725r1408b783],
39	0.9	CD	NUMBER	0.9	dep	38	SENT_62	[p4l1463t717r1578b787],
40	vs	CC	O	vs	_	0	SENT_62	[p4l1621t738r1701b787],
41	2.6	CD	NUMBER	2.6	conj_vs	39	SENT_62	[p4l1748t717r1862b787],
42	:	:	O	:	_	0	SENT_62	[p4l1918t725r1976b783],
43	0.7	CD	NUMBER	0.7	num	44	SENT_62	[p4l2031t717r2147b787],
44	mg/kg/day	NN	O	mg/kg/day	dep	31	SENT_62	[p4l10t831r447b924],
45	,	,	O	,	_	0	SENT_62	[p4l10t831r447b924],
46	p	NN	O	p	appos	20	SENT_62	[p4l475t856r533b923],
47	=	JJ	O	=	amod	49	SENT_62	[p4l585t859r642b881],
48	0.02	CD	NUMBER	0.02	tmod	47	SENT_62	[p4l693t830r914b926],
49	)	NN	O	)	dep	46	SENT_62	[p4l693t830r914b926],
50	.	.	O	.	_	0	SENT_62	[p4l693t830r914b926],

1	Two	CD	NUMBER	two	num	2	SENT_63	[p4l958t834r1134b903],
2	patients	NNS	O	patient	nsubj	9	SENT_63	[p4l1175t831r1520b924],
3	,	,	O	,	_	0	SENT_63	[p4l1175t831r1520b924],
4	both	DT	O	both	appos	2	SENT_63	[p4l1561t831r1748b903],
5	on	IN	O	on	_	0	SENT_63	[p4l1789t854r1889b903],
6	triple	JJ	O	triple	amod	7	SENT_63	[p4l1930t831r2146b924],
7	therapy	NN	O	therapy	prep_on	4	SENT_63	[p4l11t948r340b1042],
8	,	,	O	,	_	0	SENT_63	[p4l11t948r340b1042],
9	experienced	VBD	O	experience	_	0	SENT_63	[p4l411t949r903b1042],
10	unexpected	JJ	O	unexpected	acomp	9	SENT_63	[p4l969t948r1437b1042],
11	acute	JJ	O	acute	amod	16	SENT_63	[p4l1505t959r1720b1020],
12	rejection	NN	O	rejection	nn	16	SENT_63	[p4l1788t949r2148b1041],
13	(	CD	NUMBER	(	num	16	SENT_63	[p4l15t1063r306b1159],
14	Grade	NNP	O	Grade	nn	16	SENT_63	[p4l15t1063r306b1159],
15	3A	NN	O	3a	nn	16	SENT_63	[p4l338t1063r489b1159],
16	)	NN	O	)	dep	10	SENT_63	[p4l338t1063r489b1159],
17	Without	IN	O	without	dep	10	SENT_63	[p4l518t1065r832b1136],
18	hemodynamic	JJ	O	hemodynamic	amod	19	SENT_63	[p4l862t1065r1436b1157],
19	compromise	NN	O	compromise	pobj	17	SENT_63	[p4l1465t1065r1966b1158],
20	at	IN	O	at	dep	10	SENT_63	[p4l2000t1075r2073b1136],
21	5	CD	NUMBER	5	num	25	SENT_63	[p4l2103t1065r2144b1136],
22	and	CC	O	and	_	0	SENT_63	[p4l13t1181r160b1252],
23	7	CD	DURATION	7	num	25	SENT_63	[p4l212t1183r256b1252],
24	years	NNS	NUMBER	year	nn	25	SENT_63	[p4l303t1203r515b1274],
25	post	NN	O	post	pobj	20	SENT_63	[p4l566t1183r912b1274],
26	.	.	O	.	_	0	SENT_63	[p4l566t1183r912b1274],

1	—	NN	O	—	_	0	SENT_64	[p4l566t1183r912b1274],
2	.	.	O	.	_	0	SENT_64	[p4l566t1183r912b1274],

1	HT	NNP	O	HT	_	0	SENT_65	[p4l566t1183r912b1274],
2	during	IN	O	during	_	0	SENT_65	[p4l964t1181r1228b1274],
3	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	4	SENT_65	[p4l1280t1180r1872b1274],
4	treatment	NN	O	treatment	prep_during	1	SENT_65	[p4l1924t1191r2145b1252, p4l10t1307r238b1368],
5	.	.	O	.	_	0	SENT_65	[p4l1924t1191r2145b1252, p4l10t1307r238b1368],

1	Concomitant	JJ	O	concomitant	amod	3	SENT_66	[p4l306t1297r838b1369],
2	CSA	NN	O	csa	nn	3	SENT_66	[p4l901t1298r1077b1369],
3	levels	NNS	O	level	nsubjpass	5	SENT_66	[p4l1136t1297r1360b1368],
4	were	VBD	O	be	auxpass	5	SENT_66	[p4l1417t1320r1614b1368],
5	reduced	VBN	O	reduce	_	0	SENT_66	[p4l1676t1297r2006b1368],
6	to	TO	O	to	xcomp	5	SENT_66	[p4l2067t1307r2146b1368],

1	<	JJR	O	<	_	0	SENT_67	[p4l17t1414r232b1484],
2	100	CD	NUMBER	100	num	3	SENT_67	[p4l17t1414r232b1484],
3	ng/ml	NN	O	ng/ml	npadvmod	1	SENT_67	[p4l267t1413r495b1506],
4	in	IN	O	in	_	0	SENT_67	[p4l531t1413r606b1483],
5	both	DT	O	both	det	6	SENT_67	[p4l640t1413r826b1484],
6	patients	NNS	O	patient	prep_in	1	SENT_67	[p4l860t1413r1206b1506],
7	,	,	O	,	_	0	SENT_67	[p4l860t1413r1206b1506],
8	who	WP	O	who	nsubjpass	11	SENT_67	[p4l1239t1413r1409b1484],
9	were	VBD	O	be	auxpass	11	SENT_67	[p4l1442t1436r1639b1484],
10	successfully	RB	O	successfully	advmod	11	SENT_67	[p4l1677t1413r2150b1506],
11	treated	VBN	O	treat	rcmod	6	SENT_67	[p4l11t1529r302b1600],
12	with	IN	O	with	_	0	SENT_67	[p4l354t1529r531b1600],
13	standard	JJ	O	standard	amod	15	SENT_67	[p4l589t1529r942b1600],
14	IV	CD	NUMBER	iv	num	15	SENT_67	[p4l1000t1531r1107b1601],
15	steroids	NNS	O	steroid	prep_with	11	SENT_67	[p4l1164t1529r1500b1600],
16	.	.	O	.	_	0	SENT_67	[p4l1164t1529r1500b1600],

1	We	PRP	O	we	nsubj	2	SENT_68	[p4l1559t1531r1698b1601],
2	noted	VBD	O	note	_	0	SENT_68	[p4l1756t1529r1990b1600],
3	no	DT	O	no	det	6	SENT_68	[p4l2045t1552r2146b1600],
4	additional	JJ	O	additional	amod	6	SENT_68	[p4l13t1644r424b1716],
5	side	JJ	O	side	amod	6	SENT_68	[p4l480t1644r638b1716],
6	effects	NNS	O	effect	dobj	2	SENT_68	[p4l696t1645r959b1716],
7	associated	VBN	O	associate	partmod	6	SENT_68	[p4l1018t1644r1434b1716],
8	with	IN	O	with	_	0	SENT_68	[p4l1484t1644r1661b1716],
9	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	7	SENT_68	[p4l1718t1644r2146b1737, p4l10t1783r222b1832],
10	.	.	O	.	_	0	SENT_68	[p4l1718t1644r2146b1737, p4l10t1783r222b1832],

1	We	PRP	O	we	nsubj	2	SENT_69	[p4l255t1763r394b1832],
2	found	VBD	O	find	_	0	SENT_69	[p4l425t1760r664b1832],
3	no	DT	O	no	det	4	SENT_69	[p4l693t1783r794b1832],
4	episodes	NNS	O	episode	dobj	2	SENT_69	[p4l826t1760r1173b1853],
5	of	IN	O	of	_	0	SENT_69	[p4l1205t1761r1290b1832],
6	gout	NN	O	gout	prep_of	4	SENT_69	[p4l1314t1770r1516b1853],
7	,	,	O	,	_	0	SENT_69	[p4l1314t1770r1516b1853],
8	no	DT	O	no	det	9	SENT_69	[p4l1549t1783r1649b1832],
9	evidence	NN	O	evidence	dobj	2	SENT_69	[p4l1681t1760r2036b1832],
10	of	IN	O	of	_	0	SENT_69	[p4l2068t1761r2153b1832],
11	urolithiasis	NN	O	urolithiasis	prep_of	9	SENT_69	[p4l10t1876r482b1963],
12	,	,	O	,	_	0	SENT_69	[p4l10t1876r482b1963],
13	and	CC	O	and	_	0	SENT_69	[p4l523t1876r670b1948],
14	no	DT	O	no	det	16	SENT_69	[p4l705t1899r806b1948],
15	uratic	JJ	O	uratic	amod	16	SENT_69	[p4l842t1877r1078b1948],
16	nephropathy	NN	O	nephropathy	conj_and	4	SENT_69	[p4l1112t1876r1652b1970],
17	.	.	O	.	_	0	SENT_69	[p4l1112t1876r1652b1970],

1	DISCUSSION	NN	O	discussion	_	0	SENT_70	[p4l10t2062r521b2133],

1	Qrclosporine	NN	PERSON	qrclosporine	nsubj	6	SENT_71	[p4l13t2226r544b2319],
2	remains	VBZ	O	remain	cop	6	SENT_71	[p4l571t2226r893b2297],
3	the	DT	O	the	det	6	SENT_71	[p4l920t2226r1047b2297],
4	mainstay	NN	O	mainstay	nn	6	SENT_71	[p4l1073t2226r1437b2319],
5	immunosuppressive	JJ	O	immunosuppressive	amod	6	SENT_71	[p4l1460t2226r2145b2319, p4l12t2342r160b2413],
6	drug	NN	O	drug	_	0	SENT_71	[p4l218t2342r403b2435],
7	for	IN	O	for	_	0	SENT_71	[p4l457t2342r575b2413],
8	prevention	NN	O	prevention	prep_for	6	SENT_71	[p4l628t2342r1070b2435],
9	of	IN	O	of	_	0	SENT_71	[p4l1125t2342r1211b2413],
10	allograft	NN	O	allograft	nn	11	SENT_71	[p4l1262t2342r1604b2435],
11	rejection	NN	O	rejection	prep_of	8	SENT_71	[p4l1658t2342r2018b2435],
12	in	IN	O	in	_	0	SENT_71	[p4l2072t2342r2147b2412],
13	organ	NN	O	organ	nn	14	SENT_71	[p4l12t2481r244b2551],
14	transplantation	NN	O	transplantation	prep_in	11	SENT_71	[p4l288t2458r932b2551],
15	.	.	O	.	_	0	SENT_71	[p4l288t2458r932b2551],

1	Early	RB	O	early	advmod	2	SENT_72	[p4l980t2458r1199b2551],
2	reports	NNS	O	report	nsubj	7	SENT_72	[p4l1241t2468r1532b2551],
3	of	IN	O	of	_	0	SENT_72	[p4l1578t2459r1663b2529],
4	its	PRP$	O	its	poss	6	SENT_72	[p4l1702t2458r1791b2529],
5	side	JJ	O	side	amod	6	SENT_72	[p4l1837t2458r1995b2529],
6	effects	NNS	O	effect	prep_of	2	SENT_72	[p4l2042t2459r2146b2529, p4l10t2574r196b2645],
7	focused	VBD	O	focus	_	0	SENT_72	[p4l243t2573r557b2645],
8	on	IN	O	on	_	0	SENT_72	[p4l604t2596r705b2645],
9	nephrotoxicity	NN	O	nephrotoxicity	prep_on	7	SENT_72	[p4l751t2573r1360b2666],
10	,	,	O	,	_	0	SENT_72	[p4l751t2573r1360b2666],
11	which	WDT	O	which	nsubj	13	SENT_72	[p4l1405t2573r1645b2645],
12	is	VBZ	O	be	cop	13	SENT_72	[p4l1692t2573r1750b2644],
13	dosedependent	JJ	O	dosedependent	rcmod	9	SENT_72	[p4l1799t2573r2146b2645, p4l9t2689r345b2782],
14	and	CC	O	and	_	0	SENT_72	[p4l391t2689r538b2760],
15	common	JJ	O	common	conj_and	13	SENT_72	[p4l583t2712r957b2761],
16	.	.	O	.	_	0	SENT_72	[p4l583t2712r957b2761],

1	More	RBR	O	more	advmod	2	SENT_73	[p4l1006t2692r1229b2761],
2	recently	RB	DATE	recently	advmod	8	SENT_73	[p4l1274t2689r1619b2782],
3	,	,	O	,	_	0	SENT_73	[p4l1274t2689r1619b2782],
4	CsAassociated	JJ	O	csaassociated	amod	5	SENT_73	[p4l1668t2689r2145b2761, p4l13t2806r187b2877],
5	hyperuricemia	NN	O	hyperuricemia	nsubjpass	8	SENT_73	[p4l236t2806r825b2899],
6	has	VBZ	O	have	aux	8	SENT_73	[p4l873t2806r1006b2877],
7	been	VBN	O	be	auxpass	8	SENT_73	[p4l1054t2806r1252b2877],
8	recognized	VBN	O	recognize	_	0	SENT_73	[p4l1301t2802r1939b2898],
9	.5	CD	NUMBER	.5	iobj	8	SENT_73	[p4l1301t2802r1939b2898],
10	’	CD	NUMBER	’	number	11	SENT_73	[p4l1301t2802r1939b2898],
11	6	CD	NUMBER	6	dobj	8	SENT_73	[p4l1301t2802r1939b2898],
12	»	NN	O	»	dep	11	SENT_73	[p4l1301t2802r1939b2898],
13	12	CD	NUMBER	12	num	12	SENT_73	[p4l1301t2802r1939b2898],
14	The	DT	O	the	det	15	SENT_73	[p4l1987t2806r2146b2877],
15	pathophysiology	NN	O	pathophysiology	nsubj	22	SENT_73	[p4l9t2922r679b3015],
16	of	IN	O	of	_	0	SENT_73	[p4l720t2922r806b2993],
17	hyperuricemia	NN	O	hyperuricemia	prep_of	15	SENT_73	[p4l842t2922r1431b3015],
18	in	IN	O	in	_	0	SENT_73	[p4l1473t2922r1548b2992],
19	this	DT	O	this	det	20	SENT_73	[p4l1590t2922r1733b2993],
20	setting	NN	O	setting	prep_in	17	SENT_73	[p4l1777t2922r2046b3015],
21	is	VBZ	O	be	cop	22	SENT_73	[p4l2088t2922r2146b2993],
22	complex	NN	O	complex	rcmod	11	SENT_73	[p4l12t3038r370b3131],
23	.	.	O	.	_	0	SENT_73	[p4l12t3038r370b3131],

1	In	IN	O	in	_	0	SENT_74	[p4l428t3040r514b3108],
2	fact	NN	O	fact	prep_in	16	SENT_74	[p4l567t3038r737b3124],
3	,	,	O	,	_	0	SENT_74	[p4l567t3038r737b3124],
4	CsA-induced	JJ	O	csa-induced	amod	6	SENT_74	[p4l796t3038r1328b3109],
5	renal	JJ	O	renal	amod	6	SENT_74	[p4l1381t3038r1589b3109],
6	insufﬁciency	NN	O	insufﬁciency	conj_and	2	SENT_74	[p4l1642t3037r2150b3131],
7	and	CC	O	and	_	0	SENT_74	[p4l13t3154r160b3225],
8	reduction	NN	O	reduction	conj_and	2	SENT_74	[p4l206t3154r598b3225],
9	in	IN	O	in	_	0	SENT_74	[p4l643t3154r719b3224],
10	glomerular	JJ	O	glomerular	amod	14	SENT_74	[p4l764t3154r1214b3247],
11	ﬁltration	NN	O	ﬁltration	nn	14	SENT_74	[p4l1259t3154r1615b3225],
12	rate	NN	O	rate	nn	14	SENT_74	[p4l1660t3164r1819b3225],
13	(	CD	NUMBER	(	num	14	SENT_74	[p4l1869t3152r2144b3248],
14	GFR	NN	O	gfr	prep_in	8	SENT_74	[p4l1869t3152r2144b3248],
15	)	CD	NUMBER	)	nsubj	16	SENT_74	[p4l1869t3152r2144b3248],
16	cause	VBP	O	cause	_	0	SENT_74	[p4l12t3293r233b3341],
17	the	DT	O	the	det	19	SENT_74	[p4l293t3270r420b3341],
18	renal	JJ	O	renal	amod	19	SENT_74	[p4l479t3270r687b3341],
19	retention	NN	O	retention	dobj	16	SENT_74	[p4l745t3270r1122b3341],
20	of	IN	O	of	_	0	SENT_74	[p4l1181t3271r1267b3341],
21	urate	NN	O	urate	prep_of	19	SENT_74	[p4l1318t3280r1531b3341],
22	by	IN	O	by	_	0	SENT_74	[p4l1588t3270r1683b3363],
23	modifying	VBG	O	modify	prepc_by	16	SENT_74	[p4l1739t3270r2148b3363],
24	several	JJ	O	several	amod	25	SENT_74	[p4l12t3386r293b3457],
25	steps	NNS	O	step	dobj	23	SENT_74	[p4l358t3397r558b3479],
26	in	IN	O	in	_	0	SENT_74	[p4l621t3386r697b3456],
27	urate	NN	O	urate	nn	28	SENT_74	[p4l759t3397r971b3457],
28	excretion	NN	O	excretion	prep_in	23	SENT_74	[p4l1037t3383r1468b3457],
29	.5	CD	NUMBER	.5	num	30	SENT_74	[p4l1037t3383r1468b3457],
30	Hyperuricemia	NN	O	hyperuricemia	nsubj	35	SENT_74	[p4l1533t3386r2148b3479],
31	may	MD	O	may	aux	35	SENT_74	[p4l10t3524r179b3594],
32	not	RB	O	not	neg	35	SENT_74	[p4l205t3511r338b3573],
33	only	RB	O	only	advmod	35	SENT_74	[p4l367t3501r539b3594],
34	be	VB	O	be	cop	35	SENT_74	[p4l563t3501r659b3573],
35	secondary	JJ	O	secondary	rcmod	28	SENT_74	[p4l690t3501r1100b3594],
36	to	TO	O	to	_	0	SENT_74	[p4l1125t3511r1204b3573],
37	reduced	VBN	O	reduce	amod	38	SENT_74	[p4l1234t3501r1563b3573],
38	GFR	NN	O	gfr	prep_to	35	SENT_74	[p4l1594t3502r1800b3573],
39	but	CC	O	but	_	0	SENT_74	[p4l1826t3501r1960b3573],
40	also	RB	O	also	_	0	SENT_74	[p4l1990t3501r2146b3573],
41	to	TO	O	to	_	0	SENT_74	[p4l10t3628r89b3689],
42	CsA-induced	JJ	O	csa-induced	amod	45	SENT_74	[p4l139t3618r672b3689],
43	proximal	JJ	O	proximal	amod	45	SENT_74	[p4l717t3618r1078b3711],
44	tubular	JJ	O	tubular	amod	45	SENT_74	[p4l1124t3618r1421b3689],
45	dysfunction	NN	O	dysfunction	prep_to	23	SENT_74	[p4l1468t3614r2146b3710],
46	.5	CD	NUMBER	.5	num	47	SENT_74	[p4l1468t3614r2146b3710],
47	‘	NN	O	‘	dep	45	SENT_74	[p4l1468t3614r2146b3710],
48	7	CD	NUMBER	7	num	49	SENT_74	[p4l1468t3614r2146b3710],
49	~	NN	O	~	dep	47	SENT_74	[p4l1468t3614r2146b3710],
50	13	CD	NUMBER	13	dep	47	SENT_74	[p4l1468t3614r2146b3710],

1	Management	NN	O	management	nsubj	14	SENT_75	[p5l12t20r552b110],
2	of	IN	O	of	prep	1	SENT_75	[p5l589t18r674b89],
3	hyperuricemia	NN	O	hyperuricemia	dep	2	SENT_75	[p5l703t18r1293b111],
4	in	IN	O	in	_	0	SENT_75	[p5l1328t18r1404b88],
5	transplant	NN	O	transplant	nn	6	SENT_75	[p5l1439t18r1851b111],
6	recipients	NNS	O	recipient	prep_in	3	SENT_75	[p5l1887t18r2145b111, p5l12t144r175b205],
7	and	CC	O	and	_	0	SENT_75	[p5l216t134r384b220],
8	,	,	O	,	_	0	SENT_75	[p5l216t134r384b220],
9	particularly	RB	O	particularly	dep	3	SENT_75	[p5l424t134r912b227],
10	,	,	O	,	_	0	SENT_75	[p5l424t134r912b227],
11	in	IN	O	in	_	0	SENT_75	[p5l953t134r1029b204],
12	HT	NN	O	ht	nn	13	SENT_75	[p5l1067t136r1207b204],
13	patients	NNS	O	patient	prep_in	3	SENT_75	[p5l1242t134r1565b227],
14	poses	VBZ	O	pose	_	0	SENT_75	[p5l1603t156r1826b227],
15	several	JJ	O	several	amod	17	SENT_75	[p5l1866t134r2147b205],
16	speciﬁc	NN	O	speciﬁc	nn	17	SENT_75	[p5l12t251r311b344],
17	problems	NNS	O	problem	dobj	14	SENT_75	[p5l353t251r753b344],
18	.	.	O	.	_	0	SENT_75	[p5l353t251r753b344],

1	Asymptomatic	JJ	MISC	asymptomatic	amod	2	SENT_76	[p5l799t251r1396b344],
2	hyperuricemia	NN	O	hyperuricemia	nsubj	16	SENT_76	[p5l1439t251r2028b344],
3	in	IN	O	in	_	0	SENT_76	[p5l2072t251r2147b321],
4	HT	JJ	O	ht	amod	5	SENT_76	[p5l11t369r151b437],
5	patients	NNS	O	patient	prep_in	2	SENT_76	[p5l202t367r526b460],
6	with	IN	O	with	_	0	SENT_76	[p5l576t367r753b438],
7	mild	JJ	O	mild	amod	9	SENT_76	[p5l807t367r988b438],
8	CsA	NN	O	csa	nn	9	SENT_76	[p5l1044t367r1672b439],
9	—	NN	O	—	prep_with	5	SENT_76	[p5l1044t367r1672b439],
10	associated	VBN	O	associate	partmod	9	SENT_76	[p5l1044t367r1672b439],
11	renal	JJ	O	renal	amod	12	SENT_76	[p5l1725t367r1933b438],
12	dysfunction	NN	O	dysfunction	dobj	10	SENT_76	[p5l1989t367r2145b460, p5l10t483r350b554],
13	is	VBZ	O	be	cop	14	SENT_76	[p5l380t483r438b554],
14	common	JJ	O	common	_	0	SENT_76	[p5l469t506r824b554],
15	and	CC	O	and	_	0	SENT_76	[p5l855t483r1002b554],
16	represents	VBZ	O	represent	conj_and	14	SENT_76	[p5l1032t493r1455b576],
17	a	DT	O	a	det	18	SENT_76	[p5l1488t506r1530b554],
18	cardiovascular	JJ	O	cardiovascular	dobj	16	SENT_76	[p5l1559t483r2148b554],

1	The	DT	O	the	det	2	SENT_77	[p5l105t651r167b679],
2	Journal	NNP	O	Journal	_	0	SENT_77	[p5l181t651r301b679],
3	of	IN	O	of	_	0	SENT_77	[p5l315t651r349b679],
4	Heart	NNP	O	Heart	nn	8	SENT_77	[p5l360t652r453b679],
5	and	CC	O	and	_	0	SENT_77	[p5l468t651r525b678],
6	Lung	NN	O	lung	nn	8	SENT_77	[p5l539t652r621b687],
7	Transplantation	NN	O	transplantation	nn	8	SENT_77	[p5l635t651r890b687],
8	Caforio	NNP	O	Caforio	prep_of	2	SENT_77	[p5l1723t651r1843b679],
9	et	FW	O	et	nn	10	SENT_77	[p5l1858t655r1887b679],
10	al.	FW	O	al.	dep	8	SENT_77	[p5l1902t651r1936b679],
11	1207	CD	DATE	1207	num	12	SENT_77	[p5l1982t652r2054b679],
12	Volume	NN	DATE	volume	dep	10	SENT_77	[p5l105t696r232b724],
13	19	CD	DATE	19	dep	2	SENT_77	[p5l255t697r297b730],
14	,	,	O	,	_	0	SENT_77	[p5l255t697r297b730],
15	Number	NNP	O	Number	appos	13	SENT_77	[p5l318t696r451b724],
16	12	CD	NUMBER	12	num	15	SENT_77	[p5l473t697r507b724],

1	TABLE	NNP	O	TABLE	nn	2	SENT_78	[p5l104t805r215b836],
2	Data	NNP	O	Data	_	0	SENT_78	[p5l259t807r346b837],
3	before	IN	O	before	dep	2	SENT_78	[p5l360t806r475b837],
4	and	CC	O	and	_	0	SENT_78	[p5l491t806r555b837],
5	after	IN	O	after	dep	2	SENT_78	[p5l571t806r654b837],
6	allopurinol	NN	O	allopurinol	pobj	3	SENT_78	[p5l670t805r863b846],
7	and	CC	O	and	_	0	SENT_78	[p5l879t806r943b837],
8	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	9	SENT_78	[p5l959t805r1215b846],
9	treatment	NN	O	treatment	pobj	3	SENT_78	[p5l1231t810r1405b837],

1	Befo1	NN	O	befo1	_	0	SENT_79	[p5l1005t889r1130b917],
2	'	''	O	'	_	0	SENT_79	[p5l1005t889r1130b917],
3	eA	NNP	O	eA	nn	4	SENT_79	[p5l1005t889r1130b917],
4	AfterA	NNP	O	AfterA	dep	1	SENT_79	[p5l1530t889r1630b917],

1	Variable	JJ	O	variable	amod	3	SENT_80	[p5l335t937r457b964],
2	(	NN	O	(	nn	3	SENT_80	[p5l991t937r1023b971],
3	n	NN	O	n	_	0	SENT_80	[p5l991t937r1023b971],
4	=	JJ	O	=	dep	3	SENT_80	[p5l1038t946r1061b958],
5	120	CD	NUMBER	120	number	6	SENT_80	[p5l1077t937r1143b971],
6	)	CD	NUMBER	)	num	12	SENT_80	[p5l1077t937r1143b971],
7	(	NN	O	(	nn	12	SENT_80	[p5l1504t937r1536b971],
8	n	NN	O	n	nn	12	SENT_80	[p5l1504t937r1536b971],
9	=	JJ	O	=	amod	12	SENT_80	[p5l1550t946r1574b958],
10	120	CD	NUMBER	120	num	12	SENT_80	[p5l1590t937r1655b971],
11	)	NN	O	)	nn	12	SENT_80	[p5l1590t937r1655b971],
12	pvalue	NN	O	pvalue	dep	4	SENT_80	[p5l1942t937r2052b972],

1	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1044r191b1097],
2	uricemia	NN	O	uricemia	dep	100	SENT_81	[p5l218t1042r495b1097],
3	(	CD	NUMBER	(	dep	100	SENT_81	[p5l525t1041r908b1115],
4	mmol/liter	NN	O	mmol/liter	dep	100	SENT_81	[p5l525t1041r908b1115],
5	)	CD	NUMBER	)	dep	100	SENT_81	[p5l525t1041r908b1115],
6	0.58	CD	NUMBER	0.58	dep	100	SENT_81	[p5l1765t1042r1892b1097],
7	:	:	O	:	_	0	SENT_81	[p5l1922t1050r1966b1094],
8	0.12	CD	NUMBER	0.12	dep	100	SENT_81	[p5l1995t1043r2124b1097],
9	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1135r191b1188],
10	serum	NN	O	serum	dep	100	SENT_81	[p5l219t1150r413b1188],
11	creatinine	NN	O	creatinine	dep	100	SENT_81	[p5l440t1133r756b1188],
12	(	CD	NUMBER	(	dep	100	SENT_81	[p5l787t1131r1159b1206],
13	ptmol/liter	NN	O	ptmol/liter	dep	100	SENT_81	[p5l787t1131r1159b1206],
14	)	NN	O	)	dep	100	SENT_81	[p5l787t1131r1159b1206],
15	164	CD	NUMBER	164	dep	100	SENT_81	[p5l1788t1134r1892b1188],
16	:	:	O	:	_	0	SENT_81	[p5l1922t1140r1966b1185],
17	35	CD	NUMBER	35	dep	100	SENT_81	[p5l1995t1133r2064b1188],
18	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1225r191b1278],
19	blood	NN	O	blood	dep	100	SENT_81	[p5l217t1223r398b1278],
20	urea	NN	O	urea	dep	100	SENT_81	[p5l425t1241r567b1278],
21	(	CD	NUMBER	(	dep	100	SENT_81	[p5l597t1222r980b1297],
22	mmol/liter	NN	O	mmol/liter	dep	100	SENT_81	[p5l597t1222r980b1297],
23	)	CD	NUMBER	)	dep	100	SENT_81	[p5l597t1222r980b1297],
24	14	CD	NUMBER	14	dep	100	SENT_81	[p5l1825t1224r1892b1278],
25	i	FW	O	i	dep	100	SENT_81	[p5l1922t1231r1966b1276],
26	5	CD	NUMBER	5	dep	100	SENT_81	[p5l1995t1224r2027b1279],
27	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1317r191b1370],
28	trough	NN	O	trough	dep	100	SENT_81	[p5l218t1315r428b1387],
29	CsA	NN	O	csa	dep	100	SENT_81	[p5l457t1316r594b1371],
30	levels	NNS	O	level	dep	100	SENT_81	[p5l619t1315r793b1370],
31	(	VBP	O	(	dep	100	SENT_81	[p5l824t1314r1052b1388],
32	ng/ml	JJ	O	ng/ml	dep	100	SENT_81	[p5l824t1314r1052b1388],
33	)	NN	O	)	dep	100	SENT_81	[p5l824t1314r1052b1388],
34	193	CD	NUMBER	193	dep	100	SENT_81	[p5l1788t1316r1890b1370],
35	:	:	O	:	_	0	SENT_81	[p5l1922t1323r1966b1367],
36	73.5	CD	NUMBER	73.5	dep	100	SENT_81	[p5l1995t1315r2120b1370],
37	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1408r191b1461],
38	CsA	NN	O	csa	dep	100	SENT_81	[p5l220t1407r357b1461],
39	daily	JJ	SET	daily	dep	100	SENT_81	[p5l384t1406r533b1478],
40	dose	NN	O	dose	dep	100	SENT_81	[p5l560t1406r703b1461],
41	(	NN	O	(	dep	100	SENT_81	[p5l734t1405r1108b1479],
42	mg/kg/day	NN	O	mg/kg/day	dep	100	SENT_81	[p5l734t1405r1108b1479],
43	)	CD	NUMBER	)	dep	100	SENT_81	[p5l734t1405r1108b1479],
44	2.7	CD	NUMBER	2.7	dep	100	SENT_81	[p5l1803t1407r1893b1461],
45	:	:	O	:	_	0	SENT_81	[p5l1922t1413r1966b1458],
46	0.8	CD	NUMBER	0.8	dep	100	SENT_81	[p5l1995t1407r2084b1461],
47	Before	IN	O	before	dep	100	SENT_81	[p5l1788t1498r1994b1552],
48	S	NN	O	s	dep	100	SENT_81	[p5l2025t1498r2061b1552],
49	(	CD	NUMBER	(	dep	100	SENT_81	[p5l1771t1590r1829b1655],
50	n	NN	O	n	dep	100	SENT_81	[p5l1771t1590r1829b1655],
51	=	JJ	O	=	dep	100	SENT_81	[p5l1866t1607r1912b1631],
52	120	CD	NUMBER	120	dep	100	SENT_81	[p5l1949t1590r2079b1655],
53	)	CD	NUMBER	)	dep	100	SENT_81	[p5l1949t1590r2079b1655],
54	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1681r191b1734],
55	uricemia	NN	O	uricemia	dep	100	SENT_81	[p5l218t1679r495b1734],
56	(	CD	NUMBER	(	dep	100	SENT_81	[p5l525t1678r908b1752],
57	mmol/liter	NN	O	mmol/liter	dep	100	SENT_81	[p5l525t1678r908b1752],
58	)	CD	NUMBER	)	dep	100	SENT_81	[p5l525t1678r908b1752],
59	0.51	CD	NUMBER	0.51	dep	100	SENT_81	[p5l1765t1679r1889b1734],
60	:	:	O	:	_	0	SENT_81	[p5l1922t1686r1966b1731],
61	0.13	CD	NUMBER	0.13	dep	100	SENT_81	[p5l1995t1680r2120b1734],
62	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1771r191b1824],
63	serum	NN	O	serum	dep	100	SENT_81	[p5l219t1787r413b1824],
64	creatinine	NN	O	creatinine	dep	100	SENT_81	[p5l440t1769r756b1824],
65	(	CD	NUMBER	(	dep	100	SENT_81	[p5l787t1768r1159b1842],
66	p.	NN	O	p.	dep	100	SENT_81	[p5l787t1768r1159b1842],
67	mol/liter	NN	O	mol/liter	dep	100	SENT_81	[p5l787t1768r1159b1842],
68	)	NN	O	)	dep	100	SENT_81	[p5l787t1768r1159b1842],
69	160	CD	NUMBER	160	dep	100	SENT_81	[p5l1788t1770r1892b1825],
70	i	FW	O	i	dep	100	SENT_81	[p5l1922t1777r1966b1822],
71	35	CD	NUMBER	35	dep	100	SENT_81	[p5l1995t1770r2065b1825],
72	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1863r191b1916],
73	blood	NN	O	blood	dep	100	SENT_81	[p5l217t1861r398b1916],
74	urea	NN	O	urea	dep	100	SENT_81	[p5l425t1879r567b1916],
75	(	CD	NUMBER	(	dep	100	SENT_81	[p5l597t1860r980b1934],
76	mmol/liter	NN	O	mmol/liter	dep	100	SENT_81	[p5l597t1860r980b1934],
77	)	CD	NUMBER	)	dep	100	SENT_81	[p5l597t1860r980b1934],
78	14.01	CD	NUMBER	14.01	dep	100	SENT_81	[p5l1732t1862r1889b1916],
79	:	:	O	:	_	0	SENT_81	[p5l1922t1869r1966b1913],
80	5	CD	NUMBER	5	dep	100	SENT_81	[p5l1995t1861r2027b1916],
81	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t1954r191b2007],
82	trough	NN	O	trough	dep	100	SENT_81	[p5l218t1952r428b2024],
83	CsA	NN	O	csa	dep	100	SENT_81	[p5l457t1953r594b2007],
84	levels	NNS	O	level	dep	100	SENT_81	[p5l619t1952r793b2007],
85	(	VBP	O	(	dep	100	SENT_81	[p5l824t1950r1052b2025],
86	ng/ml	JJ	O	ng/ml	dep	100	SENT_81	[p5l824t1950r1052b2025],
87	)	NN	O	)	dep	100	SENT_81	[p5l824t1950r1052b2025],
88	183	CD	NUMBER	183	dep	100	SENT_81	[p5l1788t1953r1890b2007],
89	:	:	O	:	_	0	SENT_81	[p5l1922t1959r1966b2004],
90	89	CD	NUMBER	89	dep	100	SENT_81	[p5l1996t1953r2066b2007],
91	Mean	NN	O	mean	dep	100	SENT_81	[p5l9t2044r191b2097],
92	CsA	NN	O	csa	dep	100	SENT_81	[p5l220t2043r357b2098],
93	daily	JJ	SET	daily	dep	100	SENT_81	[p5l384t2042r533b2114],
94	dose	NN	O	dose	dep	100	SENT_81	[p5l560t2042r703b2097],
95	(	NN	O	(	dep	100	SENT_81	[p5l734t2041r1108b2115],
96	mg/kg/day	NN	O	mg/kg/day	dep	100	SENT_81	[p5l734t2041r1108b2115],
97	)	CD	NUMBER	)	dep	100	SENT_81	[p5l734t2041r1108b2115],
98	2.6	CD	NUMBER	2.6	dep	100	SENT_81	[p5l1803t2043r1892b2098],
99	i	FW	O	i	dep	100	SENT_81	[p5l1922t2050r1966b2095],
100	0.9	CD	NUMBER	0.9	_	0	SENT_81	[p5l1995t2043r2084b2098],

1	A	DT	O	a	_	0	SENT_82	[p5l6t2206r71b2264],
2	,	,	O	,	_	0	SENT_82	[p5l6t2206r71b2264],
3	allopurinol	NN	O	allopurinol	dep	9	SENT_82	[p5l99t2205r423b2269],
4	;	:	O	;	_	0	SENT_82	[p5l99t2205r423b2269],
5	CsA	NN	O	csa	dep	3	SENT_82	[p5l452t2205r586b2264],
6	,	,	O	,	_	0	SENT_82	[p5l452t2205r586b2264],
7	cyclosporine	NN	O	cyclosporine	appos	5	SENT_82	[p5l613t2205r978b2269],
8	;	:	O	;	_	0	SENT_82	[p5l613t2205r978b2269],
9	NS	NN	O	n	dep	1	SENT_82	[p5l1005t2206r1105b2264],
10	,	,	O	,	_	0	SENT_82	[p5l1005t2206r1105b2264],
11	not	RB	O	not	neg	12	SENT_82	[p5l1132t2212r1224b2254],
12	signiﬁcant	NN	O	signiﬁcant	dep	1	SENT_82	[p5l1249t2205r1549b2269],
13	;	:	O	;	_	0	SENT_82	[p5l1249t2205r1549b2269],
14	S	NN	O	s	dep	1	SENT_82	[p5l1578t2205r1625b2264],
15	,	,	O	,	_	0	SENT_82	[p5l1578t2205r1625b2264],
16	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	appos	14	SENT_82	[p5l1653t2204r2075b2269],
17	.	.	O	.	_	0	SENT_82	[p5l1653t2204r2075b2269],

1	0.41	CD	NUMBER	0.41	num	3	SENT_83	[p5l764t2453r917b2519],
2	:	:	O	:	_	0	SENT_83	[p5l957t2461r1012b2516],
3	0.07	CD	NUMBER	0.07	_	0	SENT_83	[p5l1048t2453r1206b2519],
4	0.0001	CD	NUMBER	0.0001	number	5	SENT_83	[p5l1894t2453r2139b2519],
5	171	CD	NUMBER	171	dep	3	SENT_83	[p5l792t2564r917b2630],
6	:	:	O	:	_	0	SENT_83	[p5l957t2571r1012b2626],
7	42	CD	NUMBER	42	dep	3	SENT_83	[p5l1048t2564r1137b2629],
8	0.01	CD	NUMBER	0.01	num	9	SENT_83	[p5l1941t2564r2093b2630],
9	15	CD	NUMBER	15	dep	7	SENT_83	[p5l839t2674r918b2742],
10	:	:	O	:	_	0	SENT_83	[p5l957t2683r1012b2738],
11	7	CD	NUMBER	7	num	12	SENT_83	[p5l1049t2675r1090b2742],
12	NS	NN	O	n	dep	3	SENT_83	[p5l1959t2674r2076b2742],
13	188	CD	NUMBER	188	dep	12	SENT_83	[p5l792t2788r920b2855],
14	:	:	O	:	_	0	SENT_83	[p5l957t2796r1012b2851],
15	65	CD	NUMBER	65	num	16	SENT_83	[p5l1049t2787r1133b2855],
16	NS	NN	O	n	dep	3	SENT_83	[p5l1959t2788r2076b2856],
17	2.6	CD	NUMBER	2.6	dep	16	SENT_83	[p5l810t2900r920b2967],
18	:	:	O	:	_	0	SENT_83	[p5l957t2908r1012b2963],
19	0.8	CD	NUMBER	0.8	num	20	SENT_83	[p5l1049t2900r1158b2967],
20	0.0075	CD	NUMBER	0.0075	dep	3	SENT_83	[p5l1894t2899r2141b2967],
21	After	IN	O	after	dep	28	SENT_83	[p5l840t3012r1044b3078],
22	S	NN	O	s	nn	24	SENT_83	[p5l1080t3012r1124b3078],
23	(	CD	NUMBER	(	num	24	SENT_83	[p5l794t3125r866b3205],
24	n	NN	O	n	pobj	21	SENT_83	[p5l794t3125r866b3205],
25	=	JJ	O	=	amod	24	SENT_83	[p5l911t3146r968b3176],
26	120	CD	NUMBER	120	number	27	SENT_83	[p5l1015t3125r1175b3205],
27	)	CD	NUMBER	)	dep	25	SENT_83	[p5l1015t3125r1175b3205],
28	0.40	CD	NUMBER	0.40	rcmod	20	SENT_83	[p5l764t3235r921b3301],
29	:	:	O	:	_	0	SENT_83	[p5l957t3242r1012b3297],
30	0.12	CD	NUMBER	0.12	number	31	SENT_83	[p5l1049t3235r1206b3301],
31	0.0001	CD	NUMBER	0.0001	dep	3	SENT_83	[p5l1894t3235r2139b3301],
32	154	CD	NUMBER	154	dep	31	SENT_83	[p5l792t3346r921b3414],
33	:	:	O	:	_	0	SENT_83	[p5l957t3354r1012b3410],
34	48	CD	NUMBER	48	num	35	SENT_83	[p5l1048t3346r1135b3414],
35	NS	NN	O	n	dep	3	SENT_83	[p5l1960t3346r2076b3414],
36	12.6	CD	NUMBER	12.6	dep	35	SENT_83	[p5l769t3460r920b3527],
37	:	:	O	:	_	0	SENT_83	[p5l957t3469r1012b3524],
38	5	CD	NUMBER	5	dep	3	SENT_83	[p5l1048t3459r1087b3527],
39	0.0004	CD	NUMBER	0.0004	number	40	SENT_83	[p5l1894t3460r2143b3527],
40	121	CD	NUMBER	121	dep	38	SENT_83	[p5l792t3572r917b3637],
41	:	:	O	:	_	0	SENT_83	[p5l957t3579r1012b3634],
42	63	CD	NUMBER	63	number	43	SENT_83	[p5l1049t3572r1133b3638],
43	0.0001	CD	NUMBER	0.0001	dep	3	SENT_83	[p5l1894t3572r2139b3638],
44	2.8	CD	NUMBER	2.8	dep	43	SENT_83	[p5l810t3683r920b3751],
45	i	FW	O	i	dep	3	SENT_83	[p5l957t3691r1012b3747],
46	0.9	CD	NUMBER	0.9	number	47	SENT_83	[p5l1049t3683r1159b3751],
47	0.0001	CD	NUMBER	0.0001	dep	45	SENT_83	[p5l1894t3683r2139b3751],

1	risk	NN	O	risk	_	0	SENT_84	[p6l12t133r161b204],
2	factor	NN	O	factor	dep	1	SENT_84	[p6l195t134r455b219],
3	,	,	O	,	_	0	SENT_84	[p6l195t134r455b219],
4	as	RB	O	as	_	0	SENT_84	[p6l497t156r575b204],
5	well	RB	O	well	_	0	SENT_84	[p6l607t133r774b204],
6	as	IN	O	as	_	0	SENT_84	[p6l812t156r890b204],
7	a	DT	O	a	det	9	SENT_84	[p6l930t156r972b204],
8	risk	NN	O	risk	nn	9	SENT_84	[p6l1007t133r1157b204],
9	factor	NN	O	factor	conj_and	2	SENT_84	[p6l1190t134r1431b204],
10	for	IN	O	for	_	0	SENT_84	[p6l1466t134r1584b204],
11	development	NN	O	development	prep_for	1	SENT_84	[p6l1621t133r2152b226],
12	of	IN	O	of	_	0	SENT_84	[p6l13t249r99b319],
13	gouty	JJ	O	gouty	amod	14	SENT_84	[p6l123t258r349b341],
14	arthritis	NN	O	arthritis	prep_of	11	SENT_84	[p6l379t248r699b319],
15	and	CC	O	and	_	0	SENT_84	[p6l733t248r880b319],
16	uratic	JJ	O	uratic	amod	17	SENT_84	[p6l910t248r1146b320],
17	nephropathy	NN	O	nephropathy	prep_of	11	SENT_84	[p6l1175t248r1715b341],
18	.	.	O	.	_	0	SENT_84	[p6l1175t248r1715b341],

1	Thus	RB	O	thus	advmod	5	SENT_85	[p6l1749t248r1973b334],
2	,	,	O	,	_	0	SENT_85	[p6l1749t248r1973b334],
3	it	PRP	O	it	nsubj	5	SENT_85	[p6l2007t248r2062b319],
4	is	VBZ	O	be	cop	5	SENT_85	[p6l2092t248r2150b319],
5	desirable	JJ	O	desirable	_	0	SENT_85	[p6l14t363r380b434],
6	to	TO	O	to	aux	7	SENT_85	[p6l442t373r521b434],
7	achieve	VB	O	achieve	xcomp	5	SENT_85	[p6l586t363r887b434],
8	metabolic	JJ	O	metabolic	amod	9	SENT_85	[p6l948t363r1351b434],
9	control	NN	O	control	dobj	7	SENT_85	[p6l1411t363r1702b434],
10	with	IN	O	with	_	0	SENT_85	[p6l1758t363r1935b434],
11	uric	JJ	O	uric	amod	13	SENT_85	[p6l1995t363r2152b434],
12	acid	NN	O	acid	nn	13	SENT_85	[p6l14t478r581b571],
13	—	NN	O	—	prep_with	7	SENT_85	[p6l14t478r581b571],
14	lowering	VBG	O	lower	partmod	13	SENT_85	[p6l14t478r581b571],
15	therapy	NN	O	therapy	dobj	14	SENT_85	[p6l612t478r942b571],
16	,	,	O	,	_	0	SENT_85	[p6l612t478r942b571],
17	similar	JJ	O	similar	amod	15	SENT_85	[p6l978t478r1253b549],
18	to	TO	O	to	_	0	SENT_85	[p6l1284t488r1363b549],
19	that	DT	O	that	nsubj	20	SENT_85	[p6l1396t478r1556b549],
20	advocated	VBD	O	advocate	prepc_to	17	SENT_85	[p6l1589t478r2002b549],
21	for	IN	O	for	_	0	SENT_85	[p6l2033t479r2152b549],
22	kidney	NN	O	kidney	nn	24	SENT_85	[p6l11t593r284b686],
23	transplant	NN	O	transplant	nn	24	SENT_85	[p6l306t593r720b686],
24	recipients	NNS	O	recipient	prep_for	20	SENT_85	[p6l745t590r1235b686],
25	.	.	O	.	_	0	SENT_85	[p6l745t590r1235b686],

1	”	RB	O	”	advmod	4	SENT_86	[p6l745t590r1235b686],
2	Colchicine	NNP	MISC	Colchicine	nsubj	10	SENT_86	[p6l1262t593r1693b665],
3	is	VBZ	O	be	cop	4	SENT_86	[p6l1720t593r1778b664],
4	effective	JJ	O	effective	_	0	SENT_86	[p6l1806t593r2150b664],
5	in	IN	O	in	_	0	SENT_86	[p6l12t708r87b778],
6	gouty	JJ	O	gouty	amod	7	SENT_86	[p6l129t718r355b801],
7	arthritis	NN	O	arthritis	prep_in	4	SENT_86	[p6l397t708r717b779],
8	and	CC	O	and	_	0	SENT_86	[p6l763t708r910b779],
9	may	MD	O	may	aux	10	SENT_86	[p6l952t731r1120b801],
10	prevent	VB	O	prevent	conj_and	4	SENT_86	[p6l1159t718r1470b801],
11	recurrence	NN	O	recurrence	dobj	10	SENT_86	[p6l1512t731r1974b794],
12	,	,	O	,	_	0	SENT_86	[p6l1512t731r1974b794],
13	but	CC	O	but	_	0	SENT_86	[p6l2017t708r2152b779],
14	gastrointestinal	JJ	O	gastrointestinal	amod	15	SENT_86	[p6l12t823r641b915],
15	intolerance	NN	O	intolerance	nsubj	16	SENT_86	[p6l690t823r1150b893],
16	limits	VBZ	O	limit	conj_but	4	SENT_86	[p6l1201t822r1423b893],
17	its	PRP$	O	its	poss	19	SENT_86	[p6l1473t823r1564b893],
18	use	NN	O	use	nn	19	SENT_86	[p6l1613t818r1922b894],
19	.14	NN	NUMBER	.14	nsubj	24	SENT_86	[p6l1613t818r1922b894],
20	=	JJ	O	=	dep	22	SENT_86	[p6l1613t818r1922b894],
21	15	CD	NUMBER	15	tmod	20	SENT_86	[p6l1613t818r1922b894],
22	Furthermore	RB	O	furthermore	rcmod	19	SENT_86	[p6l1973t825r2149b893, p6l11t937r415b1023],
23	,	,	O	,	_	0	SENT_86	[p6l1973t825r2149b893, p6l11t937r415b1023],
24	reduced	VBD	O	reduce	ccomp	16	SENT_86	[p6l477t937r806b1008],
25	kidney	NN	O	kidney	nn	26	SENT_86	[p6l864t937r1137b1030],
26	function	NN	O	function	nsubj	27	SENT_86	[p6l1193t937r1533b1008],
27	increases	VBZ	O	increase	ccomp	24	SENT_86	[p6l1592t937r1963b1008],
28	the	DT	O	the	det	29	SENT_86	[p6l2022t937r2150b1008],
29	risk	NN	O	risk	dobj	27	SENT_86	[p6l12t1052r161b1123],
30	of	IN	O	of	_	0	SENT_86	[p6l216t1053r301b1123],
31	bone	NN	O	bone	nn	32	SENT_86	[p6l350t1052r552b1123],
32	marrow	NN	O	marrow	prep_of	29	SENT_86	[p6l609t1075r926b1123],
33	and	CC	O	and	_	0	SENT_86	[p6l983t1052r1131b1123],
34	neuromuscular	JJ	O	neuromuscular	amod	35	SENT_86	[p6l1187t1052r1802b1123],
35	toxicity	NN	O	toxicity	nsubj	36	SENT_86	[p6l1858t1052r2153b1145],
36	induced	VBN	O	induce	conj_and	4	SENT_86	[p6l12t1166r336b1237],
37	by	IN	O	by	_	0	SENT_86	[p6l375t1167r470b1259],
38	colchicine	NN	O	colchicine	nn	39	SENT_86	[p6l510t1162r1092b1237],
39	.14	NN	NUMBER	.14	prep_by	36	SENT_86	[p6l510t1162r1092b1237],
40	=	JJ	O	=	amod	39	SENT_86	[p6l510t1162r1092b1237],
41	15	CD	NUMBER	15	tmod	40	SENT_86	[p6l510t1162r1092b1237],
42	Because	IN	O	because	mark	47	SENT_86	[p6l1136t1169r1472b1237],
43	allopurinol	NN	O	allopurinol	nsubj	47	SENT_86	[p6l1517t1166r1964b1259],
44	is	VBZ	O	be	cop	47	SENT_86	[p6l2006t1167r2065b1237],
45	a	DT	O	a	det	47	SENT_86	[p6l2109t1190r2152b1237],
46	Xanthine-oxydase	NN	MISC	xanthine-oxydase	nn	47	SENT_86	[p6l8t1281r716b1374],
47	inhibitor	NN	O	inhibitor	dep	4	SENT_86	[p6l761t1281r1116b1352],
48	and	CC	O	and	_	0	SENT_86	[p6l1160t1281r1308b1352],
49	this	DT	O	this	nsubj	52	SENT_86	[p6l1351t1281r1494b1352],
50	is	VBZ	O	be	cop	52	SENT_86	[p6l1539t1281r1598b1352],
51	the	DT	O	the	det	52	SENT_86	[p6l1642t1281r1769b1352],
52	pathway	NN	O	pathway	conj_and	4	SENT_86	[p6l1813t1281r2153b1374],
53	by	IN	O	by	_	0	SENT_86	[p6l9t1396r105b1489],
54	which	WDT	O	which	agent	57	SENT_86	[p6l141t1396r382b1467],
55	Aza	NNP	PERSON	Aza	nsubjpass	57	SENT_86	[p6l422t1397r586b1467],
56	is	VBZ	O	be	auxpass	57	SENT_86	[p6l628t1396r687b1467],
57	metabolized	VBN	O	metabolize	rcmod	52	SENT_86	[p6l731t1396r1253b1482],
58	,	,	O	,	_	0	SENT_86	[p6l731t1396r1253b1482],
59	a	DT	O	a	det	63	SENT_86	[p6l1302t1419r1344b1467],
60	potentially	RB	O	potentially	advmod	61	SENT_86	[p6l1385t1396r1823b1489],
61	serious	JJ	O	serious	amod	63	SENT_86	[p6l1866t1396r2150b1467],
62	drug	NN	O	drug	nn	63	SENT_86	[p6l14t1511r198b1604],
63	interaction	NN	O	interaction	nsubj	69	SENT_86	[p6l243t1511r688b1582],
64	between	IN	O	between	_	0	SENT_86	[p6l731t1511r1073b1582],
65	allopurinol	NN	O	allopurinol	prep_between	63	SENT_86	[p6l1120t1511r1567b1604],
66	and	CC	O	and	_	0	SENT_86	[p6l1614t1511r1762b1582],
67	Aza	NN	O	aza	prep_between	63	SENT_86	[p6l1804t1512r1968b1582],
68	can	MD	O	can	aux	69	SENT_86	[p6l2013t1534r2151b1582],
69	result	VB	O	result	ccomp	4	SENT_86	[p6l12t1626r261b1712],
70	,	,	O	,	_	0	SENT_86	[p6l12t1626r261b1712],
71	leading	VBG	O	lead	csubj	82	SENT_86	[p6l316t1626r614b1719],
72	to	TO	O	to	_	0	SENT_86	[p6l666t1637r745b1697],
73	life-threatening	JJ	O	life-threatening	amod	74	SENT_86	[p6l798t1626r1434b1719],
74	leukopenia	NN	O	leukopenia	prep_to	71	SENT_86	[p6l1486t1623r1997b1719],
75	.9	CD	NUMBER	.9	dobj	71	SENT_86	[p6l1486t1623r1997b1719],
76	At	IN	O	at	_	0	SENT_86	[p6l2046t1628r2152b1697],
77	present	JJ	DATE	present	prep_at	80	SENT_86	[p6l10t1751r335b1834],
78	,	,	O	,	_	0	SENT_86	[p6l10t1751r335b1834],
79	Aza	NN	PERSON	aza	nsubj	80	SENT_86	[p6l385t1742r549b1812],
80	remains	VBZ	O	remain	rcmod	75	SENT_86	[p6l597t1741r921b1812],
81	widely	RB	O	widely	advmod	82	SENT_86	[p6l966t1741r1231b1834],
82	used	VBN	O	use	conj_and	4	SENT_86	[p6l1277t1741r1465b1812],
83	in	IN	O	in	_	0	SENT_86	[p6l1514t1741r1589b1811],
84	combination	NN	O	combination	prep_in	82	SENT_86	[p6l1640t1741r2151b1812],
85	with	IN	O	with	_	0	SENT_86	[p6l7t1856r184b1927],
86	CsA	NN	O	csa	prep_with	82	SENT_86	[p6l222t1857r399b1928],
87	in	IN	O	in	_	0	SENT_86	[p6l432t1856r507b1926],
88	HT	JJ	O	ht	amod	89	SENT_86	[p6l543t1858r683b1926],
89	patients	NNS	O	patient	prep_in	82	SENT_86	[p6l717t1856r1062b1949],
90	,	,	O	,	_	0	SENT_86	[p6l717t1856r1062b1949],
91	including	VBG	O	include	conj_and	4	SENT_86	[p6l1101t1856r1478b1949],
92	at	IN	O	at	pcomp	91	SENT_86	[p6l1516t1866r1589b1927],
93	our	PRP$	O	we	poss	94	SENT_86	[p6l1626t1879r1764b1927],
94	center	NN	O	center	pobj	92	SENT_86	[p6l1800t1866r2074b1927],
95	.	.	O	.	_	0	SENT_86	[p6l1800t1866r2074b1927],

1	These	DT	O	these	det	2	SENT_87	[p6l108t1971r352b2042],
2	considerations	NNS	O	consideration	nsubj	3	SENT_87	[p6l390t1971r981b2042],
3	led	VBD	O	lead	_	0	SENT_87	[p6l1018t1971r1142b2042],
4	us	PRP	O	we	nsubj	6	SENT_87	[p6l1178t1994r1264b2042],
5	to	TO	O	to	aux	6	SENT_87	[p6l1301t1981r1380b2042],
6	study	VB	O	study	xcomp	3	SENT_87	[p6l1419t1971r1633b2064],
7	a	DT	O	a	det	9	SENT_87	[p6l1670t1994r1712b2042],
8	uricosuric	JJ	O	uricosuric	amod	9	SENT_87	[p6l1747t1971r2152b2042],
9	drug	NN	O	drug	dobj	6	SENT_87	[p6l14t2086r219b2179],
10	,	,	O	,	_	0	SENT_87	[p6l14t2086r219b2179],
11	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	appos	9	SENT_87	[p6l284t2086r899b2179],
12	,	,	O	,	_	0	SENT_87	[p6l284t2086r899b2179],
13	in	IN	O	in	_	0	SENT_87	[p6l962t2086r1038b2156],
14	our	PRP$	O	we	poss	16	SENT_87	[p6l1100t2109r1238b2157],
15	HT	NN	O	ht	nn	16	SENT_87	[p6l1298t2088r1439b2156],
16	patients	NNS	O	patient	prep_in	9	SENT_87	[p6l1496t2086r1842b2179],
17	.	.	O	.	_	0	SENT_87	[p6l1496t2086r1842b2179],

1	These	DT	O	these	det	2	SENT_88	[p6l1905t2086r2150b2157],
2	patients	NNS	O	patient	nsubj	3	SENT_88	[p6l10t2201r335b2294],
3	had	VBD	O	have	conj_or	3	SENT_88	[p6l368t2201r518b2272],
4	moderate	JJ	O	moderate	amod	5	SENT_88	[p6l550t2201r942b2272],
5	hyperuricemia	NN	O	hyperuricemia	dobj	3	SENT_88	[p6l976t2201r1587b2294],
6	,	,	O	,	_	0	SENT_88	[p6l976t2201r1587b2294],
7	with	IN	O	with	_	0	SENT_88	[p6l1618t2201r1795b2272],
8	or	CC	O	or	_	0	SENT_88	[p6l1829t2224r1915b2272],
9	without	IN	O	without	_	0	SENT_88	[p6l1942t2201r2149b2272, p6l13t2326r146b2387],
10	previous	JJ	O	previous	amod	11	SENT_88	[p6l184t2316r531b2409],
11	history	NN	O	history	prep_with	3	SENT_88	[p6l573t2316r852b2409],
12	of	IN	O	of	_	0	SENT_88	[p6l891t2317r977b2387],
13	gout	NN	O	gout	prep_of	11	SENT_88	[p6l1011t2326r1213b2409],
14	,	,	O	,	_	0	SENT_88	[p6l1011t2326r1213b2409],
15	and	CC	O	and	_	0	SENT_88	[p6l1259t2316r1406b2387],
16	mild	JJ	O	mild	amod	19	SENT_88	[p6l1447t2316r1628b2387],
17	CsAassociated	JJ	O	csaassociated	amod	19	SENT_88	[p6l1671t2316r2149b2388, p6l14t2431r188b2502],
18	renal	JJ	O	renal	amod	19	SENT_88	[p6l221t2431r429b2502],
19	dysfunction	NN	O	dysfunction	prep_without	3	SENT_88	[p6l464t2431r954b2524],
20	.	.	O	.	_	0	SENT_88	[p6l464t2431r954b2524],

1	Safety	NN	O	safety	nsubjpass	11	SENT_89	[p6l994t2432r1245b2524],
2	and	CC	O	and	_	0	SENT_89	[p6l1278t2431r1426b2502],
3	efﬁcacy	NN	O	efﬁcacy	nsubjpass	11	SENT_89	[p6l1460t2431r1766b2524],
4	of	IN	O	of	_	0	SENT_89	[p6l1799t2432r1884b2502],
5	uricosuric	JJ	O	uricosuric	amod	6	SENT_89	[p6l1911t2431r2149b2502, p6l13t2546r205b2617],
6	drugs	NNS	O	drug	prep_of	1	SENT_89	[p6l261t2546r482b2639],
7	have	VBP	O	have	aux	11	SENT_89	[p6l538t2546r725b2617],
8	not	RB	O	not	neg	11	SENT_89	[p6l783t2556r916b2617],
9	been	VBN	O	be	auxpass	11	SENT_89	[p6l970t2546r1168b2617],
10	extensively	RB	O	extensively	advmod	11	SENT_89	[p6l1225t2546r1669b2639],
11	studied	VBN	O	study	_	0	SENT_89	[p6l1723t2546r2020b2617],
12	in	IN	O	in	_	0	SENT_89	[p6l2075t2546r2151b2616],
13	CsA-treated	JJ	O	csa-treated	amod	15	SENT_89	[p6l14t2661r515b2733],
14	HT	NN	O	ht	nn	15	SENT_89	[p6l557t2664r697b2731],
15	patients	NNS	O	patient	prep_in	11	SENT_89	[p6l737t2661r1082b2754],
16	.	.	O	.	_	0	SENT_89	[p6l737t2661r1082b2754],

1	However	RB	O	however	advmod	6	SENT_90	[p6l1128t2664r1518b2747],
2	,	,	O	,	_	0	SENT_90	[p6l1128t2664r1518b2747],
3	Zurker	NNP	PERSON	Zurker	nsubj	6	SENT_90	[p6l1564t2661r1854b2732],
4	et	FW	O	et	nn	5	SENT_90	[p6l1897t2672r1971b2732],
5	al15	FW	O	al15	dep	3	SENT_90	[p6l2015t2658r2151b2732],
6	showed	VBD	O	show	_	0	SENT_90	[p6l13t2776r316b2847],
7	that	IN	O	that	complm	15	SENT_90	[p6l364t2776r524b2847],
8	benzbromarone	NN	O	benzbromarone	nsubj	15	SENT_90	[p6l569t2776r1240b2862],
9	,	,	O	,	_	0	SENT_90	[p6l569t2776r1240b2862],
10	a	DT	O	a	det	12	SENT_90	[p6l1293t2799r1336b2847],
11	uricosuric	JJ	O	uricosuric	amod	12	SENT_90	[p6l1382t2776r1787b2847],
12	drug	NN	O	drug	appos	8	SENT_90	[p6l1835t2776r2041b2869],
13	,	,	O	,	_	0	SENT_90	[p6l1835t2776r2041b2869],
14	is	VBZ	O	be	cop	15	SENT_90	[p6l2092t2776r2150b2847],
15	effective	JJ	O	effective	ccomp	6	SENT_90	[p6l13t2891r357b2962],
16	in	IN	O	in	_	0	SENT_90	[p6l385t2891r461b2961],
17	renal	JJ	O	renal	amod	19	SENT_90	[p6l487t2891r695b2962],
18	transplant	NN	O	transplant	nn	19	SENT_90	[p6l721t2891r1135b2984],
19	patients	NNS	O	patient	prep_in	15	SENT_90	[p6l1160t2891r1484b2984],
20	on	IN	O	on	_	0	SENT_90	[p6l1512t2914r1613b2962],
21	CsA	NN	O	csa	nn	22	SENT_90	[p6l1642t2892r1819b2963],
22	therapy	NN	O	therapy	prep_on	19	SENT_90	[p6l1842t2891r2153b2984],
23	regardless	RB	O	regardless	_	0	SENT_90	[p6l12t3006r424b3099],
24	of	IN	O	of	_	0	SENT_90	[p6l468t3007r554b3077],
25	their	PRP$	O	they	poss	27	SENT_90	[p6l590t3006r783b3077],
26	creatinine	NN	O	creatinine	nn	27	SENT_90	[p6l826t3006r1232b3077],
27	clearance	NN	O	clearance	prep_regardless_of	15	SENT_90	[p6l1276t3006r1684b3077],
28	.	.	O	.	_	0	SENT_90	[p6l1276t3006r1684b3077],

1	We	PRP	O	we	nsubj	2	SENT_91	[p6l1729t3008r1868b3078],
2	found	VBD	O	find	_	0	SENT_91	[p6l1912t3006r2151b3077],
3	that	IN	O	that	complm	6	SENT_91	[p6l11t3121r172b3192],
4	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nsubj	13	SENT_91	[p6l226t3121r818b3214],
5	effectively	RB	O	effectively	advmod	6	SENT_91	[p6l873t3121r1290b3214],
6	achieved	VBD	O	achieve	ccomp	2	SENT_91	[p6l1342t3121r1698b3192],
7	metabolic	JJ	O	metabolic	amod	8	SENT_91	[p6l1750t3121r2152b3192],
8	control	NN	O	control	dobj	6	SENT_91	[p6l13t3236r303b3307],
9	of	IN	O	of	_	0	SENT_91	[p6l362t3237r448b3307],
10	hyperuricemia	NN	O	hyperuricemia	prep_of	8	SENT_91	[p6l500t3236r1090b3329],
11	and	CC	O	and	_	0	SENT_91	[p6l1150t3236r1297b3307],
12	was	VBD	O	be	cop	13	SENT_91	[p6l1350t3259r1500b3307],
13	well-tolerated	JJ	O	well-tolerated	conj_and	6	SENT_91	[p6l1554t3236r2147b3307],
14	.	.	O	.	_	0	SENT_91	[p6l1554t3236r2147b3307],

1	However	RB	O	however	advmod	5	SENT_92	[p6l12t3353r402b3438],
2	,	,	O	,	_	0	SENT_92	[p6l12t3353r402b3438],
3	this	DT	O	this	det	4	SENT_92	[p6l454t3351r597b3422],
4	drug	NN	O	drug	nsubj	5	SENT_92	[p6l648t3351r833b3444],
5	seemed	VBD	O	seem	_	0	SENT_92	[p6l883t3351r1190b3422],
6	to	TO	O	to	aux	7	SENT_92	[p6l1239t3361r1318b3422],
7	interact	VB	O	interact	xcomp	5	SENT_92	[p6l1368t3351r1682b3422],
8	with	IN	O	with	_	0	SENT_92	[p6l1725t3351r1902b3422],
9	CSA	NNP	ORGANIZATION	CSA	prep_with	7	SENT_92	[p6l1953t3352r2148b3437],
10	,	,	O	,	_	0	SENT_92	[p6l1953t3352r2148b3437],
11	decreasing	VBG	O	decrease	xcomp	5	SENT_92	[p6l14t3466r447b3559],
12	its	PRP$	O	its	poss	14	SENT_92	[p6l493t3466r583b3537],
13	plasma	NN	O	plasma	nn	14	SENT_92	[p6l628t3466r917b3559],
14	level	NN	O	level	dobj	11	SENT_92	[p6l962t3466r1170b3537],
15	.	.	O	.	_	0	SENT_92	[p6l962t3466r1170b3537],

1	In	IN	O	in	_	0	SENT_93	[p6l1221t3468r1306b3536],
2	our	PRP$	O	we	poss	3	SENT_93	[p6l1353t3489r1491b3537],
3	study	NN	O	study	prep_in	6	SENT_93	[p6l1538t3466r1771b3559],
4	,	,	O	,	_	0	SENT_93	[p6l1538t3466r1771b3559],
5	we	PRP	O	we	nsubj	6	SENT_93	[p6l1816t3489r1928b3537],
6	conducted	VBD	O	conduct	_	0	SENT_93	[p6l1976t3489r2149b3537, p6l14t3581r288b3652],
7	follow-ups	NNS	O	follow-up	dobj	6	SENT_93	[p6l335t3581r782b3674],
8	,	,	O	,	_	0	SENT_93	[p6l335t3581r782b3674],
9	including	VBG	O	include	dep	6	SENT_93	[p6l832t3581r1209b3674],
10	control	NN	O	control	nn	11	SENT_93	[p6l1256t3581r1547b3652],
11	investigations	NNS	O	investigation	pobj	9	SENT_93	[p6l1595t3581r2150b3674],
12	of	IN	O	of	_	0	SENT_93	[p6l13t3697r99b3767],
13	CsA	NN	O	csa	prep_of	11	SENT_93	[p6l149t3697r344b3782],
14	,	,	O	,	_	0	SENT_93	[p6l149t3697r344b3782],
15	uric	JJ	O	uric	amod	17	SENT_93	[p6l401t3696r558b3767],
16	acid	NN	O	acid	nn	17	SENT_93	[p6l614t3696r777b3767],
17	levels	NNS	O	level	appos	13	SENT_93	[p6l831t3696r1077b3782],
18	,	,	O	,	_	0	SENT_93	[p6l831t3696r1077b3782],
19	etc.	FW	O	etc.	dep	13	SENT_93	[p6l1137t3706r1298b3782],
20	,	,	O	,	_	0	SENT_93	[p6l1137t3706r1298b3782],
21	every	DT	SET	every	quantmod	22	SENT_93	[p6l1358t3719r1574b3789],
22	2	CD	SET	2	num	23	SENT_93	[p6l1627t3697r1671b3766],
23	months	NNS	NUMBER	month	tmod	11	SENT_93	[p6l1725t3696r2049b3783],
24	,	,	O	,	_	0	SENT_93	[p6l1725t3696r2049b3783],
25	a	DT	O	a	det	27	SENT_93	[p6l2109t3719r2152b3767],
26	routine	JJ	O	routine	amod	27	SENT_93	[p7l12t18r308b89],
27	schedule	NN	O	schedule	dobj	6	SENT_93	[p7l351t18r704b89],
28	for	IN	O	for	_	0	SENT_93	[p7l746t19r864b89],
29	long-term	JJ	O	long-term	amod	32	SENT_93	[p7l903t18r1306b111],
30	stable	JJ	O	stable	amod	32	SENT_93	[p7l1348t18r1582b89],
31	HT	NN	O	ht	nn	32	SENT_93	[p7l1625t20r1764b88],
32	patients	NNS	O	patient	prep_for	27	SENT_93	[p7l1802t18r2147b111],
33	.	.	O	.	_	0	SENT_93	[p7l1802t18r2147b111],

1	Uric	JJ	O	uric	amod	3	SENT_94	[p7l12t133r194b205],
2	acid	NN	O	acid	nn	3	SENT_94	[p7l220t133r384b204],
3	levels	NNS	O	level	nsubj	4	SENT_94	[p7l409t133r633b204],
4	decreased	VBD	O	decrease	_	0	SENT_94	[p7l660t133r1067b204],
5	more	RBR	O	more	advmod	6	SENT_94	[p7l1092t156r1303b204],
6	rapidly	RB	O	rapidly	advmod	4	SENT_94	[p7l1330t133r1614b226],
7	than	IN	O	than	prep	6	SENT_94	[p7l1637t133r1818b204],
8	and	CC	O	and	cc	9	SENT_94	[p7l1846t133r1993b204],
9	not	RB	O	not	pobj	7	SENT_94	[p7l2017t143r2152b204],
10	simultaneously	RB	O	simultaneously	advmod	7	SENT_94	[p7l12t248r622b341],
11	with	IN	O	with	_	0	SENT_94	[p7l679t248r856b319],
12	CsA	NN	O	csa	nn	13	SENT_94	[p7l923t249r1099b320],
13	levels	NNS	O	level	prep_with	4	SENT_94	[p7l1160t248r1405b319],
14	.	.	O	.	_	0	SENT_94	[p7l1160t248r1405b319],

1	In	IN	O	in	_	0	SENT_95	[p7l1474t250r1560b318],
2	addition	NN	O	addition	prep_in	13	SENT_95	[p7l1625t248r1983b334],
3	,	,	O	,	_	0	SENT_95	[p7l1625t248r1983b334],
4	an	DT	O	a	det	5	SENT_95	[p7l2053t271r2147b319],
5	interaction	NN	O	interaction	nsubjpass	13	SENT_95	[p7l11t363r456b434],
6	between	IN	O	between	_	0	SENT_95	[p7l478t363r820b434],
7	CsA	NN	O	csa	prep_between	5	SENT_95	[p7l848t364r1024b435],
8	and	CC	O	and	_	0	SENT_95	[p7l1048t363r1195b434],
9	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_between	5	SENT_95	[p7l1222t363r1814b456],
10	had	VBD	O	have	aux	13	SENT_95	[p7l1840t363r1990b434],
11	not	RB	O	not	neg	13	SENT_95	[p7l2014t373r2148b434],
12	been	VBN	O	be	auxpass	13	SENT_95	[p7l8t478r206b549],
13	reported	VBN	O	report	_	0	SENT_95	[p7l242t478r597b571],
14	previously	RB	DATE	previously	advmod	13	SENT_95	[p7l631t478r1067b571],
15	.	.	O	.	_	0	SENT_95	[p7l631t478r1067b571],

1	This	DT	O	this	nsubj	2	SENT_96	[p7l1106t478r1282b549],
2	explains	VBZ	O	explain	_	0	SENT_96	[p7l1319t478r1646b571],
3	why	WRB	O	why	advmod	7	SENT_96	[p7l1677t478r1842b571],
4	we	PRP	O	we	nsubj	7	SENT_96	[p7l1870t501r1983b549],
5	did	VBD	O	do	aux	7	SENT_96	[p7l2021t478r2148b549],
6	not	RB	O	not	neg	7	SENT_96	[p7l10t603r144b664],
7	terminate	VB	O	terminate	advcl	2	SENT_96	[p7l207t593r603b664],
8	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	9	SENT_96	[p7l668t593r1260b686],
9	treatment	NN	O	treatment	dobj	7	SENT_96	[p7l1324t603r1727b664],
10	until	IN	O	until	mark	12	SENT_96	[p7l1788t593r1976b664],
11	we	PRP	O	we	nsubj	12	SENT_96	[p7l2034t616r2146b664],
12	analyzed	VBD	O	analyze	advcl	7	SENT_96	[p7l13t708r367b801],
13	the	DT	O	the	det	14	SENT_96	[p7l397t708r524b779],
14	data	NNS	O	datum	dobj	12	SENT_96	[p7l558t708r733b779],
15	at	IN	O	at	_	0	SENT_96	[p7l765t718r838b779],
16	six	CD	DURATION	six	num	17	SENT_96	[p7l870t708r974b779],
17	months	NNS	NUMBER	month	prep_at	12	SENT_96	[p7l1002t708r1303b779],
18	of	IN	O	of	_	0	SENT_96	[p7l1336t709r1421b779],
19	treatment	NN	O	treatment	prep_of	17	SENT_96	[p7l1446t718r1868b779],
20	.	.	O	.	_	0	SENT_96	[p7l1446t718r1868b779],

1	When	WRB	O	when	advmod	3	SENT_97	[p7l1902t708r2147b780],
2	we	PRP	O	we	nsubj	3	SENT_97	[p7l6t846r119b894],
3	compared	VBD	O	compare	advcl	17	SENT_97	[p7l158t823r565b916],
4	the	DT	O	the	det	5	SENT_97	[p7l603t823r729b894],
5	results	NNS	O	result	dobj	3	SENT_97	[p7l768t823r1032b894],
6	in	IN	O	in	_	0	SENT_97	[p7l1071t823r1147b893],
7	patients	NNS	O	patient	prep_in	3	SENT_97	[p7l1182t823r1506b916],
8	with	IN	O	with	_	0	SENT_97	[p7l1540t823r1716b894],
9	double	JJ	O	double	prep_with	7	SENT_97	[p7l1755t823r2032b894],
10	vs	CC	O	vs	_	0	SENT_97	[p7l2066t846r2146b894],
11	those	DT	O	those	prep_with	7	SENT_97	[p7l10t938r227b1009],
12	with	IN	O	with	_	0	SENT_97	[p7l263t938r440b1009],
13	triple	JJ	O	triple	amod	14	SENT_97	[p7l478t938r695b1031],
14	therapy	NN	O	therapy	prep_with	3	SENT_97	[p7l735t938r1065b1031],
15	,	,	O	,	_	0	SENT_97	[p7l735t938r1065b1031],
16	we	PRP	O	we	nsubj	17	SENT_97	[p7l1102t961r1214b1009],
17	found	VBD	O	find	_	0	SENT_97	[p7l1254t938r1494b1009],
18	no	DT	O	no	det	19	SENT_97	[p7l1532t961r1633b1009],
19	differences	NNS	O	difference	dobj	17	SENT_97	[p7l1675t938r2144b1024],
20	,	,	O	,	_	0	SENT_97	[p7l1675t938r2144b1024],
21	except	IN	O	except	_	0	SENT_97	[p7l12t1064r272b1147],
22	for	IN	O	for	_	0	SENT_97	[p7l317t1055r435b1125],
23	a	DT	O	a	det	32	SENT_97	[p7l482t1077r524b1125],
24	slightly	RB	O	slightly	advmod	25	SENT_97	[p7l570t1054r858b1147],
25	higher	JJR	O	higher	amod	32	SENT_97	[p7l900t1054r1162b1147],
26	(	NN	O	(	nn	32	SENT_97	[p7l1210t1053r1285b1148],
27	p	NN	O	p	nn	32	SENT_97	[p7l1210t1053r1285b1148],
28	=	JJ	O	=	amod	32	SENT_97	[p7l1343t1082r1400b1104],
29	0.02	CD	NUMBER	0.02	number	30	SENT_97	[p7l1456t1053r1654b1148],
30	)	CD	NUMBER	)	num	32	SENT_97	[p7l1456t1053r1654b1148],
31	mean	NN	O	mean	nn	32	SENT_97	[p7l1703t1077r1926b1125],
32	CsA	NN	O	csa	prep_except_for	17	SENT_97	[p7l1974t1055r2151b1126],
33	daily	RB	SET	daily	advmod	34	SENT_97	[p7l13t1168r205b1261],
34	dose	NN	O	dose	rcmod	32	SENT_97	[p7l251t1168r435b1239],
35	at	IN	O	at	_	0	SENT_97	[p7l485t1178r559b1239],
36	the	DT	O	the	det	37	SENT_97	[p7l605t1168r732b1239],
37	end	NN	O	end	prep_at	34	SENT_97	[p7l781t1168r929b1239],
38	of	IN	O	of	_	0	SENT_97	[p7l978t1169r1063b1239],
39	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	40	SENT_97	[p7l1105t1168r1697b1261],
40	treatment	NN	O	treatment	prep_of	37	SENT_97	[p7l1745t1178r2148b1239],
41	among	IN	O	among	_	0	SENT_97	[p7l13t1306r286b1376],
42	patients	NNS	O	patient	prep_among	17	SENT_97	[p7l335t1283r658b1376],
43	on	IN	O	on	_	0	SENT_97	[p7l710t1306r811b1354],
44	triple	JJ	O	triple	amod	45	SENT_97	[p7l861t1283r1077b1376],
45	therapy	NN	O	therapy	prep_on	42	SENT_97	[p7l1128t1283r1457b1376],
46	.	.	O	.	_	0	SENT_97	[p7l1128t1283r1457b1376],

1	At	IN	O	at	_	0	SENT_98	[p7l1507t1284r1613b1354],
2	present	JJ	DATE	present	prep_at	7	SENT_98	[p7l1661t1293r1985b1376],
3	,	,	O	,	_	0	SENT_98	[p7l1661t1293r1985b1376],
4	we	PRP	O	we	nsubj	7	SENT_98	[p7l2034t1306r2146b1354],
5	can	MD	O	can	aux	7	SENT_98	[p7l12t1408r287b1469],
6	not	RB	O	not	neg	7	SENT_98	[p7l12t1408r287b1469],
7	explain	VB	O	explain	_	0	SENT_98	[p7l339t1398r631b1491],
8	the	DT	O	the	det	9	SENT_98	[p7l681t1398r809b1469],
9	cause	NN	O	cause	dobj	7	SENT_98	[p7l862t1421r1084b1469],
10	of	IN	O	of	_	0	SENT_98	[p7l1137t1399r1223b1469],
11	this	DT	O	this	det	12	SENT_98	[p7l1268t1398r1412b1469],
12	increase	NN	O	increase	prep_of	9	SENT_98	[p7l1464t1398r1820b1485],
13	;	:	O	;	_	0	SENT_98	[p7l1464t1398r1820b1485],
14	it	PRP	O	it	nsubj	16	SENT_98	[p7l1876t1398r1930b1469],
15	may	MD	O	may	aux	16	SENT_98	[p7l1981t1421r2150b1491],
16	reﬂect	VB	O	reﬂect	parataxis	7	SENT_98	[p7l11t1513r269b1584],
17	a	DT	O	a	det	19	SENT_98	[p7l331t1536r373b1584],
18	chance	NN	O	chance	nn	19	SENT_98	[p7l434t1513r713b1584],
19	association	NN	O	association	dobj	16	SENT_98	[p7l777t1513r1224b1584],
20	because	IN	O	because	_	0	SENT_98	[p7l1283t1513r1606b1584],
21	of	IN	O	of	prepc_because_of	16	SENT_98	[p7l1668t1514r1754b1584],
22	multiple	JJ	O	multiple	amod	23	SENT_98	[p7l1808t1513r2146b1606],
23	comparisons	NNS	O	comparison	pobj	16	SENT_98	[p7l12t1629r544b1722],
24	.	.	O	.	_	0	SENT_98	[p7l12t1629r544b1722],

1	Our	PRP$	O	we	poss	2	SENT_99	[p7l110t1745r272b1816],
2	study	NN	O	study	nsubj	5	SENT_99	[p7l301t1744r515b1837],
3	was	VBD	O	be	cop	5	SENT_99	[p7l536t1767r685b1815],
4	not	RB	O	not	neg	5	SENT_99	[p7l713t1754r847b1815],
5	prospective	JJ	O	prospective	_	0	SENT_99	[p7l873t1744r1340b1837],
6	and	CC	O	and	_	0	SENT_99	[p7l1371t1744r1518b1815],
7	controlled	JJ	O	controlled	conj_and	5	SENT_99	[p7l1547t1744r1985b1830],
8	,	,	O	,	_	0	SENT_99	[p7l1547t1744r1985b1830],
9	but	CC	O	but	_	0	SENT_99	[p7l2013t1744r2148b1815],
10	retrospective	NN	O	retrospective	nsubj	14	SENT_99	[p7l11t1860r564b1953],
11	;	:	O	;	_	0	SENT_99	[p7l11t1860r564b1953],
12	thus	RB	O	thus	advmod	14	SENT_99	[p7l647t1860r817b1932],
13	there	EX	O	there	expl	14	SENT_99	[p7l897t1860r1109b1931],
14	was	VBD	O	be	conj_but	5	SENT_99	[p7l1185t1883r1335b1931],
15	no	DT	O	no	det	19	SENT_99	[p7l1415t1883r1516b1931],
16	appropriately	RB	O	appropriately	advmod	19	SENT_99	[p7l1599t1860r2150b1953],
17	matched	VBN	O	match	amod	19	SENT_99	[p7l10t1975r361b2046],
18	control	NN	O	control	nn	19	SENT_99	[p7l420t1975r710b2046],
19	group	NN	O	group	nsubj	14	SENT_99	[p7l768t1998r1006b2068],
20	of	IN	O	of	_	0	SENT_99	[p7l1066t1976r1151b2046],
21	patients	NNS	O	patient	prep_of	19	SENT_99	[p7l1202t1975r1526b2068],
22	who	WP	O	who	nsubjpass	25	SENT_99	[p7l1581t1975r1751b2046],
23	was	VBD	O	be	auxpass	25	SENT_99	[p7l1806t1998r1955b2046],
24	not	RB	O	not	neg	25	SENT_99	[p7l2014t1985r2148b2046],
25	treated	VBN	O	treat	rcmod	19	SENT_99	[p7l10t2090r302b2161],
26	with	IN	O	with	_	0	SENT_99	[p7l334t2090r511b2161],
27	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_with	25	SENT_99	[p7l549t2090r1162b2183],
28	.	.	O	.	_	0	SENT_99	[p7l549t2090r1162b2183],

1	However	RB	O	however	advmod	9	SENT_100	[p7l1203t2092r1592b2176],
2	,	,	O	,	_	0	SENT_100	[p7l1203t2092r1592b2176],
3	to	TO	O	to	aux	4	SENT_100	[p7l1632t2100r1710b2161],
4	overcome	VB	O	overcome	purpcl	9	SENT_100	[p7l1750t2113r2146b2161],
5	this	DT	O	this	det	6	SENT_100	[p7l11t2205r154b2276],
6	limitation	NN	O	limitation	dobj	4	SENT_100	[p7l181t2205r599b2291],
7	,	,	O	,	_	0	SENT_100	[p7l181t2205r599b2291],
8	we	PRP	O	we	nsubj	9	SENT_100	[p7l624t2228r737b2276],
9	analyzed	VBD	O	analyze	_	0	SENT_100	[p7l767t2205r1141b2298],
10	,	,	O	,	_	0	SENT_100	[p7l767t2205r1141b2298],
11	as	IN	O	as	_	0	SENT_100	[p7l1173t2228r1251b2276],
12	control	NN	O	control	nn	13	SENT_100	[p7l1279t2205r1570b2276],
13	data	NNS	O	datum	prep_as	9	SENT_100	[p7l1598t2205r1793b2291],
14	,	,	O	,	_	0	SENT_100	[p7l1598t2205r1793b2291],
15	those	DT	O	those	appos	13	SENT_100	[p7l1823t2205r2039b2276],
16	of	IN	O	of	_	0	SENT_100	[p7l2068t2206r2153b2276],
17	the	DT	O	the	det	20	SENT_100	[p7l11t2320r138b2391],
18	same	JJ	O	same	amod	20	SENT_100	[p7l179t2343r384b2391],
19	120	CD	NUMBER	120	num	20	SENT_100	[p7l429t2321r564b2391],
20	patients	NNS	O	patient	prep_of	15	SENT_100	[p7l602t2320r947b2413],
21	,	,	O	,	_	0	SENT_100	[p7l602t2320r947b2413],
22	who	WP	O	who	nsubjpass	24	SENT_100	[p7l984t2320r1154b2391],
23	were	VBD	O	be	auxpass	24	SENT_100	[p7l1189t2343r1386b2391],
24	treated	VBN	O	treat	rcmod	13	SENT_100	[p7l1426t2320r1718b2391],
25	with	IN	O	with	_	0	SENT_100	[p7l1752t2320r1929b2391],
26	allopurinol	NN	O	allopurinol	prep_with	24	SENT_100	[p7l1969t2320r2145b2391, p7l9t2435r308b2528],
27	before	IN	O	before	_	0	SENT_100	[p7l367t2435r632b2506],
28	initiation	NN	O	initiation	prep_before	24	SENT_100	[p7l695t2435r1066b2506],
29	of	IN	O	of	_	0	SENT_100	[p7l1129t2436r1214b2506],
30	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_of	28	SENT_100	[p7l1271t2435r1885b2528],
31	.	.	O	.	_	0	SENT_100	[p7l1271t2435r1885b2528],

1	Such	JJ	O	such	amod	2	SENT_101	[p7l1952t2435r2147b2507],
2	data	NNS	O	datum	nsubj	4	SENT_101	[p7l13t2550r187b2621],
3	further	RB	O	further	advmod	4	SENT_101	[p7l230t2550r518b2621],
4	strengthened	VBD	O	strengthen	_	0	SENT_101	[p7l563t2550r1096b2643],
5	our	PRP$	O	we	poss	6	SENT_101	[p7l1141t2573r1280b2621],
6	observation	NN	O	observation	dobj	4	SENT_101	[p7l1325t2550r1820b2621],
7	.	.	O	.	_	0	SENT_101	[p7l1325t2550r1820b2621],

1	In	IN	O	in	_	0	SENT_102	[p7l1869t2552r1954b2620],
2	fact	NN	O	fact	prep_in	4	SENT_102	[p7l1998t2551r2148b2621],
3	we	PRP	O	we	nsubj	4	SENT_102	[p7l6t2688r118b2736],
4	found	VBD	O	find	_	0	SENT_102	[p7l145t2665r384b2736],
5	no	DT	O	no	det	6	SENT_102	[p7l410t2688r510b2736],
6	reduction	NN	O	reduction	dobj	4	SENT_102	[p7l538t2665r930b2736],
7	of	IN	O	of	_	0	SENT_102	[p7l957t2666r1042b2736],
8	CsA	NN	O	csa	nn	9	SENT_102	[p7l1064t2666r1240b2737],
9	level	NN	O	level	prep_of	6	SENT_102	[p7l1262t2665r1450b2736],
10	with	IN	O	with	_	0	SENT_102	[p7l1471t2665r1649b2736],
11	allopurinol	NN	O	allopurinol	prep_with	4	SENT_102	[p7l1676t2665r2144b2758],
12	,	,	O	,	_	0	SENT_102	[p7l1676t2665r2144b2758],
13	despite	IN	O	despite	_	0	SENT_102	[p7l13t2780r301b2873],
14	a	DT	O	a	det	15	SENT_102	[p7l355t2803r397b2851],
15	reduction	NN	O	reduction	prep_despite	4	SENT_102	[p7l448t2780r839b2852],
16	in	IN	O	in	_	0	SENT_102	[p7l890t2780r965b2850],
17	CsA	NN	O	csa	nn	19	SENT_102	[p7l1018t2781r1195b2852],
18	daily	JJ	SET	daily	amod	19	SENT_102	[p7l1244t2780r1437b2873],
19	dose	NN	O	dose	prep_in	15	SENT_102	[p7l1487t2780r1691b2851],
20	.	.	O	.	_	0	SENT_102	[p7l1487t2780r1691b2851],

1	This	DT	O	this	det	4	SENT_103	[p7l1745t2780r1921b2851],
2	CSA	NNP	O	CSA	nn	4	SENT_103	[p7l1974t2781r2151b2852],
3	dose	NN	O	dose	nn	4	SENT_103	[p7l13t2895r196b2966],
4	reduction	NN	O	reduction	nsubj	7	SENT_103	[p7l223t2895r616b2966],
5	is	VBZ	O	be	cop	7	SENT_103	[p7l643t2895r701b2966],
6	not	RB	O	not	neg	7	SENT_103	[p7l729t2905r862b2966],
7	surprising	JJ	O	surprising	_	0	SENT_103	[p7l891t2895r1291b2988],
8	because	IN	O	because	mark	11	SENT_103	[p7l1316t2895r1639b2966],
9	it	PRP	O	it	nsubj	11	SENT_103	[p7l1667t2895r1722b2966],
10	is	VBZ	O	be	cop	11	SENT_103	[p7l1749t2895r1807b2966],
11	secondary	JJ	O	secondary	advcl	7	SENT_103	[p7l1836t2895r2146b2966, p7l13t3033r137b3103],
12	to	TO	O	to	_	0	SENT_103	[p7l200t3020r279b3081],
13	the	DT	O	the	det	15	SENT_103	[p7l347t3010r474b3081],
14	dose	NN	O	dose	nn	15	SENT_103	[p7l543t3010r726b3081],
15	adjustments	NNS	O	adjustment	prep_to	11	SENT_103	[p7l795t3010r1283b3103],
16	routinely	RB	O	routinely	advmod	17	SENT_103	[p7l1350t3010r1719b3103],
17	made	VBN	O	make	partmod	15	SENT_103	[p7l1782t3010r2005b3081],
18	in	IN	O	in	_	0	SENT_103	[p7l2072t3010r2147b3080],
19	long-term	JJ	O	long-term	amod	20	SENT_103	[p7l11t3125r413b3218],
20	follow-up	NN	O	follow-up	prep_in	17	SENT_103	[p7l471t3125r859b3218],
21	of	IN	O	of	_	0	SENT_103	[p7l920t3126r1005b3196],
22	all	DT	O	all	det	24	SENT_103	[p7l1061t3125r1155b3196],
23	transplant	NN	O	transplant	nn	24	SENT_103	[p7l1213t3125r1627b3218],
24	patients	NNS	O	patient	prep_of	20	SENT_103	[p7l1684t3125r2007b3218],
25	to	TO	O	to	aux	26	SENT_103	[p7l2067t3135r2146b3196],
26	reduce	VB	O	reduce	xcomp	17	SENT_103	[p7l11t3240r286b3311],
27	the	DT	O	the	det	29	SENT_103	[p7l346t3240r473b3311],
28	well-known	JJ	O	well-known	amod	29	SENT_103	[p7l529t3240r1000b3311],
29	nephrotoxicity	NN	O	nephrotoxicity	dobj	26	SENT_103	[p7l1059t3240r1649b3333],
30	of	IN	O	of	_	0	SENT_103	[p7l1707t3241r1792b3311],
31	chronic	JJ	O	chronic	amod	33	SENT_103	[p7l1845t3240r2149b3311],
32	CsA	NN	O	csa	nn	33	SENT_103	[p7l13t3357r190b3427],
33	therapy	NN	O	therapy	prep_of	29	SENT_103	[p7l239t3352r639b3448],
34	.	.	O	.	_	0	SENT_103	[p7l239t3352r639b3448],

1	”	NN	O	”	nn	3	SENT_104	[p7l239t3352r639b3448],
2	The	DT	O	the	det	3	SENT_104	[p7l692t3355r851b3426],
3	increase	NN	O	increase	nsubj	14	SENT_104	[p7l906t3355r1238b3426],
4	in	IN	O	in	_	0	SENT_104	[p7l1293t3355r1368b3425],
5	creatinine	NN	O	creatinine	prep_in	3	SENT_104	[p7l1422t3355r1828b3426],
6	during	IN	O	during	_	0	SENT_104	[p7l1884t3355r2148b3448],
7	allopurinol	NN	O	allopurinol	nn	8	SENT_104	[p7l13t3470r460b3563],
8	therapy	NN	O	therapy	prep_during	5	SENT_104	[p7l506t3470r817b3563],
9	that	IN	O	that	dep	11	SENT_104	[p7l861t3470r1021b3541],
10	we	PRP	O	we	nsubj	11	SENT_104	[p7l1062t3493r1174b3541],
11	documented	VBD	O	document	dep	5	SENT_104	[p7l1223t3470r1730b3541],
12	may	MD	O	may	aux	14	SENT_104	[p7l1776t3493r1944b3563],
13	also	RB	O	also	advmod	14	SENT_104	[p7l1990t3470r2146b3541],
14	reﬂect	VB	O	reﬂect	_	0	SENT_104	[p7l11t3585r289b3671],
15	,	,	O	,	_	0	SENT_104	[p7l11t3585r289b3671],
16	at	IN	O	at	advmod	14	SENT_104	[p7l322t3595r395b3656],
17	least	JJS	O	least	pobj	16	SENT_104	[p7l421t3585r608b3656],
18	in	IN	O	in	_	0	SENT_104	[p7l635t3585r710b3655],
19	part	NN	O	part	prep_in	16	SENT_104	[p7l736t3595r923b3678],
20	,	,	O	,	_	0	SENT_104	[p7l736t3595r923b3678],
21	the	DT	O	the	det	24	SENT_104	[p7l953t3585r1080b3656],
22	known	JJ	O	known	amod	24	SENT_104	[p7l1107t3585r1378b3656],
23	nephrotoxic	JJ	O	nephrotoxic	amod	24	SENT_104	[p7l1405t3585r1893b3678],
24	effect	NN	O	effect	dobj	14	SENT_104	[p7l1920t3586r2148b3656],
25	of	IN	O	of	_	0	SENT_104	[p7l12t3701r97b3771],
26	allopurinol	NN	O	allopurinol	prep_of	24	SENT_104	[p7l139t3697r677b3793],
27	.	.	O	.	_	0	SENT_104	[p7l139t3697r677b3793],

1	”	NN	O	”	nsubj	9	SENT_105	[p7l139t3697r677b3793],
2	Conversely	RB	O	conversely	advmod	1	SENT_105	[p7l724t3700r1195b3793],
3	,	,	O	,	_	0	SENT_105	[p7l724t3700r1195b3793],
4	during	IN	O	during	_	0	SENT_105	[p7l1245t3700r1509b3793],
5	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	6	SENT_105	[p7l1555t3700r2146b3793],
6	administration	NN	O	administration	prep_during	9	SENT_105	[p8l13t18r629b104],
7	,	,	O	,	_	0	SENT_105	[p8l13t18r629b104],
8	creatinine	NN	O	creatinine	nsubj	9	SENT_105	[p8l681t18r1087b89],
9	tended	VBD	O	tend	_	0	SENT_105	[p8l1136t18r1418b89],
10	to	TO	O	to	aux	11	SENT_105	[p8l1466t28r1545b89],
11	decrease	VB	O	decrease	xcomp	9	SENT_105	[p8l1596t18r1949b89],
12	and	CC	O	and	dep	17	SENT_105	[p8l2000t18r2148b89],
13	blood	NN	O	blood	nn	14	SENT_105	[p8l8t133r242b204],
14	urea	NN	O	urea	nsubj	17	SENT_105	[p8l292t156r475b204],
15	was	VBD	O	be	cop	17	SENT_105	[p8l519t156r669b204],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_105	[p8l721t133r1205b226],
17	lower	JJR	O	lower	parataxis	11	SENT_105	[p8l1253t133r1499b219],
18	,	,	O	,	_	0	SENT_105	[p8l1253t133r1499b219],
19	despite	IN	O	despite	_	0	SENT_105	[p8l1553t133r1842b226],
20	an	DT	O	a	det	21	SENT_105	[p8l1896t156r1990b204],
21	increase	NN	O	increase	prep_despite	17	SENT_105	[p8l2041t133r2145b203, p8l12t271r265b319],
22	in	IN	O	in	_	0	SENT_105	[p8l296t248r371b318],
23	CsA	NN	O	csa	nn	24	SENT_105	[p8l403t249r579b320],
24	dose	NN	O	dose	prep_in	21	SENT_105	[p8l607t248r813b334],
25	,	,	O	,	_	0	SENT_105	[p8l607t248r813b334],
26	and	CC	O	and	_	0	SENT_105	[p8l848t248r995b319],
27	as	IN	O	as	_	0	SENT_105	[p8l1026t271r1104b319],
28	a	DT	O	a	det	29	SENT_105	[p8l1137t271r1179b319],
29	result	NN	O	result	prep_as	17	SENT_105	[p8l1208t248r1437b319],
30	of	IN	O	of	_	0	SENT_105	[p8l1467t249r1552b319],
31	the	DT	O	the	det	34	SENT_105	[p8l1576t248r1703b319],
32	signiﬁcant	JJ	O	signiﬁcant	amod	34	SENT_105	[p8l1735t248r2148b341],
33	1208	CD	DATE	1208	tmod	32	SENT_105	[p8l14t371r180b433],
34	Caforio	NNP	O	Caforio	prep_of	29	SENT_105	[p8l282t369r560b433],
35	et	FW	O	et	nn	36	SENT_105	[p8l595t378r662b433],
36	al.	FW	O	al.	dobj	11	SENT_105	[p8l695t369r775b433],
37	.	.	O	.	_	0	SENT_105	[p8l695t369r775b433],

1	reduction	NN	O	reduction	_	0	SENT_106	[p8l11t607r403b678],
2	in	IN	O	in	_	0	SENT_106	[p8l455t607r530b677],
3	CsA	NN	O	csa	nn	4	SENT_106	[p8l585t608r762b679],
4	levels	NNS	O	level	prep_in	1	SENT_106	[p8l811t607r1055b678],
5	.	.	O	.	_	0	SENT_106	[p8l811t607r1055b678],

1	In	IN	O	in	_	0	SENT_107	[p8l1113t609r1198b677],
2	2	CD	NUMBER	2	prep_in	14	SENT_107	[p8l1250t608r1295b677],
3	of	IN	O	of	_	0	SENT_107	[p8l1348t608r1433b678],
4	our	PRP$	O	we	poss	5	SENT_107	[p8l1481t630r1619b678],
5	patients	NNS	O	patient	prep_of	2	SENT_107	[p8l1669t607r1992b700],
6	on	IN	O	on	_	0	SENT_107	[p8l2047t630r2147b678],
7	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nn	8	SENT_107	[p8l12t722r604b815],
8	therapy	NN	O	therapy	prep_on	5	SENT_107	[p8l642t722r971b815],
9	,	,	O	,	_	0	SENT_107	[p8l642t722r971b815],
10	reduction	NN	O	reduction	nsubjpass	14	SENT_107	[p8l1011t722r1403b793],
11	in	IN	O	in	_	0	SENT_107	[p8l1439t722r1515b792],
12	CsA	NN	O	csa	prep_in	10	SENT_107	[p8l1553t723r1730b794],
13	was	VBD	O	be	auxpass	14	SENT_107	[p8l1759t745r1908b793],
14	associated	VBN	O	associate	_	0	SENT_107	[p8l1948t745r2145b793, p8l12t837r255b908],
15	with	IN	O	with	_	0	SENT_107	[p8l306t837r483b908],
16	unexpected	JJ	O	unexpected	amod	19	SENT_107	[p8l537t837r1005b930],
17	late	JJ	O	late	amod	19	SENT_107	[p8l1060t837r1208b908],
18	acute	JJ	O	acute	amod	19	SENT_107	[p8l1267t847r1481b908],
19	rejection	NN	O	rejection	prep_with	14	SENT_107	[p8l1538t837r1919b930],
20	,	,	O	,	_	0	SENT_107	[p8l1538t837r1919b930],
21	thus	RB	O	thus	advmod	14	SENT_107	[p8l1977t837r2146b908],
22	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nsubjpass	30	SENT_107	[p8l12t952r604b1045],
23	is	VBZ	O	be	cop	25	SENT_107	[p8l634t952r692b1023],
24	potentially	RB	O	potentially	advmod	25	SENT_107	[p8l721t952r1158b1045],
25	harmful	JJ	O	harmful	ccomp	14	SENT_107	[p8l1185t952r1509b1023],
26	and	CC	O	and	_	0	SENT_107	[p8l1540t952r1687b1023],
27	should	MD	O	should	aux	30	SENT_107	[p8l1717t952r1985b1023],
28	not	RB	O	not	neg	30	SENT_107	[p8l2014t962r2147b1023],
29	be	VB	O	be	auxpass	30	SENT_107	[p8l8t1067r105b1138],
30	used	VBN	O	use	conj_and	25	SENT_107	[p8l149t1067r337b1138],
31	routinely	RB	O	routinely	advmod	30	SENT_107	[p8l382t1067r750b1160],
32	in	IN	O	in	_	0	SENT_107	[p8l793t1067r868b1137],
33	combination	NN	O	combination	prep_in	30	SENT_107	[p8l914t1067r1424b1138],
34	with	IN	O	with	_	0	SENT_107	[p8l1464t1067r1642b1138],
35	CsA	NN	O	csa	prep_with	30	SENT_107	[p8l1688t1068r1881b1139],
36	.	.	O	.	_	0	SENT_107	[p8l1688t1068r1881b1139],

1	Early	RB	O	early	advmod	2	SENT_108	[p8l1930t1067r2150b1160],
2	observations	NNS	O	observation	nsubj	3	SENT_108	[p8l12t1182r522b1253],
3	suggest	VBP	O	suggest	_	0	SENT_108	[p8l582t1192r877b1275],
4	that	IN	O	that	complm	22	SENT_108	[p8l933t1182r1094b1253],
5	mycophenolate	JJ	O	mycophenolate	amod	6	SENT_108	[p8l1150t1182r1774b1275],
6	mofetil	NN	O	mofetil	nsubjpass	22	SENT_108	[p8l1832t1182r2145b1268],
7	,	,	O	,	_	0	SENT_108	[p8l1832t1182r2145b1268],
8	which	WDT	O	which	nsubj	10	SENT_108	[p8l6t1297r247b1368],
9	has	VBZ	O	have	aux	10	SENT_108	[p8l300t1297r432b1368],
10	replaced	VBN	O	replace	rcmod	6	SENT_108	[p8l486t1297r837b1390],
11	Aza	NN	O	aza	dobj	10	SENT_108	[p8l886t1298r1050b1368],
12	for	IN	O	for	_	0	SENT_108	[p8l1102t1298r1221b1368],
13	chemoprophylaxis	NNS	O	chemoprophylaxi	prep_for	11	SENT_108	[p8l1274t1297r2013b1390],
14	of	IN	O	of	_	0	SENT_108	[p8l2068t1298r2153b1368],
15	rejection	NN	O	rejection	prep_of	13	SENT_108	[p8l11t1412r371b1505],
16	in	IN	O	in	_	0	SENT_108	[p8l398t1412r473b1482],
17	many	JJ	O	many	amod	18	SENT_108	[p8l500t1435r721b1505],
18	protocols	NNS	O	protocol	prep_in	10	SENT_108	[p8l745t1412r1147b1505],
19	,	,	O	,	_	0	SENT_108	[p8l745t1412r1147b1505],
20	can	MD	O	can	aux	22	SENT_108	[p8l1178t1435r1316b1483],
21	be	VB	O	be	auxpass	22	SENT_108	[p8l1341t1412r1437b1483],
22	used	VBN	O	use	ccomp	3	SENT_108	[p8l1464t1412r1652b1483],
23	more	RBR	O	more	advmod	22	SENT_108	[p8l1678t1435r1890b1483],
24	safely	RB	O	safely	advmod	22	SENT_108	[p8l1919t1412r2150b1505],
25	in	IN	O	in	_	0	SENT_108	[p8l11t1527r87b1597],
26	combination	NN	O	combination	prep_in	22	SENT_108	[p8l143t1527r654b1598],
27	with	IN	O	with	_	0	SENT_108	[p8l705t1527r882b1598],
28	allopurinol	NN	O	allopurinol	prep_with	26	SENT_108	[p8l940t1524r1480b1620],
29	.	.	O	.	_	0	SENT_108	[p8l940t1524r1480b1620],

1	”	NN	O	”	dep	5	SENT_109	[p8l940t1524r1480b1620],
2	If	IN	O	if	dep	5	SENT_109	[p8l1536t1528r1606b1597],
3	this	DT	O	this	nsubjpass	5	SENT_109	[p8l1655t1527r1799b1598],
4	is	VBZ	O	be	auxpass	5	SENT_109	[p8l1856t1527r1915b1598],
5	conﬁrmed	VBN	O	conﬁrmed	advcl	12	SENT_109	[p8l1972t1550r2145b1598, p8l10t1642r278b1713],
6	in	IN	O	in	_	0	SENT_109	[p8l310t1642r386b1712],
7	controlled	JJ	O	controlled	amod	8	SENT_109	[p8l419t1642r836b1713],
8	studies	NNS	O	study	prep_in	5	SENT_109	[p8l869t1642r1170b1728],
9	,	,	O	,	_	0	SENT_109	[p8l869t1642r1170b1728],
10	it	PRP	O	it	nsubj	12	SENT_109	[p8l1205t1642r1260b1713],
11	may	MD	O	may	aux	12	SENT_109	[p8l1291t1665r1460b1735],
12	provide	VB	O	provide	_	0	SENT_109	[p8l1489t1642r1798b1735],
13	a	DT	O	a	det	16	SENT_109	[p8l1833t1665r1875b1713],
14	favorable	JJ	O	favorable	amod	16	SENT_109	[p8l1906t1643r2145b1713, p8l13t1757r179b1828],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_109	[p8l218t1757r685b1850],
16	option	NN	O	option	dobj	12	SENT_109	[p8l724t1757r1008b1850],
17	,	,	O	,	_	0	SENT_109	[p8l724t1757r1008b1850],
18	particularly	RB	O	particularly	advmod	40	SENT_109	[p8l1049t1757r1519b1850],
19	for	IN	O	for	dep	40	SENT_109	[p8l1555t1758r1673b1828],
20	patients	NNS	O	patient	dep	34	SENT_109	[p8l1710t1757r2033b1850],
21	at	IN	O	at	_	0	SENT_109	[p8l2074t1767r2148b1828],
22	high	JJ	O	high	amod	23	SENT_109	[p8l11t1872r187b1965],
23	risk	NN	O	risk	prep_at	20	SENT_109	[p8l236t1872r384b1943],
24	(	CD	NUMBER	(	dep	34	SENT_109	[p8l436t1871r629b1966],
25	e.g.	FW	O	e.g.	amod	34	SENT_109	[p8l436t1871r629b1966],
26	,	,	O	,	_	0	SENT_109	[p8l436t1871r629b1966],
27	those	DT	O	those	dep	25	SENT_109	[p8l681t1872r898b1943],
28	with	IN	O	with	_	0	SENT_109	[p8l944t1872r1121b1943],
29	multiple	JJ	O	multiple	amod	32	SENT_109	[p8l1170t1872r1508b1965],
30	cardiovascular	JJ	O	cardiovascular	amod	32	SENT_109	[p8l1559t1872r2148b1943],
31	risk	NN	O	risk	nn	32	SENT_109	[p8l11t1987r160b2058],
32	factors	NNS	O	factor	prep_with	27	SENT_109	[p8l193t1988r490b2073],
33	,	,	O	,	_	0	SENT_109	[p8l193t1988r490b2073],
34	and/or	NN	O	and/or	dep	40	SENT_109	[p8l531t1987r794b2066],
35	with	IN	O	with	_	0	SENT_109	[p8l825t1987r1002b2058],
36	history	NN	O	history	prep_with	34	SENT_109	[p8l1037t1987r1316b2080],
37	of	IN	O	of	_	0	SENT_109	[p8l1350t1988r1436b2058],
38	gout	NN	O	gout	prep_of	36	SENT_109	[p8l1466t1984r1774b2082],
39	)	CD	NUMBER	)	num	40	SENT_109	[p8l1466t1984r1774b2082],
40	.14	CD	NUMBER	.14	dep	12	SENT_109	[p8l1466t1984r1774b2082],

1	Because	IN	O	because	mark	4	SENT_110	[p8l108t2103r443b2172],
2	CsA	NN	O	csa	nsubjpass	4	SENT_110	[p8l484t2102r660b2173],
3	is	VBZ	O	be	auxpass	4	SENT_110	[p8l694t2101r753b2172],
4	metabolized	VBN	O	metabolize	advcl	57	SENT_110	[p8l791t2101r1292b2172],
5	in	IN	O	in	_	0	SENT_110	[p8l1329t2101r1405b2171],
6	the	DT	O	the	det	7	SENT_110	[p8l1442t2101r1569b2172],
7	liver	NN	O	liver	prep_in	4	SENT_110	[p8l1608t2101r1786b2172],
8	by	IN	O	by	_	0	SENT_110	[p8l1820t2101r1915b2194],
9	cytochrome	NN	O	cytochrome	nn	10	SENT_110	[p8l1950t2111r2145b2194, p8l12t2216r317b2287],
10	P-450IIIA	NN	O	p-450iium	agent	4	SENT_110	[p8l355t2216r792b2302],
11	,	,	O	,	_	0	SENT_110	[p8l355t2216r792b2302],
12	drugs	NNS	O	drug	appos	10	SENT_110	[p8l833t2216r1053b2309],
13	that	WDT	O	that	nsubj	14	SENT_110	[p8l1091t2216r1251b2287],
14	induce	VBP	O	induce	rcmod	12	SENT_110	[p8l1288t2216r1557b2288],
15	or	CC	O	or	_	0	SENT_110	[p8l1597t2239r1682b2287],
16	inhibit	VBP	O	inhibit	conj_or	14	SENT_110	[p8l1719t2216r1983b2287],
17	the	DT	O	the	det	20	SENT_110	[p8l2019t2216r2146b2287],
18	same	JJ	O	same	amod	20	SENT_110	[p8l12t2354r217b2402],
19	enzyme	NN	O	enzyme	nn	20	SENT_110	[p8l250t2354r556b2424],
20	isoform	NN	O	isoform	dobj	14	SENT_110	[p8l587t2331r899b2402],
21	could	MD	O	could	aux	22	SENT_110	[p8l930t2331r1152b2402],
22	interact	VB	O	interact	rcmod	20	SENT_110	[p8l1182t2331r1495b2402],
23	with	IN	O	with	_	0	SENT_110	[p8l1520t2331r1697b2402],
24	CsA	NN	O	csa	prep_with	22	SENT_110	[p8l1729t2332r1906b2403],
25	when	WRB	O	when	advmod	36	SENT_110	[p8l1928t2331r2147b2402],
26	given	VBN	O	give	prep	36	SENT_110	[p8l11t2446r225b2539],
27	in	IN	O	in	pcomp	26	SENT_110	[p8l273t2446r349b2516],
28	association	NN	O	association	pobj	27	SENT_110	[p8l400t2446r847b2517],
29	with	IN	O	with	_	0	SENT_110	[p8l891t2446r1068b2517],
30	it	PRP	O	it	prep_with	28	SENT_110	[p8l1117t2443r1262b2517],
31	.18	CD	NUMBER	.18	tmod	28	SENT_110	[p8l1117t2443r1262b2517],
32	This	DT	O	this	det	33	SENT_110	[p8l1311t2446r1486b2517],
33	hypothesis	NN	O	hypothesis	nsubjpass	36	SENT_110	[p8l1536t2446r1964b2539],
34	has	VBZ	O	have	aux	36	SENT_110	[p8l2014t2446r2146b2517],
35	been	VBN	O	be	auxpass	36	SENT_110	[p8l8t2561r206b2632],
36	tested	VBN	O	test	advcl	22	SENT_110	[p8l247t2561r492b2632],
37	in	FW	O	in	nn	38	SENT_110	[p8l532t2561r608b2631],
38	vitro	FW	O	vitro	advmod	36	SENT_110	[p8l644t2561r834b2632],
39	on	IN	O	on	_	0	SENT_110	[p8l878t2584r979b2632],
40	primary	JJ	O	primary	amod	41	SENT_110	[p8l1018t2561r1341b2654],
41	cultures	NNS	O	culture	prep_on	36	SENT_110	[p8l1380t2561r1702b2632],
42	of	IN	O	of	_	0	SENT_110	[p8l1745t2562r1830b2632],
43	human	JJ	O	human	amod	44	SENT_110	[p8l1866t2561r2147b2632],
44	hepatocytes	NNS	O	hepatocyte	prep_of	41	SENT_110	[p8l10t2676r492b2769],
45	and	CC	O	and	_	0	SENT_110	[p8l541t2676r688b2747],
46	human	JJ	O	human	amod	48	SENT_110	[p8l734t2676r1016b2747],
47	liver	NN	O	liver	nn	48	SENT_110	[p8l1062t2676r1240b2747],
48	microsomes	NNS	O	microsome	prep_on	36	SENT_110	[p8l1284t2673r1863b2747],
49	.18	CD	NUMBER	.18	dep	48	SENT_110	[p8l1284t2673r1863b2747],
50	Using	VBG	O	use	xcomp	14	SENT_110	[p8l1909t2676r2147b2769],
51	this	DT	O	this	det	53	SENT_110	[p8l11t2792r154b2863],
52	experimental	JJ	O	experimental	amod	53	SENT_110	[p8l184t2792r718b2885],
53	approach	NN	O	approach	dobj	50	SENT_110	[p8l748t2792r1149b2885],
54	,	,	O	,	_	0	SENT_110	[p8l748t2792r1149b2885],
55	researchers	NNS	O	researcher	nsubj	57	SENT_110	[p8l1180t2792r1645b2863],
56	have	VBP	O	have	aux	57	SENT_110	[p8l1675t2792r1862b2863],
57	shown	VBN	O	show	_	0	SENT_110	[p8l1892t2792r2147b2863],
58	that	IN	O	that	complm	70	SENT_110	[p8l11t2907r170b2978],
59	several	JJ	O	several	amod	66	SENT_110	[p8l202t2907r484b2978],
60	clinically	RB	O	clinically	advmod	61	SENT_110	[p8l515t2907r873b3000],
61	observed	VBN	O	observe	amod	66	SENT_110	[p8l902t2907r1267b2978],
62	and	CC	O	and	_	0	SENT_110	[p8l1299t2907r1447b2978],
63	previously	RB	DATE	previously	advmod	64	SENT_110	[p8l1476t2907r1895b3000],
64	unexplained	JJ	O	unexplained	conj_and	61	SENT_110	[p8l1922t2930r2146b2978, p8l9t3022r313b3115],
65	drug	NN	O	drug	nn	66	SENT_110	[p8l340t3022r525b3115],
66	interactions	NNS	O	interaction	nsubjpass	70	SENT_110	[p8l551t3022r1031b3093],
67	involving	VBG	O	involve	partmod	66	SENT_110	[p8l1057t3022r1425b3115],
68	CSA	NNP	O	CSA	dobj	67	SENT_110	[p8l1453t3023r1629b3094],
69	were	VBD	O	be	auxpass	70	SENT_110	[p8l1647t3045r1844b3093],
70	caused	VBN	O	cause	ccomp	57	SENT_110	[p8l1872t3022r2147b3093],
71	by	IN	O	by	_	0	SENT_110	[p8l8t3137r103b3230],
72	this	DT	O	this	det	73	SENT_110	[p8l129t3137r272b3208],
73	mechanism	NN	O	mechanism	agent	70	SENT_110	[p8l301t3137r782b3208],
74	.	.	O	.	_	0	SENT_110	[p8l301t3137r782b3208],

1	Interestingly	RB	O	interestingly	advmod	5	SENT_111	[p8l815t3137r1348b3230],
2	,	,	O	,	_	0	SENT_111	[p8l815t3137r1348b3230],
3	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	nsubjpass	5	SENT_111	[p8l1380t3137r1972b3230],
4	was	VBD	O	be	auxpass	5	SENT_111	[p8l1997t3160r2146b3208],
5	detected	VBN	O	detect	_	0	SENT_111	[p8l13t3252r361b3323],
6	as	IN	O	as	_	0	SENT_111	[p8l397t3275r474b3323],
7	a	DT	O	a	det	9	SENT_111	[p8l511t3275r553b3323],
8	potential	JJ	O	potential	amod	9	SENT_111	[p8l584t3252r951b3345],
9	inducer	NN	O	inducer	prep_as	5	SENT_111	[p8l984t3252r1293b3323],
10	of	IN	O	of	_	0	SENT_111	[p8l1327t3253r1413b3323],
11	CsA	NN	O	csa	nn	12	SENT_111	[p8l1442t3253r1619b3324],
12	metabolism	NN	O	metabolism	prep_of	9	SENT_111	[p8l1648t3252r2144b3338],
13	,	,	O	,	_	0	SENT_111	[p8l1648t3252r2144b3338],
14	similar	JJ	O	similar	amod	9	SENT_111	[p8l12t3367r287b3438],
15	to	TO	O	to	_	0	SENT_111	[p8l329t3377r408b3438],
16	other	JJ	O	other	amod	18	SENT_111	[p8l453t3367r670b3438],
17	well-known	JJ	O	well-known	amod	18	SENT_111	[p8l708t3367r1179b3438],
18	inducers	NNS	O	inducer	prep_to	14	SENT_111	[p8l1222t3367r1587b3453],
19	,	,	O	,	_	0	SENT_111	[p8l1222t3367r1587b3453],
20	i.e.	FW	O	i.e.	appos	18	SENT_111	[p8l1633t3367r1773b3453],
21	,	,	O	,	_	0	SENT_111	[p8l1633t3367r1773b3453],
22	rifampicin	NN	O	rifampicin	appos	18	SENT_111	[p8l1818t3367r2145b3460, p8l12t3482r150b3568],
23	,	,	O	,	_	0	SENT_111	[p8l1818t3367r2145b3460, p8l12t3482r150b3568],
24	phenobarbital	NN	O	phenobarbital	appos	18	SENT_111	[p8l183t3482r778b3575],
25	,	,	O	,	_	0	SENT_111	[p8l183t3482r778b3575],
26	carbamazepine	NN	O	carbamazepine	appos	18	SENT_111	[p8l812t3482r1451b3575],
27	,	,	O	,	_	0	SENT_111	[p8l812t3482r1451b3575],
28	etc.	FW	O	etc.	appos	18	SENT_111	[p8l1486t3479r1694b3553],
29	18	CD	NUMBER	18	num	32	SENT_111	[p8l1486t3479r1694b3553],
30	This	DT	O	this	npadvmod	31	SENT_111	[p8l1724t3482r1900b3553],
31	likely	JJ	O	likely	amod	32	SENT_111	[p8l1931t3482r2150b3575],
32	accounts	NNS	O	account	dep	28	SENT_111	[p8l13t3607r365b3668],
33	for	IN	O	for	_	0	SENT_111	[p8l408t3598r527b3668],
34	at	IN	O	at	quantmod	36	SENT_111	[p8l571t3607r645b3668],
35	least	JJS	O	least	mwe	34	SENT_111	[p8l687t3597r874b3668],
36	some	DT	O	some	prep_for	5	SENT_111	[p8l917t3620r1127b3668],
37	of	IN	O	of	_	0	SENT_111	[p8l1173t3598r1258b3668],
38	the	DT	O	the	det	40	SENT_111	[p8l1295t3597r1422b3668],
39	clinical	JJ	O	clinical	amod	40	SENT_111	[p8l1467t3597r1753b3668],
40	effect	NN	O	effect	prep_of	36	SENT_111	[p8l1797t3598r2025b3668],
41	of	IN	O	of	_	0	SENT_111	[p8l2068t3598r2154b3668],
42	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_of	40	SENT_111	[p8l12t3712r604b3805],
43	in	IN	O	in	_	0	SENT_111	[p8l656t3712r732b3782],
44	HT	JJ	O	ht	amod	45	SENT_111	[p8l782t3714r922b3782],
45	patients	NNS	O	patient	prep_in	42	SENT_111	[p8l970t3712r1315b3805],
46	.	.	O	.	_	0	SENT_111	[p8l970t3712r1315b3805],

1	Further	JJ	O	further	amod	2	SENT_112	[p8l1370t3712r1686b3783],
2	studies	NNS	O	study	nsubjpass	19	SENT_112	[p8l1736t3712r2015b3783],
3	to	TO	O	to	aux	5	SENT_112	[p8l2067t3722r2146b3783],
4	fully	RB	O	fully	advmod	5	SENT_112	[p9l10t19r189b112],
5	elucidate	VB	O	elucidate	infmod	2	SENT_112	[p9l231t19r600b90],
6	the	DT	O	the	det	10	SENT_112	[p9l644t19r771b90],
7	molecular	JJ	O	molecular	amod	10	SENT_112	[p9l815t19r1224b90],
8	mechanism	NN	O	mechanism	nn	10	SENT_112	[p9l1265t18r1834b114],
9	(	NN	O	(	nn	10	SENT_112	[p9l1265t18r1834b114],
10	s	NNS	O	s	nsubj	11	SENT_112	[p9l1265t18r1834b114],
11	)	CD	NUMBER	)	xcomp	5	SENT_112	[p9l1265t18r1834b114],
12	of	IN	O	of	_	0	SENT_112	[p9l1881t20r1967b90],
13	this	DT	O	this	det	15	SENT_112	[p9l2003t19r2147b90],
14	drug	NN	O	drug	nn	15	SENT_112	[p9l13t133r197b226],
15	interaction	NN	O	interaction	prep_of	11	SENT_112	[p9l233t133r677b204],
16	in	IN	O	in	_	0	SENT_112	[p9l713t133r788b203],
17	patients	NNS	O	patient	prep_in	15	SENT_112	[p9l823t133r1147b226],
18	are	VBP	O	be	auxpass	19	SENT_112	[p9l1185t156r1310b204],
19	warranted	VBN	O	warrant	_	0	SENT_112	[p9l1343t133r1782b204],
20	.	.	O	.	_	0	SENT_112	[p9l1343t133r1782b204],

1	REFERENCES	NNS	O	reference	_	0	SENT_113	[p9l9t400r494b464],
2	1	CD	NUMBER	1	num	1	SENT_113	[p9l54t509r101b565],
3	.	.	O	.	_	0	SENT_113	[p9l54t509r101b565],

1	Ochiai	NNP	PERSON	Ochiai	nn	2	SENT_114	[p9l147t509r361b566],
2	T	NN	O	t	_	0	SENT_114	[p9l404t510r469b577],
3	,	,	O	,	_	0	SENT_114	[p9l404t510r469b577],
4	Gunji	NNP	PERSON	Gunji	nn	5	SENT_114	[p9l516t509r700b583],
5	Y	NN	PERSON	y	appos	2	SENT_114	[p9l742t510r816b577],
6	,	,	O	,	_	0	SENT_114	[p9l742t510r816b577],
7	Nagata	NNP	ORGANIZATION	Nagata	nn	8	SENT_114	[p9l861t510r1095b582],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_114	[p9l1138t510r1224b577],
9	,	,	O	,	_	0	SENT_114	[p9l1138t510r1224b577],
10	Isono	NNP	PERSON	Isono	nn	12	SENT_114	[p9l1270t510r1450b565],
11	K.	NNP	O	K.	nn	12	SENT_114	[p9l1495t510r1564b565],
12	Combination	NNP	O	Combination	appos	2	SENT_114	[p9l1612t509r2041b566],
13	of	IN	O	of	_	0	SENT_114	[p9l2084t509r2153b565],
14	immunosuppressive	JJ	O	immunosuppressive	amod	15	SENT_114	[p9l146t604r793b678],
15	drugs	NNS	O	drug	prep_of	12	SENT_114	[p9l825t604r1001b678],
16	for	IN	O	for	_	0	SENT_114	[p9l1032t604r1127b661],
17	organ	NN	O	organ	nn	18	SENT_114	[p9l1157t621r1342b678],
18	transplantation	NN	O	transplantation	prep_for	15	SENT_114	[p9l1372t604r1887b678],
19	.	.	O	.	_	0	SENT_114	[p9l1372t604r1887b678],

1	Ann	NNP	PERSON	Ann	nn	5	SENT_115	[p9l1919t605r2062b660],
2	N	NNP	O	N	nn	5	SENT_115	[p9l2091t605r2149b660],
3	Y	NN	O	y	nn	5	SENT_115	[p9l145t700r202b754],
4	Acad	NNP	O	Acad	nn	5	SENT_115	[p9l228t698r401b755],
5	Sci	NNP	O	Sci	_	0	SENT_115	[p9l430t698r523b755],
6	1993	CD	DATE	1993	num	5	SENT_115	[p9l557t699r1127b767],
7	;	:	O	;	_	0	SENT_115	[p9l557t699r1127b767],
8	696:270	CD	NUMBER	696:270	number	9	SENT_115	[p9l557t699r1127b767],
9	—	CD	NUMBER	—	dep	5	SENT_115	[p9l557t699r1127b767],
10	80	CD	NUMBER	80	dep	9	SENT_115	[p9l557t699r1127b767],
11	.	.	O	.	_	0	SENT_115	[p9l557t699r1127b767],

1	Kahan	NNP	PERSON	Kahan	nn	2	SENT_116	[p9l146t792r360b848],
2	BD	NNP	O	BD	_	0	SENT_116	[p9l391t793r520b861],
3	,	,	O	,	_	0	SENT_116	[p9l391t793r520b861],
4	Flechner	NNP	O	Flechner	nn	5	SENT_116	[p9l553t791r844b849],
5	SM	NNP	O	SM	appos	2	SENT_116	[p9l875t792r1003b860],
6	,	,	O	,	_	0	SENT_116	[p9l875t792r1003b860],
7	Lorber	NNP	ORGANIZATION	Lorber	nn	8	SENT_116	[p9l1037t792r1264b849],
8	MI	NNP	ORGANIZATION	MI	appos	5	SENT_116	[p9l1295t793r1410b861],
9	,	,	O	,	_	0	SENT_116	[p9l1295t793r1410b861],
10	Golden	NNP	O	Golden	nn	11	SENT_116	[p9l1446t791r1689b849],
11	D	NNP	O	D	appos	5	SENT_116	[p9l1720t793r1796b861],
12	,	,	O	,	_	0	SENT_116	[p9l1720t793r1796b861],
13	Conley	NNP	PERSON	Conley	nn	14	SENT_116	[p9l1831t792r2060b865],
14	S	NNP	O	S	appos	5	SENT_116	[p9l2090t792r2146b860],
15	,	,	O	,	_	0	SENT_116	[p9l2090t792r2146b860],
16	Van	NNP	PERSON	Van	nn	18	SENT_116	[p9l145t889r282b945],
17	Buren	NNP	PERSON	Buren	nn	18	SENT_116	[p9l323t890r525b945],
18	CT	NNP	O	CT	appos	5	SENT_116	[p9l568t888r685b945],
19	.	.	O	.	_	0	SENT_116	[p9l568t888r685b945],

1	Complications	NNS	O	complication	nsubj	11	SENT_117	[p9l731t888r1201b962],
2	of	IN	O	of	_	0	SENT_117	[p9l1244t888r1312b945],
3	cyclosporine-prednisone	JJ	O	cyclosporine-prednisone	amod	4	SENT_117	[p9l1349t888r2147b962],
4	immunosuppression	NN	O	immunosuppression	prep_of	1	SENT_117	[p9l146t983r805b1057],
5	in	IN	O	in	_	0	SENT_117	[p9l842t983r902b1039],
6	402	CD	NUMBER	402	num	9	SENT_117	[p9l939t984r1052b1040],
7	renal	JJ	O	renal	amod	9	SENT_117	[p9l1088t983r1254b1040],
8	allograft	NN	O	allograft	nn	9	SENT_117	[p9l1292t983r1565b1057],
9	recipients	NNS	O	recipient	prep_in	4	SENT_117	[p9l1602t983r1919b1057],
10	exclusively	RB	O	exclusively	advmod	11	SENT_117	[p9l1957t983r2146b1040, p9l146t1077r323b1150],
11	followed	VBD	O	follow	_	0	SENT_117	[p9l363t1076r645b1134],
12	at	IN	O	at	_	0	SENT_117	[p9l688t1085r747b1133],
13	a	DT	O	a	det	15	SENT_117	[p9l790t1095r824b1133],
14	single	JJ	O	single	amod	15	SENT_117	[p9l866t1077r1051b1150],
15	center	NN	O	center	prep_at	11	SENT_117	[p9l1094t1085r1299b1134],
16	from	IN	O	from	_	0	SENT_117	[p9l1340t1077r1497b1133],
17	one	CD	NUMBER	one	number	19	SENT_117	[p9l1540t1094r1658b1133],
18	to	TO	NUMBER	to	dep	19	SENT_117	[p9l1701t1085r1764b1133],
19	ﬁve	CD	NUMBER	ﬁve	num	20	SENT_117	[p9l1807t1076r1919b1134],
20	years	NNS	NUMBER	year	prep_from	11	SENT_117	[p9l1959t1094r2145b1150],
21	.	.	O	.	_	0	SENT_117	[p9l1959t1094r2145b1150],

1	Transplantation	NN	O	transplantation	_	0	SENT_118	[p9l145t1173r670b1247],
2	1987	CD	DATE	1987	num	1	SENT_118	[p9l703t1174r1254b1241],
3	;	:	O	;	_	0	SENT_118	[p9l703t1174r1254b1241],
4	43:197	CD	NUMBER	43:197	number	5	SENT_118	[p9l703t1174r1254b1241],
5	-204	CD	NUMBER	-204	dep	1	SENT_118	[p9l703t1174r1254b1241],
6	.	.	O	.	_	0	SENT_118	[p9l703t1174r1254b1241],

1	.	.	O	.	_	0	SENT_119	[p9l91t1315r101b1325],

1	Zietse	NNP	PERSON	Zietse	nn	2	SENT_120	[p9l146t1268r349b1325],
2	R	NNP	PERSON	R	dep	21	SENT_120	[p9l378t1270r450b1337],
3	,	,	O	,	_	0	SENT_120	[p9l378t1270r450b1337],
4	Balk	NNP	O	Balk	nn	5	SENT_120	[p9l481t1268r632b1325],
5	AH	NNP	O	AH	appos	2	SENT_120	[p9l655t1269r794b1337],
6	,	,	O	,	_	0	SENT_120	[p9l655t1269r794b1337],
7	Van	NNP	PERSON	Van	nn	10	SENT_120	[p9l824t1270r961b1325],
8	der	FW	PERSON	der	nn	10	SENT_120	[p9l990t1268r1096b1325],
9	Dorpel	NNP	PERSON	Dorpel	nn	10	SENT_120	[p9l1124t1268r1356b1342],
10	MA	NNP	PERSON	MA	appos	2	SENT_120	[p9l1385t1269r1530b1337],
11	,	,	O	,	_	0	SENT_120	[p9l1385t1269r1530b1337],
12	Meeter	NNP	O	Meeter	nn	13	SENT_120	[p9l1561t1270r1800b1325],
13	K	NNP	O	K	appos	2	SENT_120	[p9l1828t1270r1898b1337],
14	,	,	O	,	_	0	SENT_120	[p9l1828t1270r1898b1337],
15	Bos	NNP	O	Bos	nn	16	SENT_120	[p9l1929t1270r2049b1325],
16	E	NNP	O	E	appos	2	SENT_120	[p9l2078t1270r2146b1337],
17	,	,	O	,	_	0	SENT_120	[p9l2078t1270r2146b1337],
18	Weimar	NNP	LOCATION	Weimar	nn	20	SENT_120	[p9l145t1362r409b1419],
19	W.	NNP	O	W.	nn	20	SENT_120	[p9l438t1363r528b1419],
20	Time	NNP	O	Time	appos	2	SENT_120	[p9l561t1362r731b1419],
21	course	NN	O	course	_	0	SENT_120	[p9l763t1379r974b1419],
22	of	IN	O	of	_	0	SENT_120	[p9l1006t1362r1075b1419],
23	the	DT	O	the	det	24	SENT_120	[p9l1101t1361r1202b1419],
24	decline	NN	O	decline	prep_of	21	SENT_120	[p9l1235t1362r1467b1419],
25	in	IN	O	in	_	0	SENT_120	[p9l1498t1362r1559b1418],
26	renal	JJ	O	renal	amod	27	SENT_120	[p9l1589t1361r1755b1419],
27	function	NN	O	function	prep_in	24	SENT_120	[p9l1785t1362r2057b1419],
28	in	IN	O	in	_	0	SENT_120	[p9l2088t1362r2148b1418],
29	cyclosporine-treated	JJ	O	cyclosporine-treated	amod	32	SENT_120	[p9l146t1458r814b1532],
30	heart	NN	O	heart	nn	32	SENT_120	[p9l838t1458r1008b1515],
31	transplant	NN	O	transplant	nn	32	SENT_120	[p9l1031t1458r1362b1532],
32	recipients	NNS	O	recipient	prep_in	27	SENT_120	[p9l1385t1458r1719b1532],
33	.	.	O	.	_	0	SENT_120	[p9l1385t1458r1719b1532],

1	Am	NNP	O	Am	nn	3	SENT_121	[p9l1744t1459r1866b1514],
2	J	NNP	O	J	nn	3	SENT_121	[p9l1888t1459r1920b1515],
3	Nephrol	NNP	O	Nephrol	_	0	SENT_121	[p9l1943t1458r2146b1532, p9l145t1553r235b1610],
4	1994	CD	DATE	1994	num	3	SENT_121	[p9l268t1553r666b1621],
5	;	:	O	;	_	0	SENT_121	[p9l268t1553r666b1621],
6	14:1	CD	NUMBER	14:1	number	7	SENT_121	[p9l268t1553r666b1621],
7	—	CD	NUMBER	—	dep	3	SENT_121	[p9l268t1553r666b1621],
8	5	CD	NUMBER	5	dep	7	SENT_121	[p9l268t1553r666b1621],
9	.	.	O	.	_	0	SENT_121	[p9l268t1553r666b1621],

1	The	DT	O	the	det	2	SENT_122	[p9l324t1650r469b1714],
2	Journal	NNP	O	Journal	_	0	SENT_122	[p9l501t1650r780b1714],
3	of	IN	O	of	_	0	SENT_122	[p9l813t1650r890b1714],
4	Heart	NNP	O	Heart	nn	8	SENT_122	[p9l917t1652r1133b1714],
5	and	CC	O	and	_	0	SENT_122	[p9l1167t1650r1300b1714],
6	Lung	NN	O	lung	nn	8	SENT_122	[p9l1333t1652r1524b1734],
7	Transplantation	NN	O	transplantation	nn	8	SENT_122	[p9l1555t1650r2148b1734],
8	December	NNP	DATE	December	prep_of	2	SENT_122	[p9l1544t1754r1930b1819],
9	2000	CD	DATE	2000	num	8	SENT_122	[p9l1977t1756r2147b1819],

1	.	.	O	.	_	0	SENT_123	[p9l82t2040r92b2050],

1	Mihatsch	NNP	PERSON	Mihatsch	nn	2	SENT_124	[p9l137t1993r440b2050],
2	MJ	NNP	PERSON	MJ	dep	19	SENT_124	[p9l466t1995r586b2062],
3	,	,	O	,	_	0	SENT_124	[p9l466t1995r586b2062],
4	Kyo	NNP	O	Kyo	nn	5	SENT_124	[p9l614t1995r743b2067],
5	M	NNP	O	M	appos	2	SENT_124	[p9l770t1995r857b2063],
6	,	,	O	,	_	0	SENT_124	[p9l770t1995r857b2063],
7	Morozumi	NNP	PERSON	Morozumi	nn	8	SENT_124	[p9l884t1994r1229b2051],
8	K	NNP	PERSON	K	appos	2	SENT_124	[p9l1255t1995r1325b2062],
9	,	,	O	,	_	0	SENT_124	[p9l1255t1995r1325b2062],
10	Yamaguchi	NNP	PERSON	Yamaguchi	nn	11	SENT_124	[p9l1352t1993r1727b2067],
11	Y	NN	PERSON	y	appos	2	SENT_124	[p9l1751t1995r1825b2062],
12	,	,	O	,	_	0	SENT_124	[p9l1751t1995r1825b2062],
13	Nickeleit	NN	O	nickeleit	nn	14	SENT_124	[p9l1852t1993r2148b2051],
14	V	NN	O	v	appos	2	SENT_124	[p9l136t2091r210b2158],
15	,	,	O	,	_	0	SENT_124	[p9l136t2091r210b2158],
16	Ryffel	NNP	PERSON	Ryffel	nn	17	SENT_124	[p9l245t2090r445b2164],
17	B.	NNP	O	B.	appos	2	SENT_124	[p9l477t2091r543b2147],
18	The	DT	O	the	det	19	SENT_124	[p9l577t2090r706b2147],
19	side	NN	O	side	_	0	SENT_124	[p9l739t2090r1108b2147],
20	—	JJ	O	—	amod	21	SENT_124	[p9l739t2090r1108b2147],
21	effects	NNS	O	effect	dep	19	SENT_124	[p9l739t2090r1108b2147],
22	of	IN	O	of	_	0	SENT_124	[p9l1141t2090r1210b2147],
23	cyclosporine-A	NN	O	cyclosporine-a	prep_of	21	SENT_124	[p9l1237t2090r1733b2164],
24	and	CC	O	and	_	0	SENT_124	[p9l1764t2090r1882b2147],
25	tacrolimus	NN	O	tacrolimus	prep_of	21	SENT_124	[p9l1914t2090r2146b2147, p9l136t2203r286b2242],
26	.	.	O	.	_	0	SENT_124	[p9l1914t2090r2146b2147, p9l136t2203r286b2242],

1	Clin	NNP	O	Clin	nn	2	SENT_125	[p9l319t2185r454b2242],
2	Nephrol	NNP	O	Nephrol	_	0	SENT_125	[p9l482t2185r755b2259],
3	1998	CD	DATE	1998	num	2	SENT_125	[p9l789t2185r1323b2254],
4	;	:	O	;	_	0	SENT_125	[p9l789t2185r1323b2254],
5	49:356	CD	NUMBER	49:356	number	6	SENT_125	[p9l789t2185r1323b2254],
6	—	CD	NUMBER	—	dep	2	SENT_125	[p9l789t2185r1323b2254],
7	63	CD	NUMBER	63	dep	6	SENT_125	[p9l789t2185r1323b2254],
8	.	.	O	.	_	0	SENT_125	[p9l789t2185r1323b2254],

1	.	.	O	.	_	0	SENT_126	[p9l82t2327r92b2337],

1	Lin	NNP	PERSON	Lin	nn	2	SENT_127	[p9l137t2280r247b2336],
2	HY	NNP	PERSON	HY	_	0	SENT_127	[p9l268t2281r405b2349],
3	,	,	O	,	_	0	SENT_127	[p9l268t2281r405b2349],
4	Rocher	NNP	PERSON	Rocher	nn	5	SENT_127	[p9l430t2280r673b2337],
5	LL	NNP	O	LL	appos	2	SENT_127	[p9l694t2281r807b2349],
6	,	,	O	,	_	0	SENT_127	[p9l694t2281r807b2349],
7	McQuillan	NNP	PERSON	McQuillan	nn	8	SENT_127	[p9l831t2279r1184b2343],
8	MA	NNP	PERSON	MA	appos	5	SENT_127	[p9l1206t2281r1353b2349],
9	,	,	O	,	_	0	SENT_127	[p9l1206t2281r1353b2349],
10	Schmaltz	NNP	O	Schmaltz	nn	11	SENT_127	[p9l1377t2279r1674b2337],
11	S	NNP	O	S	appos	5	SENT_127	[p9l1696t2280r1751b2349],
12	,	,	O	,	_	0	SENT_127	[p9l1696t2280r1751b2349],
13	Palella	NNP	PERSON	Palella	nn	14	SENT_127	[p9l1775t2279r1997b2337],
14	TD	NNP	O	TD	appos	5	SENT_127	[p9l2018t2281r2146b2349],
15	,	,	O	,	_	0	SENT_127	[p9l2018t2281r2146b2349],
16	Fox	NNP	PERSON	Fox	nn	17	SENT_127	[p9l137t2377r260b2433],
17	IH	NN	O	ih	appos	5	SENT_127	[p9l320t2377r426b2433],
18	.	.	O	.	_	0	SENT_127	[p9l320t2377r426b2433],

1	Cyclosporine-induced	JJ	O	cyclosporine-induced	amod	2	SENT_128	[p9l491t2376r1208b2450],
2	hyperuricemia	NN	O	hyperuricemia	_	0	SENT_128	[p9l1269t2376r1742b2450],
3	and	CC	O	and	_	0	SENT_128	[p9l1804t2376r1923b2432],
4	gout	NN	O	gout	conj_and	2	SENT_128	[p9l1983t2384r2145b2450],
5	.	.	O	.	_	0	SENT_128	[p9l1983t2384r2145b2450],

1	N	NN	O	n	nn	3	SENT_129	[p9l136t2473r194b2527],
2	Engl	NNP	O	Engl	nn	3	SENT_129	[p9l222t2471r374b2545],
3	J	NNP	O	J	nsubj	4	SENT_129	[p9l402t2473r434b2528],
4	Med	VBD	O	med	_	0	SENT_129	[p9l464t2471r614b2528],
5	1989	CD	DATE	1989	dobj	4	SENT_129	[p9l647t2472r1202b2540],
6	;	:	O	;	_	0	SENT_129	[p9l647t2472r1202b2540],
7	321:287	CD	NUMBER	321:287	number	8	SENT_129	[p9l647t2472r1202b2540],
8	—	CD	NUMBER	—	dep	5	SENT_129	[p9l647t2472r1202b2540],
9	92	CD	NUMBER	92	dep	8	SENT_129	[p9l647t2472r1202b2540],
10	.	.	O	.	_	0	SENT_129	[p9l647t2472r1202b2540],

1	.	.	O	.	_	0	SENT_130	[p9l82t2613r92b2623],

1	Burack	NNP	PERSON	Burack	nn	2	SENT_131	[p9l137t2565r373b2623],
2	DA	NNP	PERSON	DA	_	0	SENT_131	[p9l405t2567r541b2635],
3	,	,	O	,	_	0	SENT_131	[p9l405t2567r541b2635],
4	Grifﬁth	NNP	O	Grifﬁth	nn	5	SENT_131	[p9l580t2565r825b2624],
5	BP	NNP	O	BP	appos	2	SENT_131	[p9l859t2567r972b2635],
6	,	,	O	,	_	0	SENT_131	[p9l859t2567r972b2635],
7	Thompson	NNP	PERSON	Thompson	nn	8	SENT_131	[p9l1008t2566r1362b2641],
8	ME	NNP	O	ME	appos	2	SENT_131	[p9l1396t2567r1536b2635],
9	,	,	O	,	_	0	SENT_131	[p9l1396t2567r1536b2635],
10	Kahl	NNP	PERSON	Kahl	nn	11	SENT_131	[p9l1573t2565r1729b2623],
11	LE	NNP	O	LE	appos	2	SENT_131	[p9l1763t2567r1880b2623],
12	.	.	O	.	_	0	SENT_131	[p9l1763t2567r1880b2623],

1	Hyperuricemia	NN	O	hyperuricemia	_	0	SENT_132	[p9l1917t2567r2146b2641, p9l136t2662r423b2719],
2	and	CC	O	and	_	0	SENT_132	[p9l452t2662r571b2718],
3	gout	NN	O	gout	conj_and	1	SENT_132	[p9l599t2670r744b2736],
4	among	IN	O	among	_	0	SENT_132	[p9l774t2679r994b2736],
5	heart	NN	O	heart	nn	7	SENT_132	[p9l1022t2662r1193b2719],
6	transplant	NN	O	transplant	nn	7	SENT_132	[p9l1221t2662r1553b2736],
7	recipients	NNS	O	recipient	prep_among	1	SENT_132	[p9l1581t2662r1900b2736],
8	receiving	VBG	O	receive	partmod	1	SENT_132	[p9l1929t2662r2146b2719, p9l137t2757r235b2831],
9	cyclosporine	NN	O	cyclosporine	dobj	8	SENT_132	[p9l264t2757r689b2831],
10	.	.	O	.	_	0	SENT_132	[p9l264t2757r689b2831],

1	Am	VBP	O	be	_	0	SENT_133	[p9l718t2758r841b2813],
2	J	NN	O	j	nsubj	3	SENT_133	[p9l869t2759r901b2814],
3	Med	VBD	O	med	ccomp	1	SENT_133	[p9l930t2757r1081b2814],
4	1992	CD	DATE	1992	dobj	3	SENT_133	[p9l1114t2758r1600b2826],
5	;	:	O	;	_	0	SENT_133	[p9l1114t2758r1600b2826],
6	92:141	CD	NUMBER	92:141	number	7	SENT_133	[p9l1114t2758r1600b2826],
7	—	CD	NUMBER	—	dep	4	SENT_133	[p9l1114t2758r1600b2826],
8	6	CD	NUMBER	6	dep	7	SENT_133	[p9l1114t2758r1600b2826],
9	.	.	O	.	_	0	SENT_133	[p9l1114t2758r1600b2826],

1	Marcen	JJ	PERSON	marcen	amod	2	SENT_134	[p9l137t2853r390b2909],
2	R	NN	PERSON	r	_	0	SENT_134	[p9l438t2853r511b2921],
3	,	,	O	,	_	0	SENT_134	[p9l438t2853r511b2921],
4	Gallego	NNP	PERSON	Gallego	nn	5	SENT_134	[p9l563t2851r818b2926],
5	N	NNP	O	N	appos	2	SENT_134	[p9l867t2853r941b2921],
6	,	,	O	,	_	0	SENT_134	[p9l867t2853r941b2921],
7	Oroﬁno	NNP	O	Oroﬁno	nn	8	SENT_134	[p9l993t2851r1249b2910],
8	L	NNP	O	L	appos	2	SENT_134	[p9l1299t2853r1362b2921],
9	,	,	O	,	_	0	SENT_134	[p9l1299t2853r1362b2921],
10	et	FW	O	et	nn	11	SENT_134	[p9l1414t2860r1473b2909],
11	al.	FW	O	al.	appos	2	SENT_134	[p9l1522t2851r1593b2909],
12	.	.	O	.	_	0	SENT_134	[p9l1522t2851r1593b2909],

1	Impairment	NN	O	impairment	_	0	SENT_135	[p9l1645t2852r2036b2927],
2	of	IN	O	of	_	0	SENT_135	[p9l2084t2852r2153b2909],
3	tubular	JJ	O	tubular	amod	4	SENT_135	[p9l136t2948r375b3005],
4	secretion	NN	O	secretion	prep_of	1	SENT_135	[p9l418t2948r715b3005],
5	of	IN	O	of	_	0	SENT_135	[p9l758t2948r826b3005],
6	urate	NN	O	urate	prep_of	4	SENT_135	[p9l863t2956r1034b3005],
7	in	IN	O	in	_	0	SENT_135	[p9l1078t2948r1139b3004],
8	renal	JJ	O	renal	amod	10	SENT_135	[p9l1181t2948r1348b3005],
9	transplant	NN	O	transplant	nn	10	SENT_135	[p9l1390t2948r1722b3022],
10	patients	NNS	O	patient	prep_in	1	SENT_135	[p9l1764t2948r2023b3022],
11	on	IN	O	on	_	0	SENT_135	[p9l2067t2965r2148b3005],
12	cyclosporine	NN	O	cyclosporine	prep_on	1	SENT_135	[p9l137t3043r561b3117],
13	.	.	O	.	_	0	SENT_135	[p9l137t3043r561b3117],

1	Nephron	NNP	O	Nephron	_	0	SENT_136	[p9l593t3043r888b3117],
2	1995	CD	DATE	1995	num	1	SENT_136	[p9l921t3043r1436b3112],
3	;	:	O	;	_	0	SENT_136	[p9l921t3043r1436b3112],
4	70:307	CD	NUMBER	70:307	number	5	SENT_136	[p9l921t3043r1436b3112],
5	—	CD	NUMBER	—	dep	1	SENT_136	[p9l921t3043r1436b3112],
6	13	CD	NUMBER	13	dep	5	SENT_136	[p9l921t3043r1436b3112],
7	.	.	O	.	_	0	SENT_136	[p9l921t3043r1436b3112],

1	.	.	O	.	_	0	SENT_137	[p9l82t3183r92b3193],

1	Hansen	NNP	PERSON	Hansen	nn	2	SENT_138	[p9l137t3138r388b3194],
2	JM	NN	O	jm	nsubj	21	SENT_138	[p9l418t3138r541b3206],
3	,	,	O	,	_	0	SENT_138	[p9l418t3138r541b3206],
4	Fogh	NNP	PERSON	Fogh	nn	6	SENT_138	[p9l574t3137r742b3210],
5	Andersen	NNP	PERSON	Andersen	nn	6	SENT_138	[p9l771t3136r1093b3194],
6	N	NNP	O	N	conj_and	2	SENT_138	[p9l1124t3138r1197b3205],
7	,	,	O	,	_	0	SENT_138	[p9l1124t3138r1197b3205],
8	Leyssac	NNP	ORGANIZATION	Leyssac	nn	9	SENT_138	[p9l1231t3138r1483b3210],
9	PP	NNP	ORGANIZATION	PP	conj_and	2	SENT_138	[p9l1514t3138r1621b3205],
10	,	,	O	,	_	0	SENT_138	[p9l1514t3138r1621b3205],
11	Strandgaard	NNP	O	Strandgaard	nn	13	SENT_138	[p9l1656t3136r2058b3210],
12	S.	NNP	O	S.	nn	13	SENT_138	[p9l2090t3137r2145b3194],
13	Glomerular	NNP	O	Glomerular	conj_and	2	SENT_138	[p9l138t3233r523b3290],
14	and	CC	O	and	_	0	SENT_138	[p9l550t3233r668b3289],
15	tubular	JJ	O	tubular	amod	16	SENT_138	[p9l693t3233r931b3290],
16	function	NN	O	function	conj_and	2	SENT_138	[p9l956t3233r1228b3290],
17	in	IN	O	in	_	0	SENT_138	[p9l1254t3233r1314b3289],
18	renal	JJ	O	renal	amod	20	SENT_138	[p9l1340t3233r1506b3290],
19	transplant	NN	O	transplant	nn	20	SENT_138	[p9l1531t3233r1864b3307],
20	patients	NNS	O	patient	prep_in	16	SENT_138	[p9l1888t3233r2147b3307],
21	treated	VBN	O	treat	conj_and	21	SENT_138	[p9l136t3328r371b3385],
22	with	IN	O	with	_	0	SENT_138	[p9l401t3328r543b3385],
23	and	CC	O	and	_	0	SENT_138	[p9l579t3328r697b3385],
24	without	IN	O	without	_	0	SENT_138	[p9l727t3328r980b3385],
25	Cyclosporin	NN	O	cyclosporin	nn	26	SENT_138	[p9l1015t3328r1405b3402],
26	A.	NN	O	a.	prep_without	21	SENT_138	[p9l1436t3329r1511b3385],
27	Nephron	NNP	O	Nephron	prep_with	21	SENT_138	[p9l1548t3328r1843b3402],
28	1998	CD	DATE	1998	num	27	SENT_138	[p9l1881t3329r2144b3397],
29	;	:	O	;	_	0	SENT_138	[p9l1881t3329r2144b3397],
30	80	CD	NUMBER	80	num	27	SENT_138	[p9l1881t3329r2144b3397],
31	:	:	O	:	_	0	SENT_138	[p9l1881t3329r2144b3397],
32	450-7	CD	NUMBER	450-7	num	27	SENT_138	[p9l137t3424r353b3481],
33	.	.	O	.	_	0	SENT_138	[p9l137t3424r353b3481],

1	Cummins	NNP	ORGANIZATION	Cummins	nn	2	SENT_139	[p9l138t3519r451b3576],
2	D	NNP	ORGANIZATION	D	_	0	SENT_139	[p9l475t3520r551b3587],
3	,	,	O	,	_	0	SENT_139	[p9l475t3520r551b3587],
4	Sekar	NNP	O	Sekar	nn	5	SENT_139	[p9l579t3519r764b3576],
5	M	NNP	O	M	appos	2	SENT_139	[p9l788t3520r874b3587],
6	,	,	O	,	_	0	SENT_139	[p9l788t3520r874b3587],
7	Halil	NNP	PERSON	Halil	nn	8	SENT_139	[p9l900t3519r1062b3575],
8	o	NN	O	o	appos	2	SENT_139	[p9l1087t3520r1162b3587],
9	,	,	O	,	_	0	SENT_139	[p9l1087t3520r1162b3587],
10	Banner	NN	PERSON	banner	nn	12	SENT_139	[p9l1188t3520r1429b3576],
11	N.	NNP	PERSON	N.	nn	12	SENT_139	[p9l1452t3520r1525b3576],
12	Myelosuppression	NNP	PERSON	Myelosuppression	appos	2	SENT_139	[p9l1552t3519r2148b3593],
13	associated	VBN	O	associate	partmod	12	SENT_139	[p9l138t3614r473b3671],
14	with	IN	O	with	_	0	SENT_139	[p9l525t3614r667b3671],
15	azathioprine-allopurinol	JJ	O	azathioprine-allopurinol	amod	16	SENT_139	[p9l725t3614r1525b3688],
16	interaction	NN	O	interaction	prep_with	13	SENT_139	[p9l1581t3614r1938b3671],
17	after	IN	O	after	_	0	SENT_139	[p9l1996t3614r2149b3671],
18	heart	NN	O	heart	nn	21	SENT_139	[p9l136t3709r307b3766],
19	and	CC	O	and	_	0	SENT_139	[p9l361t3709r480b3766],
20	lung	NN	O	lung	conj_and	18	SENT_139	[p9l532t3708r673b3783],
21	transplantation	NN	O	transplantation	prep_after	13	SENT_139	[p9l725t3709r1242b3784],
22	.	.	O	.	_	0	SENT_139	[p9l725t3709r1242b3784],

1	Transplantation	NN	O	transplantation	_	0	SENT_140	[p9l1297t3708r1824b3784],
2	1996	CD	DATE	1996	num	1	SENT_140	[p9l1881t3709r2144b3778],
3	;	:	O	;	_	0	SENT_140	[p9l1881t3709r2144b3778],
4	61	CD	NUMBER	61	dep	1	SENT_140	[p9l1881t3709r2144b3778],
5	:	:	O	:	_	0	SENT_140	[p9l1881t3709r2144b3778],

1	1661-2	CD	NUMBER	1661-2	_	0	SENT_141	[p10l141t18r382b74],
2	.	.	O	.	_	0	SENT_141	[p10l141t18r382b74],

1	Milano	NNP	MISC	Milano	nn	2	SENT_142	[p10l137t113r371b170],
2	A	NNP	MISC	A	_	0	SENT_142	[p10l409t114r485b183],
3	,	,	O	,	_	0	SENT_142	[p10l409t114r485b183],
4	Caforio	NNP	ORGANIZATION	Caforio	nn	5	SENT_142	[p10l528t113r776b171],
5	ALP	NNP	ORGANIZATION	ALP	appos	2	SENT_142	[p10l814t114r986b183],
6	,	,	O	,	_	0	SENT_142	[p10l814t114r986b183],
7	Livi	NNP	PERSON	Livi	nn	8	SENT_142	[p10l1028t113r1153b170],
8	U	NNP	O	U	appos	2	SENT_142	[p10l1191t115r1269b183],
9	,	,	O	,	_	0	SENT_142	[p10l1191t115r1269b183],
10	et	FW	O	et	nn	11	SENT_142	[p10l1311t121r1371b170],
11	al.	FW	O	al.	appos	2	SENT_142	[p10l1412t113r1482b170],
12	.	.	O	.	_	0	SENT_142	[p10l1412t113r1482b170],

1	Evolution	NN	O	evolution	_	0	SENT_143	[p10l1524t113r1848b170],
2	of	IN	O	of	_	0	SENT_143	[p10l1887t114r1956b170],
3	focal	JJ	O	focal	amod	10	SENT_143	[p10l1990t113r2148b170],
4	moderate	JJ	O	moderate	amod	5	SENT_143	[p10l136t209r451b266],
5	(	JJ	O	(	amod	10	SENT_143	[p10l480t207r740b285],
6	ISHLT	NN	O	ishlt	nn	10	SENT_143	[p10l480t207r740b285],
7	grade	NN	O	grade	nn	10	SENT_143	[p10l763t208r946b283],
8	2	CD	NUMBER	2	num	10	SENT_143	[p10l972t207r1034b284],
9	)	NN	O	)	nn	10	SENT_143	[p10l972t207r1034b284],
10	rejection	NN	O	rejection	prep_of	1	SENT_143	[p10l1062t209r1352b283],
11	of	IN	O	of	_	0	SENT_143	[p10l1377t209r1446b266],
12	the	DT	O	the	det	14	SENT_143	[p10l1465t209r1568b266],
13	cardiac	JJ	O	cardiac	amod	14	SENT_143	[p10l1594t208r1829b266],
14	allograft	NN	O	allograft	prep_of	10	SENT_143	[p10l1854t209r2145b283],
15	.	.	O	.	_	0	SENT_143	[p10l1854t209r2145b283],

1	J	NNP	O	J	nn	4	SENT_144	[p10l136t306r168b362],
2	Heart	NNP	O	Heart	nn	4	SENT_144	[p10l196t306r388b362],
3	Lung	NN	O	lung	nn	4	SENT_144	[p10l417t306r587b379],
4	Transplant	NN	O	transplant	_	0	SENT_144	[p10l615t305r973b379],
5	1996	CD	DATE	1996	dep	4	SENT_144	[p10l1006t305r1540b373],
6	;	:	O	;	_	0	SENT_144	[p10l1006t305r1540b373],
7	15:456	CD	NUMBER	15:456	number	8	SENT_144	[p10l1006t305r1540b373],
8	—	CD	NUMBER	—	dep	4	SENT_144	[p10l1006t305r1540b373],
9	60	CD	NUMBER	60	dep	8	SENT_144	[p10l1006t305r1540b373],
10	.	.	O	.	_	0	SENT_144	[p10l1006t305r1540b373],

1	Billingham	NNP	PERSON	Billingham	nn	2	SENT_145	[p10l137t400r496b474],
2	ME	NNP	O	ME	_	0	SENT_145	[p10l521t402r662b469],
3	,	,	O	,	_	0	SENT_145	[p10l521t402r662b469],
4	Cary	NNP	ORGANIZATION	Cary	nn	5	SENT_145	[p10l691t401r845b474],
5	NRB	NNP	ORGANIZATION	NRB	appos	2	SENT_145	[p10l868t402r1054b469],
6	,	,	O	,	_	0	SENT_145	[p10l868t402r1054b469],
7	Hammond	NNP	PERSON	Hammond	nn	8	SENT_145	[p10l1081t400r1434b457],
8	EH	NNP	O	EH	appos	2	SENT_145	[p10l1459t402r1590b469],
9	,	,	O	,	_	0	SENT_145	[p10l1459t402r1590b469],
10	et	FW	O	et	nn	11	SENT_145	[p10l1618t408r1678b457],
11	al.	FW	O	al.	appos	2	SENT_145	[p10l1705t400r1776b457],
12	.	.	O	.	_	0	SENT_145	[p10l1705t400r1776b457],

1	A	DT	O	a	det	3	SENT_146	[p10l1801t401r1863b456],
2	working	VBG	O	work	amod	3	SENT_146	[p10l1881t400r2148b474],
3	formulation	NN	O	formulation	_	0	SENT_146	[p10l136t493r528b551],
4	for	IN	O	for	_	0	SENT_146	[p10l561t494r656b551],
5	the	DT	O	the	det	6	SENT_146	[p10l689t494r791b551],
6	standardisation	NN	O	standardisation	prep_for	3	SENT_146	[p10l826t493r1331b551],
7	of	IN	O	of	_	0	SENT_146	[p10l1365t494r1434b551],
8	nomenclature	NN	O	nomenclature	prep_of	3	SENT_146	[p10l1463t493r1916b551],
9	in	IN	O	in	_	0	SENT_146	[p10l1951t494r2012b550],
10	the	DT	O	the	det	11	SENT_146	[p10l2045t493r2147b551],
11	diagnosis	NN	O	diagnosis	prep_in	3	SENT_146	[p10l138t590r438b664],
12	of	IN	O	of	_	0	SENT_146	[p10l465t590r534b647],
13	heart	NN	O	heart	nn	16	SENT_146	[p10l555t590r726b647],
14	and	CC	O	and	_	0	SENT_146	[p10l754t590r872b646],
15	lung	NN	O	lung	nn	16	SENT_146	[p10l898t590r1039b664],
16	rejection	NN	O	rejection	prep_of	11	SENT_146	[p10l1065t590r1371b664],
17	:	:	O	:	_	0	SENT_146	[p10l1065t590r1371b664],
18	Heart	NNP	O	Heart	nn	19	SENT_146	[p10l1401t591r1593b647],
19	Rejection	NNP	O	Rejection	dep	3	SENT_146	[p10l1620t590r1938b664],
20	Study	NNP	O	Study	nn	21	SENT_146	[p10l1965t590r2150b664],
21	Group	NNP	O	Group	dep	19	SENT_146	[p10l138t686r370b759],
22	.	.	O	.	_	0	SENT_146	[p10l138t686r370b759],

1	J	NNP	O	J	nn	4	SENT_147	[p10l401t687r432b742],
2	Heart	NNP	O	Heart	nn	4	SENT_147	[p10l461t687r653b742],
3	Lung	NN	O	lung	nn	4	SENT_147	[p10l682t687r852b759],
4	Transplant	NN	O	transplant	_	0	SENT_147	[p10l879t685r1238b759],
5	1990	CD	DATE	1990	dep	4	SENT_147	[p10l1271t685r1748b754],
6	;	:	O	;	_	0	SENT_147	[p10l1271t685r1748b754],
7	8:587	CD	NUMBER	8:587	number	8	SENT_147	[p10l1271t685r1748b754],
8	—	CD	NUMBER	—	dep	4	SENT_147	[p10l1271t685r1748b754],
9	93	CD	NUMBER	93	dep	8	SENT_147	[p10l1271t685r1748b754],
10	.	.	O	.	_	0	SENT_147	[p10l1271t685r1748b754],

1	Chapman	NNP	PERSON	Chapman	nn	2	SENT_148	[p10l138t780r456b855],
2	JR	NNP	O	JR	_	0	SENT_148	[p10l479t781r587b849],
3	,	,	O	,	_	0	SENT_148	[p10l479t781r587b849],
4	Harding	NNP	ORGANIZATION	Harding	nn	5	SENT_148	[p10l614t779r887b854],
5	NGL	NNP	ORGANIZATION	NGL	appos	2	SENT_148	[p10l910t780r1096b849],
6	,	,	O	,	_	0	SENT_148	[p10l910t780r1096b849],
7	Grifﬁths	NNP	O	Grifﬁths	nn	8	SENT_148	[p10l1125t779r1399b838],
8	D	NNP	O	D	appos	2	SENT_148	[p10l1424t781r1500b849],
9	,	,	O	,	_	0	SENT_148	[p10l1424t781r1500b849],
10	Morris	NNP	PERSON	Morris	nn	11	SENT_148	[p10l1528t780r1749b837],
11	PJ	NNP	PERSON	PJ	appos	2	SENT_148	[p10l1774t781r1867b838],
12	.	.	O	.	_	0	SENT_148	[p10l1774t781r1867b838],

1	Reversibility	NN	O	reversibility	_	0	SENT_149	[p10l1896t781r2146b837, p10l137t876r321b950],
2	of	IN	O	of	_	0	SENT_149	[p10l369t876r438b933],
3	cyclosporine	NN	O	cyclosporine	nn	4	SENT_149	[p10l483t876r890b950],
4	nephrotoxicity	NN	O	nephrotoxicity	prep_of	1	SENT_149	[p10l941t876r1415b950],
5	after	IN	O	after	_	0	SENT_149	[p10l1464t876r1617b933],
6	three	CD	DURATION	three	num	7	SENT_149	[p10l1666t876r1836b933],
7	months	NNS	NUMBER	month	tmod	8	SENT_149	[p10l1886t876r2146b933],
8	’	JJ	O	’	amod	9	SENT_149	[p10l1886t876r2146b933],
9	treatment	NN	O	treatment	prep_after	1	SENT_149	[p10l136t979r476b1028],
10	.	.	O	.	_	0	SENT_149	[p10l136t979r476b1028],

1	Lancet	NNP	O	Lancet	_	0	SENT_150	[p10l508t973r733b1028],
2	1985	CD	DATE	1985	num	1	SENT_150	[p10l766t971r1253b1041],
3	;	:	O	;	_	0	SENT_150	[p10l766t971r1253b1041],
4	1:128	CD	NUMBER	1:128	number	5	SENT_150	[p10l766t971r1253b1041],
5	—	CD	NUMBER	—	dep	1	SENT_150	[p10l766t971r1253b1041],
6	30	CD	NUMBER	30	dep	5	SENT_150	[p10l766t971r1253b1041],
7	.	.	O	.	_	0	SENT_150	[p10l766t971r1253b1041],

1	Laine	NNP	PERSON	Laine	nn	2	SENT_151	[p10l137t1067r322b1124],
2	J	NNP	PERSON	J	_	0	SENT_151	[p10l348t1068r397b1136],
3	,	,	O	,	_	0	SENT_151	[p10l348t1068r397b1136],
4	Holmberg	NNP	PERSON	Holmberg	nn	6	SENT_151	[p10l424t1066r759b1141],
5	C.	NNP	O	C.	nn	6	SENT_151	[p10l785t1067r852b1125],
6	Mechanism	NN	O	mechanism	appos	2	SENT_151	[p10l881t1066r1261b1124],
7	of	IN	O	of	_	0	SENT_151	[p10l1286t1067r1355b1124],
8	hyperuricemia	NN	O	hyperuricemia	prep_of	6	SENT_151	[p10l1375t1067r1849b1142],
9	in	IN	O	in	_	0	SENT_151	[p10l1874t1067r1935b1123],
10	cyclosporine-treated	JJ	O	cyclosporine-treated	amod	13	SENT_151	[p10l1960t1066r2146b1141, p10l138t1163r642b1237],
11	renal	JJ	O	renal	amod	13	SENT_151	[p10l676t1163r844b1220],
12	transplanted	VBN	O	transplant	amod	13	SENT_151	[p10l877t1163r1290b1237],
13	children	NNS	O	child	prep_in	8	SENT_151	[p10l1325t1163r1609b1220],
14	.	.	O	.	_	0	SENT_151	[p10l1325t1163r1609b1220],

1	Nephron	NNP	O	Nephron	_	0	SENT_152	[p10l1646t1163r1941b1237],
2	1996	CD	DATE	1996	num	1	SENT_152	[p10l1980t1164r2145b1231],
3	;	:	O	;	_	0	SENT_152	[p10l1980t1164r2145b1231],
4	74:318	CD	NUMBER	74:318	number	5	SENT_152	[p10l137t1259r490b1315],
5	—	CD	NUMBER	—	dep	1	SENT_152	[p10l137t1259r490b1315],
6	23	CD	NUMBER	23	dep	5	SENT_152	[p10l137t1259r490b1315],
7	.	.	O	.	_	0	SENT_152	[p10l137t1259r490b1315],

1	Clive	NNP	O	Clive	_	0	SENT_153	[p10l138t1354r303b1412],
2	DM	NN	O	dm	dep	1	SENT_153	[p10l345t1355r494b1411],
3	.	.	O	.	_	0	SENT_153	[p10l345t1355r494b1411],

1	Renal	JJ	O	renal	amod	3	SENT_154	[p10l540t1353r736b1411],
2	transplant	NN	O	transplant	nn	3	SENT_154	[p10l777t1353r1473b1429],
3	—	NN	O	—	nsubj	4	SENT_154	[p10l777t1353r1473b1429],
4	associated	VBN	O	associate	_	0	SENT_154	[p10l777t1353r1473b1429],
5	hyperuricemia	NN	O	hyperuricemia	dobj	4	SENT_154	[p10l1514t1353r1987b1429],
6	and	CC	O	and	_	0	SENT_154	[p10l2030t1354r2148b1411],
7	gout	NN	O	gout	conj_and	5	SENT_154	[p10l136t1458r298b1524],
8	.	.	O	.	_	0	SENT_154	[p10l136t1458r298b1524],

1	J	NNP	O	J	nn	4	SENT_155	[p10l329t1451r361b1507],
2	Am	NNP	O	Am	nn	4	SENT_155	[p10l387t1451r510b1506],
3	Soc	NNP	O	Soc	nn	4	SENT_155	[p10l540t1450r655b1507],
4	Nephrol	NNP	O	Nephrol	_	0	SENT_155	[p10l682t1450r955b1524],
5	2000	CD	DATE	2000	num	4	SENT_155	[p10l985t1451r1475b1518],
6	;	:	O	;	_	0	SENT_155	[p10l985t1451r1475b1518],
7	11:974	CD	NUMBER	11:974	number	8	SENT_155	[p10l985t1451r1475b1518],
8	—	CD	NUMBER	—	dep	4	SENT_155	[p10l985t1451r1475b1518],
9	9	CD	NUMBER	9	dep	8	SENT_155	[p10l985t1451r1475b1518],
10	.	.	O	.	_	0	SENT_155	[p10l985t1451r1475b1518],

1	Kunel	NNP	O	Kunel	nn	2	SENT_156	[p10l137t1545r335b1602],
2	RW	NNP	O	RW	_	0	SENT_156	[p10l373t1547r522b1614],
3	,	,	O	,	_	0	SENT_156	[p10l373t1547r522b1614],
4	Duncan	NNP	PERSON	Duncan	nn	5	SENT_156	[p10l562t1547r821b1602],
5	G	NNP	PERSON	G	appos	2	SENT_156	[p10l860t1546r935b1614],
6	,	,	O	,	_	0	SENT_156	[p10l860t1546r935b1614],
7	Watson	NNP	PERSON	Watson	nn	8	SENT_156	[p10l974t1547r1226b1602],
8	D	NNP	O	D	appos	2	SENT_156	[p10l1263t1547r1340b1614],
9	,	,	O	,	_	0	SENT_156	[p10l1263t1547r1340b1614],
10	Alderson	NNP	PERSON	Alderson	nn	11	SENT_156	[p10l1377t1545r1681b1602],
11	K	NNP	PERSON	K	conj_and	5	SENT_156	[p10l1719t1547r1790b1614],
12	,	,	O	,	_	0	SENT_156	[p10l1719t1547r1790b1614],
13	Rogawski	NNP	PERSON	Rogawski	nn	14	SENT_156	[p10l1831t1545r2148b1619],
14	MA	NNP	PERSON	MA	conj_and	5	SENT_156	[p10l137t1641r284b1709],
15	,	,	O	,	_	0	SENT_156	[p10l137t1641r284b1709],
16	Peper	NNP	PERSON	Peper	nn	19	SENT_156	[p10l309t1641r502b1715],
17	M.	NNP	O	M.	nn	19	SENT_156	[p10l526t1641r612b1697],
18	Colchicine	NNP	O	Colchicine	nn	19	SENT_156	[p10l640t1639r986b1698],
19	myopathy	NN	O	myopathy	appos	2	SENT_156	[p10l1011t1640r1333b1715],
20	and	CC	O	and	_	0	SENT_156	[p10l1356t1639r1475b1697],
21	neuropathy	NN	O	neuropathy	appos	2	SENT_156	[p10l1498t1639r1889b1715],
22	.	.	O	.	_	0	SENT_156	[p10l1498t1639r1889b1715],

1	N	NN	O	n	nn	3	SENT_157	[p10l1915t1641r1973b1696],
2	Engl	NNP	O	Engl	nn	3	SENT_157	[p10l1995t1640r2148b1714],
3	J	NNP	O	J	nsubj	4	SENT_157	[p10l136t1737r168b1793],
4	Med	VBD	O	med	_	0	SENT_157	[p10l197t1736r348b1793],
5	1987	CD	DATE	1987	dobj	4	SENT_157	[p10l381t1736r945b1805],
6	;	:	O	;	_	0	SENT_157	[p10l381t1736r945b1805],
7	316:1562	CD	NUMBER	316:1562	number	8	SENT_157	[p10l381t1736r945b1805],
8	—	CD	NUMBER	—	dep	5	SENT_157	[p10l381t1736r945b1805],
9	8	CD	NUMBER	8	dep	8	SENT_157	[p10l381t1736r945b1805],
10	.	.	O	.	_	0	SENT_157	[p10l381t1736r945b1805],

1	Zurker	NNP	O	Zurker	nn	2	SENT_158	[p10l137t1832r370b1889],
2	RM	NN	O	rm	_	0	SENT_158	[p10l395t1834r541b1901],
3	,	,	O	,	_	0	SENT_158	[p10l395t1834r541b1901],
4	Bock	NNP	PERSON	Bock	nn	5	SENT_158	[p10l568t1832r737b1889],
5	HA	NNP	O	HA	appos	2	SENT_158	[p10l760t1833r897b1901],
6	,	,	O	,	_	0	SENT_158	[p10l760t1833r897b1901],
7	Thiel	NNP	O	Thiel	nn	11	SENT_158	[p10l924t1832r1095b1889],
8	G.	NNP	O	G.	nn	11	SENT_158	[p10l1122t1833r1196b1889],
9	Excellent	NNP	O	Excellent	nn	11	SENT_158	[p10l1224t1832r1530b1889],
10	uricosuric	JJ	O	uricosuric	amod	11	SENT_158	[p10l1554t1832r1879b1889],
11	efﬁcacy	NN	O	efﬁcacy	appos	2	SENT_158	[p10l1904t1832r2150b1906],
12	of	IN	O	of	_	0	SENT_158	[p10l137t1927r206b1984],
13	benzbromarone	NN	O	benzbromarone	prep_of	11	SENT_158	[p10l225t1927r746b1984],
14	in	IN	O	in	_	0	SENT_158	[p10l773t1927r834b1983],
15	Cyclosporin-A-treated	JJ	O	cyclosporin-a-treated	amod	18	SENT_158	[p10l861t1926r1599b2002],
16	renal	JJ	O	renal	amod	18	SENT_158	[p10l1624t1926r1791b1984],
17	transplant	NN	O	transplant	nn	18	SENT_158	[p10l1817t1926r2148b2002],
18	patients	NNS	O	patient	prep_in	2	SENT_158	[p10l136t2023r413b2097],
19	:	:	O	:	_	0	SENT_158	[p10l136t2023r413b2097],
20	a	DT	O	a	det	22	SENT_158	[p10l446t2041r480b2079],
21	prospective	JJ	O	prospective	amod	22	SENT_158	[p10l505t2023r880b2097],
22	study	NN	O	study	dep	2	SENT_158	[p10l909t2023r1096b2097],
23	.	.	O	.	_	0	SENT_158	[p10l909t2023r1096b2097],

1	Nephrol	NNP	MISC	Nephrol	nn	3	SENT_159	[p10l1125t2023r1398b2097],
2	Dial	NNP	MISC	Dial	nn	3	SENT_159	[p10l1425t2023r1565b2079],
3	Transplant	NNP	O	Transplant	_	0	SENT_159	[p10l1591t2023r1949b2097],
4	1994	CD	DATE	1994	num	3	SENT_159	[p10l1980t2024r2145b2091],
5	;	:	O	;	_	0	SENT_159	[p10l1980t2024r2145b2091],
6	9:548	CD	NUMBER	9:548	number	7	SENT_159	[p10l138t2118r451b2175],
7	—	CD	NUMBER	—	dep	3	SENT_159	[p10l138t2118r451b2175],
8	51	CD	NUMBER	51	dep	7	SENT_159	[p10l138t2118r451b2175],
9	.	.	O	.	_	0	SENT_159	[p10l138t2118r451b2175],

1	Jacobs	NNP	PERSON	Jacobs	nn	2	SENT_160	[p10l136t2213r352b2270],
2	F	NN	O	f	_	0	SENT_160	[p10l388t2214r450b2282],
3	,	,	O	,	_	0	SENT_160	[p10l388t2214r450b2282],
4	Mamzer-Bruneel	NNP	O	Mamzer-Bruneel	nn	5	SENT_160	[p10l488t2212r1051b2270],
5	MF	NN	O	mf	appos	2	SENT_160	[p10l1087t2214r1221b2282],
6	,	,	O	,	_	0	SENT_160	[p10l1087t2214r1221b2282],
7	Skhiri	NNP	O	Skhiri	nn	8	SENT_160	[p10l1260t2213r1453b2270],
8	H	NNP	O	H	appos	2	SENT_160	[p10l1488t2214r1565b2281],
9	,	,	O	,	_	0	SENT_160	[p10l1488t2214r1565b2281],
10	Thervet	NNP	O	Thervet	nn	11	SENT_160	[p10l1602t2212r1860b2270],
11	E	NNP	O	E	appos	2	SENT_160	[p10l1895t2214r1963b2282],
12	,	,	O	,	_	0	SENT_160	[p10l1895t2214r1963b2282],
13	Legendre	NNP	PERSON	Legendre	nn	14	SENT_160	[p10l2000t2214r2146b2286, p10l138t2309r323b2366],
14	C	NNP	O	C	appos	2	SENT_160	[p10l373t2309r440b2377],
15	,	,	O	,	_	0	SENT_160	[p10l373t2309r440b2377],
16	Kreis	NNP	PERSON	Kreis	nn	18	SENT_160	[p10l488t2309r660b2366],
17	H.	NNP	O	H.	nn	18	SENT_160	[p10l708t2310r784b2366],
18	Safety	NNP	O	Safety	appos	2	SENT_160	[p10l835t2309r1036b2383],
19	of	IN	O	of	_	0	SENT_160	[p10l1082t2309r1150b2366],
20	the	DT	O	the	det	23	SENT_160	[p10l1191t2309r1293b2366],
21	mycophenolate	JJ	O	mycophenolate	amod	23	SENT_160	[p10l1340t2309r1842b2383],
22	mofetilallopurinol	NN	O	mofetilallopurinol	nn	23	SENT_160	[p10l1888t2309r2146b2366, p10l138t2404r498b2478],
23	combination	NN	O	combination	prep_of	18	SENT_160	[p10l527t2404r938b2461],
24	in	IN	O	in	_	0	SENT_160	[p10l967t2404r1027b2460],
25	kidney	NN	O	kidney	nn	27	SENT_160	[p10l1055t2404r1274b2478],
26	transplant	NN	O	transplant	nn	27	SENT_160	[p10l1301t2404r1633b2478],
27	recipients	NNS	O	recipient	prep_in	23	SENT_160	[p10l1661t2404r1980b2478],
28	with	IN	O	with	_	0	SENT_160	[p10l2006t2404r2148b2461],
29	gout	NN	O	gout	prep_with	27	SENT_160	[p10l136t2507r298b2573],
30	.	.	O	.	_	0	SENT_160	[p10l136t2507r298b2573],

1	Transplantation	NN	O	transplantation	_	0	SENT_161	[p10l329t2498r856b2574],
2	1997	CD	DATE	1997	num	1	SENT_161	[p10l889t2499r1414b2568],
3	;	:	O	;	_	0	SENT_161	[p10l889t2499r1414b2568],
4	64:1087	CD	NUMBER	64:1087	number	5	SENT_161	[p10l889t2499r1414b2568],
5	—	CD	NUMBER	—	dep	1	SENT_161	[p10l889t2499r1414b2568],
6	8	CD	NUMBER	8	dep	5	SENT_161	[p10l889t2499r1414b2568],
7	.	.	O	.	_	0	SENT_161	[p10l889t2499r1414b2568],

1	Pichard	NNP	PERSON	Pichard	nn	2	SENT_162	[p10l137t2595r388b2652],
2	L	NNP	PERSON	L	_	0	SENT_162	[p10l433t2596r497b2663],
3	,	,	O	,	_	0	SENT_162	[p10l433t2596r497b2663],
4	Fabre	NNP	PERSON	Fabre	nn	5	SENT_162	[p10l545t2595r736b2652],
5	I	NNP	O	I	appos	2	SENT_162	[p10l783t2596r825b2663],
6	,	,	O	,	_	0	SENT_162	[p10l783t2596r825b2663],
7	Fabre	NNP	PERSON	Fabre	nn	8	SENT_162	[p10l873t2595r1064b2652],
8	G	NNP	O	G	appos	2	SENT_162	[p10l1112t2595r1187b2663],
9	,	,	O	,	_	0	SENT_162	[p10l1112t2595r1187b2663],
10	et	FW	O	et	nn	11	SENT_162	[p10l1235t2603r1295b2652],
11	al.	FW	O	al.	appos	2	SENT_162	[p10l1342t2595r1413b2652],
12	.	.	O	.	_	0	SENT_162	[p10l1342t2595r1413b2652],

1	Cyclosporin	NN	MISC	cyclosporin	nn	2	SENT_163	[p10l1463t2595r1852b2669],
2	A	NN	O	a	_	0	SENT_163	[p10l1895t2596r1956b2651],
3	drug	NN	O	drug	nn	4	SENT_163	[p10l2000t2595r2148b2669],
4	interactions	NNS	O	interaction	dep	2	SENT_163	[p10l137t2690r539b2747],
5	.	.	O	.	_	0	SENT_163	[p10l137t2690r539b2747],

1	Screening	VBG	O	screen	_	0	SENT_164	[p10l580t2690r903b2764],
2	for	IN	O	for	_	0	SENT_164	[p10l939t2690r1034b2747],
3	inducers	NNS	O	inducer	prep_for	1	SENT_164	[p10l1070t2690r1346b2747],
4	and	CC	O	and	_	0	SENT_164	[p10l1385t2690r1503b2747],
5	inhibitors	NNS	O	inhibitor	prep_for	1	SENT_164	[p10l1539t2690r1852b2747],
6	of	IN	O	of	_	0	SENT_164	[p10l1889t2690r1958b2747],
7	cytochrome	NN	O	cytochrome	nn	8	SENT_164	[p10l1990t2698r2146b2764, p10l137t2785r383b2842],
8	P-450	NN	O	p-450	prep_of	3	SENT_164	[p10l408t2785r592b2842],
9	(	CD	NUMBER	(	num	8	SENT_164	[p10l619t2783r1037b2860],
10	Cyclosporin	NN	MISC	cyclosporin	nn	13	SENT_164	[p10l619t2783r1037b2860],
11	A	NN	O	a	nn	13	SENT_164	[p10l1058t2786r1119b2841],
12	oxidase	NN	O	oxidase	nn	13	SENT_164	[p10l1141t2783r1410b2861],
13	)	NN	O	)	dobj	1	SENT_164	[p10l1141t2783r1410b2861],
14	in	IN	O	in	_	0	SENT_164	[p10l1437t2785r1497b2841],
15	primary	JJ	O	primary	amod	16	SENT_164	[p10l1520t2785r1779b2860],
16	cultures	NNS	O	culture	prep_in	13	SENT_164	[p10l1801t2784r2059b2842],
17	of	IN	O	of	_	0	SENT_164	[p10l2084t2785r2153b2842],
18	human	JJ	O	human	amod	19	SENT_164	[p10l136t2881r363b2938],
19	hepatocytes	NNS	O	hepatocyte	prep_of	16	SENT_164	[p10l403t2881r790b2955],
20	and	CC	O	and	_	0	SENT_164	[p10l832t2881r951b2937],
21	in	IN	O	in	_	0	SENT_164	[p10l991t2881r1052b2937],
22	liver	NN	O	liver	nn	23	SENT_164	[p10l1092t2881r1235b2938],
23	microsomes	NNS	O	microsome	prep_in	13	SENT_164	[p10l1274t2881r1682b2938],
24	.	.	O	.	_	0	SENT_164	[p10l1274t2881r1682b2938],

1	Drug	NN	O	drug	nn	3	SENT_165	[p10l1725t2882r1895b2955],
2	Metab	NNP	O	Metab	nn	3	SENT_165	[p10l1936t2881r2146b2938],
3	Dispos	NNP	O	Dispos	_	0	SENT_165	[p10l137t2976r361b3050],
4	1990	CD	DATE	1990	num	3	SENT_165	[p10l395t2976r958b3045],
5	;	:	O	;	_	0	SENT_165	[p10l395t2976r958b3045],
6	18:595	CD	NUMBER	18:595	number	7	SENT_165	[p10l395t2976r958b3045],
7	-606	CD	NUMBER	-606	dep	3	SENT_165	[p10l395t2976r958b3045],
8	.	.	O	.	_	0	SENT_165	[p10l395t2976r958b3045],

